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Abstract 
 
Introduction: Establishing best practice for knee replacement is important given the large 
number of procedures performed. Research into knee replacement is problematic given 
that implant failure is a rare event. The logistical and financial costs associated with 
prospective clinical trials are therefore high. Research using national arthroplasty registers 
may overcome some of these difficulties. 
Aim: To assess whether research performed on data recorded by the National Joint Registry 
for England and Wales has the ability to answer clinically relevant research questions 
relating to knee replacement surgery. To determine if registry research is able to answer 
specific clinical questions that are unsuited to prospective randomised clinical trial designs. 
Methods: Analyses was performed using combined data from the National Joint Registry for 
England and Wales (NJR) and the Department of Health Patient Reported Outcome 
Measures (PROMs) project. 
Results: Nine specific analyses investigated the ability of registry data to ask pertinent 
clinical questions relating to three areas of practice: unicondylar knee replacement (UKR), 
total knee replacement (TKR), revision knee replacement (RTKR).  
Discussion: Registry analyses are well suited to the analysis of rare outcomes such as 
implant revision and death. In comparison to prospective clinical trial designs they are 
cheaper, consume less time and resources and have the ability to identify associations and 
additional factors that may potentially influence outcome. As they use current national data 
they are more representative of “real-time” national practice and as such overcome some of 
the problems of generalisability associated with more rigidly designed clinical trials. 
However, as no information is collected about clinical decision making, drawing strong 
causal inferences from this type of data is problematic.  
Conclusion: Using registry data it is possible to answer a range of clinically important 
research questions. However, due to their limitations, it is necessary to combine 
information from these observational databases with clinical trial data before robust 
recommendations that influence clinical practice can be made.  The key question 
researchers have to answer now is how registry data and clinical trial data can be effectively 
integrated. 
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Chapter 1: Introduction 
1.1 Knee replacement surgery in 2013 
1.1.1 The rising incidence of knee replacements 
Over the last 50 years knee replacement has become the ‘gold standard’ for the treatment 
of end stage osteoarthritis of the knee. It is an effective way of relieving pain, restoring 
physical function and improving health related quality of life in this group of patients 
(Drewett 1992, Rissanen 1995, Jones 2000, Bachmeier 2001, Fitzgerald 2004). Changing 
social demographics and an increasingly aged population are causing a steady rise in the 
number of patients in need of knee replacement (Kurtz 2007, Lawrence 2008). As a result 
there has been a year on year increase in the number of knee replacements being 
performed in England and Wales over the last twenty years (Culliford 2010, NJR-AR 2012). 
This trend is mirrored in other developed countries including the United States (Kurtz 2007, 
Culliford 2010); Sweden, Denmark and Norway (Robertsson 2010); and South Korea (Kim 
2008).  
 
At the turn of the millennium it was estimated that approximately 20 million Americans had 
symptomatic osteoarthritis (Lawrence 1998) with more than 10 million suffering from 
osteoarthritis of the knee (Parmet 2003). The Framlington Osteoarthritis study (1983-1985) 
estimated the prevalence of radiographic knee osteoarthritis in patients aged 63-93 was 
approximately 33% (Lawrence 1998). Currently over 650,000 total knee replacements are 
performed annually in the United States (Carr 2012) and over 80,000 in England and Wales 
(NJR-AR 2012). These figures are expected to increase further over the next 20 years, 
representing an increasing public health problem, as the population of the world ages and 
medical interventions continue to increase average life expectancy (Birrel 1999, Ehrlich 
2003, Kurtz 2007).  
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1.1.2 Knee joint failure: Why are knee replacements required?  
In England and Wales, as in other developing countries, the commonest indication for 
primary knee replacement is end stage osteoarthritis (NJR-AR 2012). Osteoarthritis was the 
indication for surgery in approximately 95% of all knee replacements performed in England 
and Wales in 2011 (NJR-AR 2012). While the rates of knee replacement performed for 
osteoarthritis have increased over the last 10 years the number of knee replacements 
performed for rheumatoid and other inflammatory arthropathies has steadily declined. This 
is most likely due to the increasing use and efficacy of a range of biologically active disease 
modifying anti-inflammatory drugs (DMARDS) to treat these conditions (Louie 2010). 
 
Osteoarthritis is a degenerative process that primarily affects articular cartilage and the 
underlying subchondral bone. It is the result of a combination of genetic, metabolic, 
biochemical and biomechanical factors with secondary components of inflammation 
(Iannone 2003). Its characteristic features include cartilage loss, peri-articular bone 
response with subchondral sclerosis and cysts, and the formation of osteophytes (Figure 
1.1). Cartilage degradation in combination with a disordered repair process cause 
progressive joint damage. In the majority of patients, the initiating mechanism is damage to 
normal articular cartilage by physical forces, following either a single event of macrotrauma 
or repeated microtrauma (Mow 1992).  
 
Knee osteoarthritis is the most prevalent form of osteoarthritis, one of the most common 
diseases affecting humans and a common cause of disability (Symmons 2002). A number of 
constitutional and mechanical factors influence the development of knee osteoarthritis 
(Carr 2012) the most important of which are age, obesity, previous trauma and gender 
(Oliveria 1995, Symmons 2002, Fehring 2007). These factors are important as they influence 
bone morphology, bone density, hormone levels, mechanical loads and the propensity to 
trauma all of which are implicated in the development of arthritis (Carr 2012). The incidence 
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of knee osteoarthritis is higher in woman compared to men and this difference is most 
marked with increasing age (Dequeker 1998, Oliveria 1995). Osteoarthritis and its treatment 
has significant cost and time implications for the NHS, accounting for up to 25% of visits to 
primary care providers, and half of all NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) 
prescriptions (Green 2001). 
 
 
Figure 1.1: Radiographic representation of a knee with end-stage osteoarthritis. 
 
1.1.3 When is surgery for knee arthritis indicated? 
In 2007 the National Institute for Clinical Excellence (NICE) published guidance on the care 
and management of knee osteoarthritis as part of wider recommendations for the 
treatment of osteoarthritis in adults (NICE (CG59) 2007). This included specific guidance on 
the role of knee replacement surgery:  
 Clinicians with responsibility for referring a person with knee osteoarthritis for 
consideration of surgery should ensure that the person has been offered at least the 
core (non-surgical) treatment options.  
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 Referral for knee replacement surgery should be considered for people with 
osteoarthritis who experience knee symptoms (pain, stiffness and reduced function) 
that have a substantial impact on their quality of life and are refractory to non-surgical 
treatment. Referral should be made before there is prolonged and established 
functional limitation and severe pain. 
 Patient-specific factors (including age, gender, smoking, obesity and comorbidities) 
should not be barriers to referral for knee replacement surgery. 
 
The role of knee replacement in rheumatoid/inflammatory arthritis is similar. The American 
College of Rheumatology currently recommend that ‘In patients who have unacceptable 
levels of pain, loss of range of motion, or limitation of function because of structural joint 
damage, surgical procedures should be considered.’ (American College of Rheumatology 
2002). The consistent message from these guidelines is that knee replacement should be 
reserved for disease which has failed conservative treatment and which has a significant 
impact on the patient function, well-being and quality of life. In these patients with ‘end-
stage’ disease knee replacement is currently the treatment of choice.  In this group of 
patients it is an effective way of reducing pain, restoring functional capacity, and improving 
quality of life (Drewett 1992, Rissanen 1995, Fitzgerald 2004). These improvements occur 
irrespective of patient age (March 1999). It has been shown that approximately 32% of 
patients undergoing knee replacement return to a “normal” quality of life (a Quality of Life 
index of 1.00) following surgery (Norman-Taylor 1996).  
 
1.1.4 Which surgical options are available for the treatment of knee osteoarthritis? 
Surgeons have a number of different surgical options available for the treatment of patients 
with ‘end stage’ symptomatic knee osteoarthritis. Operative interventions can be broadly 
divided into those that preserve the knee joint (osteotomy and arthroscopic procedures) 
and those that replace the joint (arthroplasty/replacement procedures).  The role of joint 
preserving procedures such as osteotomy and arthroscopy is limited in established 
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osteoarthritic disease. Osteotomy involves dividing the bone of the proximal tibia and 
realigning the weight bearing axis of the lower limb (Figure 1.2). This helps to ‘off load’ the 
affected portion of the joint and redistributes the applied loads through the preserved 
portion of the knee. While results suggest physical functioning after osteotomy is marginally 
better than the function observed after replacement procedures the higher rates of 
complication and inferior survivorship have meant this procedure is largely reserved for 
patients with significant mechanical malalignment due to peri-articular deformity 
(Stukenborg-Colsman 2001, Brouwer 2007).  
 
   
Figure 1.2: Intra-operative sequence demonstrating a high tibial osteotomy to re-align the 
mechanical axis of the knee joint. 
 
Recent NICE guidelines on the role of knee arthroscopy state that arthroscopic knee 
washout alone should not be used as a treatment for osteoarthritis because it does not 
demonstrate clinically useful benefit in the short or long term (NICE (IPG 230) 2007). NICE 
recommends its use is limited to the small number of patients who have knee osteoarthritis 
and a clear history of mechanical locking, not including those knees with isolated gelling, 
‘giving way’ or loose bodies (NICE (IPG 230) 2007).  
 
The majority of patients who require surgery having exhausted non-operative measures will 
therefore undergo knee joint replacement. Once the decision is made to replace the knee 
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the surgeon has to determine whether the patient should undergo partial (replacement of 
only one section of the knee using a unicondylar (UKR) or patello-femoral (PFR) 
replacement) or total (replacement of the whole tibio-femoral joint with or without patella 
resurfacing) knee replacement (TKR) and which brand of replacement should be used 
(Figure 1.3).  
 
 
Figure 1.3: Radiographs of a Unicondylar (left) and Total (right) knee replacement. 
 
The indications for both partial and total knee replacement are similar. However, while total 
knee replacement replaces the whole joint partial knee replacement only replaces the 
affected compartments of the knee leaving the rest of the knee intact. Perceived 
advantages of partial replacements are that they are a less invasive procedure; produce 
better functional outcomes and are associated with easier revision when they eventually 
fail. While there is some supportive data from single surgeons/centres with surgical 
enthusiasm for this approach (Laurecin 1991, Newman 2009, Pandit 2011) the benefits of 
partial replacement at a national level remain to be proven in large scale clinical trials. In 
addition partial replacement is consistently associated with a significantly higher rate of 
failure when compared to total knee replacement (AJR-AR 2009, Labek 2011, NJR-AR 2012). 
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Encouraging reports from a number of small series have seen an increase in the use of 
partial replacement despite on-going concerns about the higher rates of failure. Currently 
there is no clear consensus within the orthopaedic community about when a unicondylar or 
total knee replacement should be used. Surgical practice varies dependent upon the 
distribution of osteoarthritis, the severity of pre-operative symptoms (Lutzner 2009), 
patient age (Mancuso 1996), obesity (Cobos 2010) and the surgeon’s own preference.   
 
For the majority of surgeons total knee replacement remains the ‘gold standard’ procedure 
for surgically treating knee osteoarthritis. Greater than 90% of all knee replacements 
performed in England and Wales in 2011 were total knee replacements (72,126 of 79,516) 
(NJR-AR 2012). In contrast only 9% of knee replacements were partial knee replacements 
(7,390 of 79,516 (1,113 Patello-femoral, 6,257 unicondylar)).  These proportions have been 
consistent over the last 7 years (NJR-AR 2012) (Figure 1.4).     
 
 
Figure 1.4: Types of knee replacements performed in England and Wales 2005 to 2011 
(Taken from NJR 9th Annual Report 2012). 
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1.2 National arthroplasty registers 
1.2.1 The evolution of knee arthroplasty registers 
The first national knee arthroplasty register commenced in Sweden in 1975 (Lidgren 2009). 
Its primary aim was to give early warning of inferior implant designs and present the 
average results for knee replacement based on the experience of a whole nation 
(Robertsson 2007). Data from this registry have been used to quantify implant failure rates 
for several decades in the Swedish population (Knutson 1986, Lidgren 2009). Following the 
success of this initial register many countries developed national registries with the aim of 
reducing implant revision rates, thereby reducing morbidity, mortality and costs associated 
with further surgical intervention (Havelin 1994, Graves 2004). Worldwide there are now 
more than 20 registers either actively collecting data or being piloted (Bohler 2009) and, 
because of their success, there has recently been a combined call for an increase in the 
number of registries from the presidents of a number of national orthopaedic associations 
(Pellegrini 2009). 
 
On the surface registries are primarily health technology audits of the procedures that have 
been performed in a given country (Robertsson 2007). They prospectively follow-up all 
patients with no limits on who is included and what implants are used. By nationally 
monitoring patients who undergo knee replacement they are able to assess the relative 
success of different approaches to surgery, different implants and also the results of 
individual surgeons and centres. They reflect the experience of a whole nation rather than 
the specific results of an individual surgeon or centre. As such they better represent the 
results that can be expected following knee replacement procedures when compared to 
information derived from case series, isolated cohort studies or prescriptive randomised 
trials (Robertsson 2007). 
 
Bohler identifies three key aims that are fundamental to any successful registry. Firstly 
registers must record all primary and revision operations in a defined area in a central 
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database. Secondly they should follow each primary implant until it has to be revised, the 
patient dies or emigrates. Thirdly, they need to use a consistent endpoint, usually revision, 
which should be defined in a standardised manner (Bohler 2009). The standardised 
definition of revision removes ambiguity for the clinicians coding and gathering the data and 
helps to ensure data accuracy in relation to the registries primary outcome measure. For 
most registries this definition is the removal or exchange of at least one part of the original 
knee implant (Bohler 2009). 
 
A number of key elements have also been suggested as necessary for the successful 
development of a national registry (Bohler 2009). These include: 
 Integration of the registry within a national health care system.  
 A professional, central structure for data collection and storage. 
 Understanding of national issues regarding data protection of personal data. 
 Involvement of specialist experts for the interpretation and statistical analysis of 
data. 
 The close involvement and support of professional orthopaedic associations within 
the host country. 
 
1.2.2 The role of knee arthroplasty registers 
There are a number of benefits to knee replacement registers. They report national trends 
in patient demographics, implant usage and surgical methods which can help with 
healthcare monitoring, purchasing and future provision planning. They allow for the early 
identification of implants, surgeons and centres associated with higher than expected levels 
of failure. Similarly newly introduced implants and surgical techniques can be rapidly and 
accurately evaluated. Monitoring performance may also be a deterrent for the use of 
implants and methods that have not been formally evaluated. Publication of results acts as a 
national benchmark for performance against which comparison can be made. It also 
provides information on the best surgical techniques and expected outcomes and helps 
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guide implant selection. National recording of operations also permits for easy identification 
and recall of implants in the case of product recall or the failure of a specific implant. This 
information not only benefits patients but also help to limit health care costs by reducing 
the burden of revision surgery.  
 
National sampling is not without its difficulties. In addition to the obvious logistical issues 
there are on-going questions surrounding the completeness of data within registries, 
compliance with data collection and the quality of data recorded. In large multicentre 
registers there is an inverse relationship between the amount of data collected and the 
quality of data delivered (Robertsson 2007). There is therefore a balance to be struck 
between ambitious data collection and the completeness and accuracy of the data on which 
registers rely. Most registers therefore currently collect a limited dataset to try and ensure 
the completeness of the data collected (Robertsson 2000). There is currently a drive to 
standardise this ‘minimal’ dataset to allow better comparison and collaboration between 
worldwide registries (Robertsson 2007). 
 
Another issue is how registries measure outcome. The strengths of national sampling and 
broad inclusions produce problems due to the variations in surgical routines and follow-up 
employed in the different centres submitting data. This method of data collection is 
different to those employed in large scale clinical trials which utilise strict inclusion criteria 
and standardised follow-up (Robertsson 2007). A lack of standardised follow-up mean 
registers are limited in the type of outcome they can assess. Radiological and functional 
outcomes assessed at differing time points are not comparable and therefore not suitable as 
a method of outcome. There is, however, one outcome pertinent to knee replacement that 
provides a definite measurable outcome; revision surgery. Revision brings the patient back 
into the healthcare system and provides an event that is recordable and linkable to previous 
surgical episodes. 
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This measure is, however, not without its limitations. Revision is crude measure of outcome. 
It does not account for knee replacements that would be deemed as failures due to poor 
function and on-going pain that do not undergo further surgery (Murray 1993, Wylde 2011). 
In addition certain patients may not be fit to undergo revision or may not consent to surgery 
even in the face of a failing implant. These patients will be overlooked using this method of 
assessment.  Furthermore patients revised outside their original healthcare system may not 
be recognised leading to an underestimation of the rates of revision. 
 
Registries fulfil different roles within the healthcare systems in which they have been 
developed and this is reflected in the way they present and publish their data. Some simply 
measure implant, centre and surgeon performance using revision as their sole outcome 
measure (England and Wales (NJR-AR 2012), Australia (AJR-AR 2012). Their annual reports 
are dominated by comparisons of the rates of revision and mortality for different implants 
and approaches to surgery. The Scandinavian registries (Sweden, Norway, Denmark (NARA 
2012)) have progressed this idea further publishing rates of revision and mortality for 
individual regions and centres and making this information available to the public. This 
approach is also seen in the Scottish registry where revision rates in addition to information 
on patient mortality, morbidity and post-operative complications are reported at a centre 
level (SAP-AR 2011). This kind of reporting aims to improve quality by making results for 
each centre publically available. More recently both the Danish arthroplasty register and the 
Swedish hip and knee arthroplasty register have started to record and report patient 
reported functional outcomes and satisfaction data as part of their routine collection. The 
Danish registry has perhaps been the most progressive in this respect as it routinely reports 
on six quality indicators which are published at a centre level (Danish arthroplasty register 
AR 2011). These indicators include: 
1) Rate of intraoperative complications – complication rate should be <10%. 
2) Rate of Follow-up (important as it allows follow-up PROMs collection) – follow-up 
rate should be >90%. 
3) Levels of satisfaction (Collected at 6-18 months post-operatively) – >90% patients 
should be very satisfied or satisfied. 
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4) Improvement in knee function (Using the Knee Society Score (KSS) collected at 6-18 
months) – >90% patients should improve by ≥25 points. 
5) Implant survival (adjusted for age and sex) – Reference provided for each centre 
against the population mean. 
6) Mortality – Low mortality is deemed to represent high quality but no reference point 
given. 
This level of reporting provides a benchmark against which all centres can be compared and 
allows transparency of reporting by putting this information in the public domain.   
 
A summary of the current key worldwide national registers is given in table 1.1. This 
demonstrates the variation in outcome reporting for the 10 registries for which results were 
publically available in the English language. It also reveals the disparity in data collection 
which covers only 42% of knee replacement procedures in Canada but can approach 100% 
for other registries (Australia, England and Wales, New Zealand, Scotland). For a further 12 
registers data was not accessible at the present time.  
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Table 1.1: Summary of the current key national knee registers. Where available, data is presented on the currently reported outcomes for each 
registry., 
Key: N/A = Not available, ¥ = Outcome reported for individual centres, # = Outcome reported for individual regions, KOOS = Knee injury and 
Osteoarthritis Outcome Score, EQ5D = Euroqol 5D score, VAS = Visual Analogue Scale. 
 
Registry 
(Annual Report  
(AR) reviewed) 
Originated Number of 
knee 
records 
(up to Year) 
Coverage / 
Compliance with 
data collection 
5 year 
survival 
reported 
10 year 
survival 
reported 
PROMs 
reported 
Satisfaction 
reported 
Complications 
(Intraoperative or 
Postoperative) 
reported 
Mortality 
reported 
Survival 
stratified by 
reason for 
revision 
reported 
Revision outcomes 
(Survival/PROMs) 
reported 
Australia 
(AR 2011) 
1999 333,764 
(2010) 
“Almost complete 
dataset” 
Yes  Yes  No No No No Yes Yes  
(re-revision rates) 
Canada 
(AR 2010) 
2001 124,783 
(2010) 
42% (2010) No No No No No No No No 
Denmark 
(AR 2010) 
1997 60,049 
(2010) 
92% (2009) Yes ¥ Yes ¥ Yes ¥ 
(KSS) 
Yes ¥ Intraoperative - Yes ¥ 
Postoperative -  Yes ¥ 
Yes ¥ No No 
England and Wales 
(AR 2011) 
2003 >500,000 
(2010) 
Approximately  
100% (2009-11) 
Yes  No No No Intraoperative - Yes 
Postoperative - No 
Yes No No 
Portugal 
(AR 2010) 
2009 4,401 
(2010) 
59% (2010) No No No No No No No No 
New Zealand 
(AR 2010) 
1999 62,408 
(2010) 
98% (2009) Yes  Yes  Yes No No No Yes Yes  
(Re-revision rates) 
Norway 
(AR 2010) 
1987 
(1994 (for Knees) 
41,542 
(2009) 
>95% (2009) Yes Yes No No No No No No 
Scotland 
(AR 2010) 
2001 54,717 
(2009) 
99% (2010) Yes # No No No Intraoperative - Yes # 
Postoperative - Yes # 
Yes # No No 
Slovakia 
(AR 2010) 
2003 
(2006 (for knees)) 
8,385 
(2010) 
N/A No No No No No No No No 
Sweden 
(AR 2011) 
 
1975 175,345 
(2010) 
96.6% 
(2009) 
Yes #¥ Yes #¥ Yes  
(Piloted in 
2011 report -
KOOS, EQ5D, 
Pain VAS) 
Yes  
(Piloted in 
2011 report) 
No No No No 
Others: Currently the following countries also have arthroplasty registers (From www.ear.efort.org/registers.aspx): 
Austria, Belgium, Croatia, Czech Republic, Finland, France, Hungary, Germany, Romania, Slovenia, Switzerland, Malawi 
Data is not currently available from these registers for the following reasons 1) No results as yet reported 2) No public access to reports 3) reports no published in English language.  
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1.3 The National Joint Registry for England and Wales (NJR) 
1.3.1 History of the NJR 
Sir John Charnley first suggested the idea of a national arthroplasty register in the 1970’s at 
a time when joint replacement was becoming increasingly popular. He recognised that to 
ensure high standards of care the surgical practices and implants in everyday use needed to 
be monitored and audited. However, despite this it was a number of years before the first 
regional registries were established in the Trent region (Fender 2000) and later the north 
west of England. Publications from these regional registries maintained the impetus for a 
national register but it was only after the Royal College of Surgeons report into the failure of 
the 3M capital hip (Massoud 1997), alongside recommendations form the National Audit 
Office and the National Institute for Clinical Excellence  that the National Joint Registry for 
England and Wales (NJR) was finally established.  
 
The NJR was established by the Department of Health in 2002 and started collecting 
information on hip and knee replacements performed in England and Wales in April 2003. It 
is currently operated by the Healthcare Quality Improvement Programme (HQIP) and is the 
largest joint registry in the world. Costs are met by a levy of £20 (2010/11) raised on every 
acetabular, talar and distal femoral component sold.  The NJR is a keystone to delivering the 
commitment of both the Department of Health and the Welsh Assembly Government to 
improve the health and wellbeing of the population and is a vital tool for improving national 
clinical standards for hip and knee replacements.  
 
The NJR collects data via a web-based system with surgeons providing information on the 
characteristics of the patients, the implants, surgical techniques, and the need for revision 
or re-operation. In March 2012 the total number of procedures recorded in the NJR passed 
1.2 million with > 99% of all hospitals on the NJR database submitting data (NJR-AR 2012). 
By linking patients within the registry, revision of a previously implanted primary can be 
identified and a cause of failure assigned. The data can be used to describe trends over 
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time, such as an increase in the mean body mass index of TKR patients, or identify implants 
or surgeons with significantly elevated revision rates—‘outliers.’ 
 
The NJR measures its performance against 3 key indicators: compliance, consent and 
linkability. Compliance is measured by comparing the number of procedure forms submitted 
to the NJR against the number of levies through implant sales and was 90.3% for 2011/12. 
The consent rate is determined by comparing the number of records where the patient has 
agreed to their personal data being stored on the NJR database compared with the total 
number of procedures recorded on the NJR. The rate of consent was 90.4% for 2011/12. 
Linkability looks at the number of records for which an NHS number was entered compared 
with the total number of procedures recorded on the NJR. This is important as the NHS 
number is required to link all primary and revision procedures relating to a single patient. 
The rate for 2011/12 was 95.5%.  
 
Despite high levels of compliance, consent and linkability little is currently known about the 
quality of data held within the NJR, specifically whether the data recorded on the database 
is representative of the clinical activity undertaken. Some work is currently being 
undertaken by the NJR to address this by looking at the quality of revision coding in the NJR 
database compared to another national dataset, the hospital episode statistics (HES). 
Discrepancies in revision coding between these datasets will be identified and a reason 
determined. It is hoped this will give some insight into the quality of revision data held 
within the NJR. However, despite this initiative more clearly needs to be done to ascertain 
whether the data stored and used by the NJR is truly representative.   
 
1.3.2 Aims of the NJR 
At the heart of the NJR is a database of information collected from all the hip and knee 
replacement procedures in England and Wales. Using this data the NJR aims to: 
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 Ensure patients obtain the best clinical care during and following their joint 
replacement operation.  
 Ensure that NHS and other healthcare resources are best used  
 Improve surgical practice through the identification of best practice in orthopaedic 
units/ hospitals.  
 Highlight in real time any brand of prosthesis showing high failure rates and allow 
prompt removal from the market, if necessary. 
 Improve evidence based purchasing of joint replacement implants for orthopaedic 
units/ hospitals.  
 Provide patients, clinicians, healthcare purchasers / commissioners, regulators and 
implant suppliers with evidence for which are the best performing implants.  
(Taken from www.njrcentre.org.uk) 
 
1.3.3 The NJR in 2013 
With over 1.2 million records the NJR is now the largest arthroplasty register in the world. In 
the last few years the NJR has taken a number of strides to increase the quality of its data 
and the outcomes it is able to report. In April 2011, the Department of Health made 
participation in the NJR mandatory for all NHS hospitals in England and the Welsh 
Government agreed mandation for Wales. This will help to ensure data completeness for 
primary hip and knee replacements being undertaken in England and Wales. Its sub-
committees have worked alongside implants manufacturers, the Medicines and Healthcare 
products Regulatory Agency (MHRA), and individual trusts and surgeons to identify 
performance outliers. The research subcommittee has been working to streamline the 
process of accessing NJR data for the purposes of research and increasing research output.  
 
In 2011 the NJR started collecting data on ankle replacements to supplement the data 
already collection for hip and knee replacements. By 2013 it should also be collecting data 
on shoulder and elbow replacements. There are also plans to increase the geographical 
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scope of the NJR with Northern Ireland likely to become included in the registry over the 
next few years. The NJR is also currently involved with the Department of Health (DoH) in 
the collection of patient reported outcome measure data enabling them to deliver even 
richer data for analysis, study and research. 
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1.4 The current status of registry research: Where does it fit in? 
1.4.1 Research into knee replacements: Where are we in 2013? 
Over the last 20 years there has been a progressive movement toward the use of ‘evidence’ 
to support clinical decision making (Sackett 2000). Initially evidence based medicine (EBM) 
and latterly evidence based practice (EBP) and evidence based treatment (EBT) have 
developed to provide clinicians with information about the effectiveness of clinical 
interventions. While there has been widespread adoption of these processes there remains 
an on-going debate about the nature of evidence and particularly how evidence supports 
the use of therapeutic interventions (Rawlins 2008). 
 
Presently hierarchies are used to ‘weight’ evidence with evidence obtained from 
randomised trails ranked higher than evidence derived from observational sources such as 
cohort, case-control and cross sectional studies (Petrie 2006). These rankings are based on 
the reliability and strength of the evidence, and its ability to determine causation (Rawlins 
2008).  The debate about the nature of evidence has connotations for the way the current 
body of evidence is viewed and how research into knee replacement is performed in the 
future.  
 
Supporting evidence for knee replacements has traditionally originated from small single-
surgeon or single-centre observational case series (Carr 2012). Reports on new knee 
replacements were often from the personal series of surgeons involved in the design of 
these implants and were therefore prone to bias and potential conflicts of interest (Font-
Rodriguez 1997, Pandit 2011). These papers reported uniformly good results and led to a 
proliferation of implants available to the surgeon (NJR-AR 2012) many of which are being 
used without evidence of their clinical effectiveness. Randomised trials comparing implants 
were rarely performed to established clinical effectiveness. 
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Due to this proliferation the orthopaedic community is left in the unenviable position of 
having a large number of knee replacements in current use without any good evidence on 
the comparative effectiveness of each implant or approaches to surgery that might help 
guide clinical decision making. The use of widespread observational research has meant 
knee replacement surgery is mired in lower level evidence that lacks the ability to make 
strong recommendations about what should be considered best practice. Formal clinical 
evaluation requires large numbers of patients and long-term follow-up to adequately assess 
the primary safety end point, which is long-term device failure or need for revision (Bohler 
2009). Furthermore assessment of the primary effectiveness end-points which are short and 
longer term patient reported outcomes require prospective data collection, planning, and 
substantial funding which present logistic and financial problems that are difficult to 
overcome with a clinical trial design (Sedrakyan 2011).  
 
Randomised controlled trials could help as they provide the best evidence of a causal 
relationship, and thus the strongest evidence on which to base practice. However, obtaining 
evidence in this way is likely to be extremely difficult. Randomised trials are costly, 
logistically complex and time-consuming. Given the large number of comparators that 
would need to be assessed and the fact that many of the outcomes of interest are relatively 
rare events it would seem that the size and the scope of such studies would make them 
unfeasible. For example, a trial designed to compare the relative rates of failure of 2 
interventions would require approximately 1000 patients in each study arm to detect a 50% 
reduction in failure from 5% to 2.5% with a power of 0.80. The numbers of patients required 
to detect smaller differences in the rate of failure or to make comparison between more 
than two groups would require significantly larger numbers. The numbers involved in even 
the simplest trial are therefore likely to be prohibitive to its completion.  
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1.4.2 Can registries help? 
One option to help provide evidence to support decision making is re-evaluate the role of 
observational data, and specifically to use the data held within national joint replacement 
registries. National registries compliment more traditional research designs (e.g. 
randomised controlled trails (RCTs)) by providing important observational data on the 
effects of specific treatment strategies within national clinical practice (Kolling 2007). They 
allow the outcome of care to be linked to current health care practices. Due to the large 
number of patients available and the extended period of observation within these 
databases they are well suited to detecting rare events and differences between 
interventions in the longer term (Garellick 2000).  
 
National observational studies have obvious advantages when compared to a randomised 
controlled trial. They contain a large number of patients giving high statistical power, they 
make it possible to perform adequate analyses of uncommon complications, and they limit 
the effects of performance bias (NARA 2012). Furthermore they can often be completed in a 
short space of time, they do not infer significant costs, are logistically easier than 
randomised trials to instigates and complete, they provide information on a large number of 
decisions, interventions and outcomes, and they provide ‘real world’ information. As they 
do not discriminate or exclude they often include groups of patients often omitted form 
randomised trials. However, because their primary function is not the production of 
research they often contain limited data and the research questions it is possible to answer 
are constrained by the data available. Importantly these databases rarely include 
information about clinical decision making; why does the surgeon choose to pursue one 
intervention in one patient on one day and an alternative intervention in a different patient 
the following day. This is important as the patient characteristics that inform clinical 
decision making may also influence clinical outcomes. This leads to uncertainty about 
whether it is the intervention or the myriad of patient factors that causes any observed 
differences in outcomes. It can therefore be difficult to attribute causality using 
observational registry data, a pitfall that must be appreciated. 
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The problem of attributing causality seen with observational data is less of an issue for 
randomised trials. This is because the data to be collected is determined as part of the 
research question and trial design and surgical decision making is abolished by 
randomisation, as long as the patient meets the relevant inclusion criteria. Randomisation 
eliminates a lot of the uncertainty that troubles observational research. However it is not 
without its problems, particularly in the evaluation of knee replacement outcomes.  
Randomised trials are designed to answer specific research questions and are not suited to 
the analysis of epidemiology and demography which can be assessed using registry data. 
The predetermined limitations imposed by trial design hamper their ability to identify 
additional factors that may potentially influence outcome (Graves 2010). Unfortunately 
many randomised trials also ask the wrong questions. Clinicians, policy makers and patients 
want to know which intervention works the best?, is intervention ‘A’ better than 
intervention ‘B’?. However, many randomised trials simply ask whether a specific 
intervention works by comparing the intervention in question to a placebo when what 
clinicians really want to know is how an intervention compares to the current ‘gold 
standard’ best practice. Unless a pertinent research question is posed there is a risk that the 
randomised trial is reduced to nothing more than an efficacy study which simply establishes 
if an intervention can work, rather than a clinical trial which establishes which intervention 
is best. This information may not be helpful to the clinical decision making process and is 
often removed from the conditions that clinicians face in daily practice.   
 
Randomised trials also suffer from problems of generalisability. In the knee replacement 
setting trials undertaken by experienced enthusiasts for a given procedure on an artificially 
defined subset of patients may not be representative of what happens in the average 
clinician’s daily practice. This limits the validity of the trials conclusions. In addition trials 
have defined start and end points and cannot comment upon actions outside this 
timeframe. Given these limitations it is questionable whether the randomised controlled 
trial can ever replace registry analysis in the assessment of longer term outcomes following 
knee replacement. For most replacements the time required to observe even a small 
number of failures mean the number of patients that would need to be enrolled and the 
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duration of follow-up for any prospective comparative trial would be prohibitive to its 
completion.   
 
A review of current nationally funded clinical trials put these logistical problems in context. 
In the last 10 years the National Institute for Health Research’s (NIHR) health technology 
assessment (HTA) programme has only funded two randomised clinical trials directly 
comparing different approaches to knee replacement.  The Knee Arthroplasty Trial (KAT) 
(HTA ref: 95/10/01) commenced in 1998. It is a randomised controlled trial of different knee 
prostheses that aims to answer 4 main questions: 1) Should the inner surface of the knee 
cap be resurfaced? 2) Should the tibial component have a metal back? 3) Should the knee 
replacement have a mobile bearing? 4) Should unicompartmental or total knee replacement 
be performed?.  Outcome data collected includes information about short-term 
complications, quality of life, functional outcomes and cost-effectiveness. The project is due 
to be completed in November 2013, 15 years after is commenced, and current HTA funding 
is £1,381,371. The Total or Partial Knee Arthroplasty Trial (TOPKAT) (HTA ref: 08/14/08) aims 
to “assess the clinical and cost effectiveness of Total Knee Replacements versus 
Unicompartmental Knee Replacements in patients with medial osteoarthritis”.  It 
commenced in 2010, with results expected in early 2020. HTA funding for this project is 
£2,700,878. These two trials highlight the enormous cost (>£4 million), resource 
implications and time (10-15 years) necessary to undertake randomised clinical trials in knee 
replacement surgery.  
 
1.4.3 The way forward? 
In his recent Harveian oration Prof Sir Michael Rawlins, Chairperson of the National Institute 
for Clinical Evidence (NICE), stated ‘The notion that evidence can be reliably placed in 
hierarchies is illusory. Hierarchies place randomised controlled trials on an uncomfortable 
pedestal as although they have advantages they also have disadvantages’ (Rawlins 2008). 
Furthermore he states that ‘Decision makers need to assess and appraise all the available 
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evidence irrespective of whether it has been derived from randomised controlled trials or 
observational studies; and the strengths and weaknesses of each need to be understood if 
reasonable and reliable conclusions are to be drawn’ (Rawlins 2008).  
 
Once the relative merits and pitfalls of both observational and randomised trial data are 
understood it becomes clear that neither approach is perfect, but instead it suggests that 
these two approaches can provide complementary information.  This appreciation has led to 
the suggestion of an alternative research approach: Comparative effectiveness research 
(Sox 2009). Comparative effectiveness research is defined as: 
 
‘The generation and synthesis of evidence that compares the benefits and harms of 
alternative methods to prevent, diagnose, treat and monitor a clinical condition, or to 
improve the delivery of care. The purpose of comparative effectiveness research is to assist 
consumers, clinicians, purchasers, and policy makers to make informed decisions that will 
improve health care at both the individual and population levels’. 
 
Within this definition is the intention to directly compare the effectiveness of interventions 
in patients who are typical of day-to-day clinical care. Furthermore this approach allows for 
the identification of clinical characteristics that predict which interventions would be most 
successful in individual groups of patients so that interventions can be tailored to different 
sub groups of patients. This emphasises the increasing appreciation that pragmatic trials 
often represent an artificial situation removed from general clinical practice and that 
research needs to provide the information that decision makers need to know. It 
understands that randomised trials are also constrained by the research questions they 
pose limiting the ability to make potentially important inferences about specific sub groups 
and alternative interventions. This approach has recently received support in the United 
States with a funding award of $1.1 billion from congress and presidential support (Sox 
2009).   
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Comparative effectiveness research appreciates the limitations of both observational 
research and randomised trials discussed previously. The committee charged with delivering 
comparative effectiveness research has implicitly stated that ‘Very large collections of the 
electronic records of patients can be a valuable resource for CER’. They believe that ‘By using 
these data sets, it is possible to compare the outcomes of several effective interventions in a 
population that is representative of daily care. The great numbers of patients in these data 
sets also makes it possible to study subgroups with precision and perhaps identify key 
predictors of response to an intervention, both of which would facilitate decision making at 
the individual and population level. These are features that are aligned with the goals of 
CER’ (Sox 2009). This has led to a recommendation that ‘The CER program should help to 
develop large scale clinical and administrative data networks to facilitate better use of data 
and more efficient ways to collect data to yield CER findings’ (Sox 2009). 
 
1.4.4 Current research output from registries 
The comments from Prof Sir Michael Rawlins and the CER committee suggest an increasing 
role for registry analyses in the formation of clinical evidence.  In a recent review of the 
scientific production and impact of national registers Boyer et al (2011) concluded that 
compared to randomised controlled trials registry papers are less often published but are 
more often cited. This gives credence to the idea that registry analysis is becoming 
increasingly accepted as a source of evidence in modern orthopaedic practice.  
 
Boyer’s analysis found that between January 1st 1980 and December 31st 2008 there had 
been 190 registry publications from a total of thirteen national arthroplasty registers 
(Swedish Hip, Swedish Knee, Finnish, Norwegian, Danish hip, Danish Knee, Australian, New 
Zealand, Scottish, Canadian, Romanian, England and Wales, Slovakian). January 1st 1980 was 
chosen as the start point for their analysis as the first article published from a national 
register was published in 1980 (Ahnfelt 1980). Over the same time period they identified 
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476 randomised controlled trials and 40 meta-analyses that were published relating to 
either hip or knee replacement surgery. The mean journal impact factor for randomised 
trials was 1.9 [IQR 1.6 to 2.2] compared to 1.8 [IQR 1.8 to 2.2] for registry publications. The 
total citations and 3 year citations for randomised trials were 7.0 [IQR 2.0 to 20.0] and 2.0 
[IQR 1.0 to 6.0] compared to 13.0 [IQR 2.0 to 31.0] and 3.5 [IQR 1.0 to 6.0] for registry 
publications (Boyer 2011). This demonstrates that the higher rates of citations for registry 
papers came from journals with equivalent scientific impact.  
 
1.5 Introduction summary 
Establishing best practice for knee replacement is important given the large number of knee 
replacements performed worldwide. Knee replacement research is problematic given the 
large number of implants and procedures being performed and the logistical and financial 
limitations associated with prospective clinical trials. Observational studies and clinical trials 
have different strengths and weaknesses. For the evaluation of knee replacements these 
approaches should be viewed as complementary, with an appreciation that for longer term 
outcomes that occur infrequently registries may be the best model for assessment. Registry 
data offers a “real-time” perspective of national practice that can be used to answer 
clinically relevant research questions. Previous publications from registries are well cited 
and achieve publication in journals with comparable scientific impact to randomised trials. 
This suggests that registry analysis have an increasing role to play in the generation of 
orthopaedic evidence.   
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Chapter 2: Aims 
2.1 Thesis aims 
Observational registry research clearly has an increasing role to play in the production of 
evidence to guide decision making surrounding knee replacement. There is currently a 
significant output from registries relating to knee replacement outcomes. However, the 
output from the NJR is poor and with over 1.2 million operative records it represents a 
wealth of clinical data that is currently underexploited.  Furthermore it remains unclear if 
observational registry data is able to answer the same clinical questions posed by 
randomised clinical trials, how much these two approaches overlap and how much 
additional value registry data provides.  
 
This work therefore has the following aims:  
1. To assess whether research performed on data recorded by the NJR has the ability to 
answer clinically relevant research questions relating to knee replacement surgery. 
2. To determine if registry research is able to answer specific clinical questions that are 
unsuited to prospective randomised clinical trial designs. 
 
These broad aims will be achieved by identifying pertinent clinical research questions 
covering differing aspects of knee replacement practice. Attempts will then be made to 
answer these questions using the registry data available. Subsequently, the conclusions 
drawn and the strengths and weaknesses of any analyses will be discussed with particular 
reference the methodological differences between registry analyses and prospective 
randomised clinical trials (specifically KAT and TOPKAT). To achieve these aims this work will 
focus on three complimentary areas of research which will be addressed individually in 
three results chapters (chapter 4, 5 and 6). These are: 
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 Chapter 4: Clinical outcomes after unicondylar knee replacement (UKR). 
 Chapter 5: Clinical outcomes after total knee replacement (TKR). 
 Chapter 6: Clinical outcome after revision total knee replacement (RTKR). 
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Chapter 3: Methods 
3.1 Systematic review of current registry publications relating specifically to knee 
replacement procedures 
As previously discussed the scientific production and impact of publications from national 
registers has recently been reviewed by Boyer et al (2011). However, due to the search 
criteria used in this analysis (inclusion of both hip and knee replacements publications and 
inclusions of both clinical and non-clinical (papers on registry development, organisation, 
statistical methods and reporting observational data similar to that found in annual reports) 
publications) it was unclear exactly how many of these publications related specifically to 
clinical research on knee replacements.  
 
A further literature search was therefore conducted to establish the current number of 
registry publications relating to outcomes after knee replacement procedures and 
specifically the number of publications from our own national registry, the National Joint 
Registry for England and Wales (NJR). The literature search was performed on the 9th March 
2011 using Medline (1946 to 2012), Ovid Embase (1974 to 2012), and Web of knowledge 
(limited to English language, research articles and orthopaedic subject area). The search 
terms used within each database are given in table 1.2. Using this search strategy a total of 
751 papers were identified.  
 
Abstracts for these papers were then screened and excluded if they fulfilled any of the 
following criteria:  
1) From an institutional registry/database i.e. not a national/regional registry 
2) Paper was not a clinical research paper e.g. review paper or commentary on 
registries, papers describing the developments, organisation, statistical methods of 
registries, reporting of observational data similar to that found in annual reports 
3) Conference abstracts or proceedings 
4) Not written in the English language 
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5) Articles relating to primary knee arthrodesis 
6) Articles relating to other joint arthroplasty (e.g. Hip, ankle) 
7) Articles relating to soft tissue knee procedures (e.g. Anterior cruciate ligament 
repair) 
8) Duplications 
 
Database Search terms Number of articles 
Medline (1946 to 2012) MeSH terms 
1. “Registries/” 
2. “Knee prosthesis/” or 
“Osteoarthritis, Knee/” 
or  “Knee/” or 
“Arthroplasty, 
Replacement, Knee/” or 
“Knee Joint/” 
3. “1” and “2” 
 
43,514 
 
 
 
 
 
57,127 
184  
Ovid Embase 1974 to 2012 4. “Registry.mp” or 
“register” 
5. “Knee arthroplasty” or 
“Knee prosthesis” or 
“Knee osteoarthritis” or 
“Total knee 
replacement” 
6. “4” and “5” 
81,033 
 
 
 
 
 
31,295 
262  
Web of Knowledge 7. “Knee” and “registry” or 
“Knee” and “register”  
 
305  
TOTAL  751  
Table 3.1: Search criteria and numbers of hits for knee replacement literature search.  
 
Where any doubt remained over the content of the paper it remained included. This initial 
screening left a total of 94 papers.  Additional papers were then sought by reviewing the 
relevant research sections of all of the previously mentioned national registries (Table 3.1). 
This produced an additional 38 papers giving 132 in total. These papers were then reviewed 
with further exclusions based on the criteria given above (Table 3.2). Final paper count was 
59 and included only two papers from the NJR (Sibanda 2006, Baker 2007).  The majority of 
these papers originate from the Scandinavian registries (Sweden/Norway/Denmark) and 
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focus on implant survival as the primary outcome. The number of publications from the NJR 
is small given its size relative to other worldwide registries (see table 1.1) the majority of 
which have previously been used to support a wide range of clinical research projects.  
 
Reason for exclusion Number of articles 
Start 132 
Not national registry papers 
- From a single institution 
- From a community or regional 
registry 
- From a national administrative 
database other than a national 
arthroplasty register 
 
4 
18 
 
3 
Papers describing development, 
organisation, statistical methods of 
registries. Reporting of observational data 
similar to that found in annual reports 
17 
Review paper or registry commentary 18 
Papers describing statistical analysis of 
registry data 
6 
Conference abstracts  5 
Non English language 1 
Hip paper 1 
Total remaining after exclusions 59 
Table 3.2: Details of the exclusions used in determining the currently published clinical 
research from national knee arthroplasty registers. 
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3.2 The NJR Research process 
3.2.1 The NJR research strategy 
“The NJR aims to provide a substrate for definitive research into the full range of biological, 
mechanical, clinical and social factors influencing the outcome of joint replacement and to 
establish the impact of joint replacement surgery on the well-being of patients and the 
population. The aim is to enhance the understanding of the science of arthroplasty, improve 
and enhance clinical practice and benefit public health. The NJR aims to provide extensive 
links to other population health resources and to encourage the widest possible access of the 
data to the research community through providing a platform for enquiry into all aspects of 
arthroplasty.” (www.njrcentre.org.uk) 
 
3.2.2 The research sub-committee 
The research sub-committee oversees all research undertaken using NJR data. It is directly 
responsible to the NJR steering committee. Their stated aim is to “maximise the value of the 
NJR to research by making data widely available.” The 7 person committee is chaired by 
Professor Alex MacGregor   and includes 4 consultant orthopaedic surgeons, 1 orthopaedic 
industry representative and 1 representative from the healthcare quality improvement 
programme (HQIP). The committee oversees the research strategy of the registry as well as 
reviewing and approving all of the research requests submitted. It takes responsibility for 
the release of data for research through an “impartial and objective” protocol and it is 
committed to “upholding the standard and consistency of work that is carried out on NJR 
data.” The Research sub-committee supports the national strategy for orthopaedic 
research. Within the NJR its specific remit is (from www.njrcentre.org.uk): 
 
 To act as a point of contact to provide impartial and informed advice on planned research 
using NJR data.  
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 To review all research data requests received on behalf of the NJR using an established 
protocol and manage the release of research data.  
 To confirm that proposed research is scientifically appropriate, methodologically feasible 
and is an appropriate use of the resource.  
 To confirm that proposed research conforms to current ethical standards.  
 To monitor the use of NJR data through an established reporting procedure.  
 To review all abstracts, presentations and publications arising from the NJR data.  
 To communicate research activity through the NJR website, NJR annual report, and the 
wider media.  
 To provide quarterly reports to the NJR steering committee.  
 
3.2.3 The NJR research application process 
Prior to 2010 data requests were made using a web based request form accessed via the 
NJR website. Applications took a substantial time to process (up to 6 months) due to a lack 
of a co-ordinated approach between the application process and the research sub-
committee. As the volume of research requests increased it was realised that this process 
was failing researchers and so in June 2010 the NJR appointed a research officer to co-
ordinate research being undertaken by groups external to the NJR. At the same time a new 
research process was developed in an attempt to streamline the application process. This 
involved the production of a standardised data request form (Appendix i), downloadable 
from the research area of the NJR website, which, when completed, is sent directly to the 
research officer. The research officer then directly circulates the requests to members of the 
research sub-committee for approval with a decision expected within 3 weeks. All 
applications for data made as part of this analysis were undertaken using this process.  
 
Once approved, the data requests are forwarded to the NJR data handlers (Northgate 
Information Solutions) for NJR data, or the Department of Health data handlers (NHS 
Information Centre) for PROMs data. Following satisfactory completion of relevant 
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information governance, data handling and data re-use agreements the data can then be 
released to the requester.  
 
3.2.4 Data applications for the current work 
Data for the current analysis were accessed in accordance with the standard NJR procedure 
relating to data access described above. This involved three separate applications for NJR 
data, one of which included a request for linked PROMs data. These included: 
- NJR extract: Analysis of revision knee arthroplasty in England and Wales. Approved by 
the NJR research sub-committee on the 6th August 2010. Data received 29th August 
2010.  
- NJR extract: Examination of revision rate following knee arthroplasty by indication for 
revision. Approved by the research sub-committee on the 3rd May 2011. Data received 
27th July 2011. 
- NJR-PROMS linked extract: PROMs following primary total knee replacement and 
unicondylar knee replacement. Approved by the NJR committee on the 6th August 2010 
and approved by the NHS information centre on the 13th December 2010 (Ref NIC-
74514-LPDX4). Linked data received on the 26th April 2011. 
 
Following preliminary analysis of the information contained within these data requests 
subsidiary projects were developed that fell outside the remit of the initial research 
requests. However, these projects did not require any additional data over and above that 
already provided. For these projects a dialogue was opened with the NJR research officer 
and the chair of the NJR research committee by which these additional projects could be 
undertaken as long as they were logged with the research committee on a project by project 
basis. In addition all work was subject to internal NJR review prior to release for publication 
or presentation in the public domain.  
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3.3 Administrative considerations 
3.3.1 Information governance 
Prior to accessing the NJR and PROMs data the National Information Governance Board for 
Health and Social Care (NGIB) ethical and confidentiality committee was contacted to 
discuss the need to gain permission under section 251 of the NHS Act 2006 to access NJR 
data for research. Section 251 allows the common law duty of confidentiality to be set aside 
in specific circumstances where anonymised information is not sufficient and where patient 
consent is not practicable. After discussion it was decided that section 251 would not be 
required for any of the proposed projects as long as patient identifiable data was not 
requested or transferred. To overcome this issue data requests were designed so that any 
patient identifiable data (name, date of birth, address, post code etc.) was either removed 
or anonymised at source prior to transfer.  
 
Data was stored on a secure server at Northgate Information Solutions (the NJR data 
handler). This server was then accessed remotely using encrypted laptops provided 
Northgate and conforming to their own information security standards. The NJR also 
permitted some subsets of NJR only data (i.e. not PROMs data) to be stored on local NHS 
and/or University servers. 
 
3.3.2 Caldicott approval 
Data handling, storage and security were performed in accordance with local trust policies 
on advisement of the local Caldicott guardian. Caldicott approvals were obtained via Richard 
Oliver the Newcastle NHS trust Caldicott guardian for the following projects:  
- Analysis Of Revision Knee Surgery Practice Within England And Wales Analysis Of Data 
From The National Joint Registry For England And Wales (Caldicott number 1220). 
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- Patients Reported Outcomes Measures proms Following Primary Total Knee 
Replacement Vs Unicondylar Knee Replacement (Caldicott number: 1280).  
The Caldicott guardian for additional data requests was Elaine Young the Healthcare Quality 
Improvement Programme (HQIP) lead for the NJR on behalf of Northgate Information 
Solutions the NJR data handler.  
 
3.3.3 Ethical considerations 
Prospective projects were discussed with the chairs of the local ethics and research and 
development committees. Correspondence with Paddy Stephenson chair of the Sunderland 
local research and ethic committee can be found the appendices. As no patient identifiable 
data was requested and as no additional patient contact was required it was decided that all 
projects could be performed as service evaluations without the need for additional ethical 
approval. The NJR has its own consent mechanism for data collection and it was felt that 
this was sufficient for the purposes of the proposed research. 
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3:4 Overview of the databases available for the current analysis 
3.4.1 Introduction 
The primary aim of this work was to assess the ability of the NJR to answer clinically relevant 
research questions relating to knee replacement surgery. As such the data held within the 
NJR were chosen as the basis for our analysis. However, we were aware that when used in 
isolation the outcome measures available from registry data are limited. This is because the 
only outcome measures available within the NJR are implant revision and mortality. As 
discussed previously implant revision is a crude measure of failure and does not 
differentiate between patients performing well and those living with a painful replacement. 
This methodology has therefore been cited as a major limitation of registry data (Wylde 
2011).  
 
To provide further information on implant performance we decided to link the NJR database 
to the patient reported outcome measures (PROMs) programme instigated as a joint 
venture by the Department of Health (DoH) and the NJR in 2009. The PROMs programme 
addresses some of the problems encountered when looking at registry data in isolation by 
providing validated subjective and objective measures of patient health and disability, both 
prior to and at specific intervals following surgery (PROMs 2011). Linking these two large, 
population-based databases provides the capability to analyse both functional and clinical 
outcomes and allows for the analysis of a wider range of variables that could potentially 
influence outcome.  
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3.4.2 Overview of the data available from the National Joint Registry (NJR) for England 
and Wales database 
The NJR has assimilated data on patients, surgeons and implants performed in both the 
private and public sector (National Health Service) in England and Wales since 2003. Knee 
replacement data is collected on dedicated data collection forms for both ‘first time’ 
primary (K1 form) and ‘re-do’ revision (K2 form) procedures (See Appendix ii). These forms 
have evolved over the lifespan of the NJR with information either added or withdrawn 
based on surgeon feedback. An overview of the information collected on the current 
versions of the K1 and K2 forms are summarised in table 3.3. Further information about the 
NJR can be found in sections 1.3 and 3.2.  
 
For the current analysis the NJR provided data on all knee replacements performed 
between April 2003 and December 2010 for whom an NHS number was available. This 
database is equivalent to the NJR outlier database on which the NJR, via the University of 
Bristol, produce their outlier analysis for monitoring surgeon, centre and implant 
performance. Due to the requirement for an NHS number this database includes 
approximately 95% of all knee replacements registered with the NJR.  
 
The database holds information on 416,628 primary knee replacements performed during 
the specified period. The information collected on the K1 form (table 3.3) was available for 
each record. Information on the status of the implant as of the 31st December 2010 was 
provided (implant unrevised, implant revised, and patient dead with implant in situ) in 
addition to the period for which it had been under observation. For those cases that had 
been revised the information collected on the K2 form (table 3.3) was also available. Details 
of the distribution of different types of knee replacement (total versus unicondylar versus 
patella-femoral versus ‘other’) and the associated numbers of revisions are given in figure 
3.1.  
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 Available on K1 form Available on K2 form 
Patient Details 
- Patient consent 
- Hospital ID 
- Body Mass Index 
 
X 
X 
X 
 
X 
X 
X 
Patient Identifiers 
- Name 
- Gender 
- Date of Birth 
- Post Code 
- NHS number 
 
X 
X 
X 
X 
X 
 
X 
X 
X 
X 
X 
Operation Details 
- Hospital 
- Operation Date  
- Anaesthetic type 
- American Society of Anaesthesiologists grade 
- Operation Funding 
 
X 
X 
X 
X 
X 
 
X 
X 
X 
X 
X 
Surgeon Details 
- Consultant in change 
- Operating surgeon 
- Operating surgeon grade 
- First assistant grade 
 
X 
X 
X 
X 
 
X 
X 
X 
X 
Procedure Details 
- Side  
- Indication for surgery 
- Pre-operative Range of Motion 
 
X 
X 
X 
 
X 
X 
- 
Primary Operation Details 
- Primary date 
- Primary Hospital 
 
N/A 
N/A 
 
X 
X 
Components Removed 
- Brand of Knee removed 
 
N/A 
 
X 
Surgical Details 
- Procedure type 
- Surgical approach 
- Minimally invasive surgery 
- Computer assisted surgery 
- Type of venous thromboprophlaxis  
- Use of bone graft 
 
X 
X 
X 
X 
X 
X 
 
X 
X 
- 
- 
X 
X 
Untoward intraoperative events X X 
 
Table 3.3: Summary of the variables relating to knee replacement recorded by the NJR.  
Key X = Recorded, - = Not recorded, N/A = Not applicable.  
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Figure 3.1: Distribution of different types of knee replacement and associated revisions 
within the NJR dataset. Note: Journey Deuce is a bicondylar implant comprising a combined 
unicondylar tibio-femoral and patella-femoral replacement.  
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3.4.3 Overview of the data available from the Patient reported outcome measures 
(PROMs) database 
Traditionally knee replacements have been assessed using objective measures of the 
surgical and technical aspects of the procedure. These included implant survivorship using 
revision as an end-point, implant alignment and rates of complications. There are three 
main problems with this approach. Firstly these measures are determined by the surgical 
team based on clinical and radiological observations and are therefore prone to reporter 
bias.  Secondly, they fail to take into account the patient’s perspective of the results of 
surgery. Thirdly, revision as an endpoint tends to underestimate problems as patients can 
have a poor functional outcome without undergoing revision surgery (Noble 2006, Bourne 
2010).  
 
Unfortunately, a technically successful procedure does not guarantee a satisfied patient. 
The presence of continuing symptoms such as pain and functional limitation can lead 
patients to feel unhappy with the outcome of their surgery (Rothwell 1997, Janse 2004). The 
priorities and concerns of patients and surgeons after knee replacement often differ 
(Bullens 2001). Surgeons tend to be focussed on the relief of specific symptoms and return 
to defined activities whereas patients tend to consider more general improvements and the 
impact that their joint replacement has had on their overall quality of life (Allyson Jones 
2005). An appreciation of this disparity has helped to shape the way in which we evaluate 
knee replacements with an increasing focus of patient reported outcomes within the 
assessment of surgical outcome (Garratt 2004, Jones 2005).  
 
In 2008 Lord Darzi produced the High Quality Care for All: NHS Next Stage Review for the 
Department of Health (Darzi 2008). At the heart of the report was an aim to put quality at 
the heart of everything the NHS does. Particular importance was placed on quality as 
assessed by patients themselves. Patient Reported Outcomes Measures (PROMs) were 
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outlined as an integral part of the assessment of the effectiveness of care from the patient’s 
perspective: 
 
“Effectiveness of care. This means understanding success rates from different treatments for 
different conditions. Assessing this will include clinical measures such as mortality or survival 
rates and measures of clinical improvement. Just as important is the effectiveness of care 
from the patient’s own perspective which will be measured through patient-reported 
outcomes measures (PROMs)…”.
  
(Darzi 2008) 
 
PROMs measure the quality of the episode of care from the patient’s perspective by 
recording aspects of functional improvement specific to the procedure being performed in 
addition to measurement of general health status and patient satisfaction (PROMs 2012). 
For knee replacement analysis these data complement existing registry based information 
and help to “fill the gap in the set of information available on the care delivered to NHS-
funded patients” (Darzi 2008).  
 
Potential uses of PROMs data include (Darzi 2008):  
 Evaluation of the relative clinical quality of providers of elective procedures. PROMs can 
be used to benchmark performance.  
 Informing patient choice, allowing patients to make informed decisions over their 
healthcare based on quality information. 
 Producing research about what works. Efficacy and cost-effectiveness of different 
technical approaches to care can be evaluated using PROMs in association with other 
measures.  
 Assessing the appropriateness of referrals to secondary care. PROMs data can be used 
to establish whether referrals for elective procedures are appropriate by examining 
variation in baseline PROMs scores across the country.  
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 Supporting the reduction of inequalities. 
 Empowering commissioners. 
 As a basis for financial remuneration through Payment by results (PbR) and the 
Commissioning for Quality and Innovation (CQUIN) payment framework. 
 
In April 2009 the NJR, alongside the Department of Health (DoH), commissioned the 
collection of PROMs data to augment the information already held within the NJR.  Since the 
programme started the DoH has been routinely collecting PROMS data before and after 
selected NHS funded elective surgery. Initially four procedures were chosen for PROMs 
collection namely total hip replacement, total knee replacement, varicose vein surgery and 
hernia repair, but work is under way to assess the feasibility of extending routine 
measurement to a range of chronic conditions. This project is intended to help the NHS 
measure and improve the quality of its care and will use patient’s perspectives to inform 
decision making. This reflects key themes in current NHS reforms to put patients in charge 
of making decisions about their care (Darzi 2008). A limited amount of PROMs data for hip 
and knee replacement is currently published online at www.hesonline.org.uk. However, this 
is a crude analysis that combines all patients and all implant types together. For the 
orthopaedic community the opportunity exists to amalgamate patient outcome measures 
with clinical outcome data from the NJR, allowing a more sophisticated and comprehensive 
analysis of specific operations and subgroups of patients to be undertaken. This will 
supplement the information already available from the NJRs annual reports. 
 
For joint replacement the PROMs questionnaires are administered pre-operatively (usually 
collected by the operating institution) and 6 months post-operatively (collected by postal 
questionnaire), and record information on general and condition specific measures of health 
status (Appendix iii). While collection is currently limited to these time points there are 
plans to extend collection to 1, 3 and 5 years for a subset of patients (NJR-AR 2012). General 
health status is measured using the Euroqol EQ5D which is common to all questionnaires 
permitting comparison both within and between procedures. The condition specific 
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measures relate to the procedure under investigation and hence can only be compared 
within that procedure. For knee replacement this is measured using the Oxford knee score 
(Dawson 1998). The generic and condition specific metrics were chosen after systematic 
review of all available measures of health utility and knee-specific outcome (Smith 2005).  
 
The EQ5D was chosen as it is a short, concise and clear questionnaire that has been 
validated as a measure of health utility in a number of different scenarios and healthcare 
settings. In addition it has been endorsed by the National Institute for Health and Clinical 
Excellence which requires “that health states should be measured using a generic and 
validated classification system for which reliable UK population preference values, elicited 
using a choice-based method such as the time trade-off or standard gamble (but not rating 
scale), are available” (Smith 2005).  
 
When considering the disease specific metric a range of scoring systems were considered 
and their reliability, validity and responsiveness assessed. This process is summarised in 
figure 3.2 taken from the report assessing which outcome measures were most pertinent 
for the PROMs project (Smith 2005). Psychometrically there was little to choose between 
the Western Ontario and McMaster Universities Arthritis Index (WOMAC) and the OKS. The 
WOMAC is widely used in the United States and has a high volume of associated literature, 
but is less widely used in the United Kingdom. In contrast the OKS was developed in the UK 
and is widely used in British orthopaedics. The OKS has acceptable reliability and 
responsiveness and most forms of validity. When questioned orthopaedic surgeons based in 
the United Kingdom expressed a preference for OKS on the basis of a perceived reluctance 
of patients to complete WOMAC which is longer and more time consuming to complete, 
increasing the possibility of missing data. On the basis of these findings the advisory panel 
therefore recommended the OKS as the knee specific metric for the PROMs project. 
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In addition to the EQ5D and Oxford score PROMs also collects other relevant information. 
As part of the pre-operative questionnaire patients are asked about co-morbidities, living 
arrangements and self-reported disability which can be used to understand the differences 
in health status between patients presenting for different surgical procedures. The post-
operative questionnaire includes information on complications (UTI/Wound 
problems/Bleeding problems/Allergic reactions) (Audit Commission 1991), reoperations and 
readmissions as well as specific questions relating to satisfaction and the patients 
perception of how successful their surgery has been (Smith 2005). An overview of the data 
recorded as part of the PROMs programme is given in table 3.4. Details of the pre-operative 
variables available in the linked NJR-PROMs dataset are described in table 3.8. Further 
details of the post-operative outcome variables used for this work are given in section 3.5. 
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 WOMAC
TM
 OHS OKS LEFS PSI AIMS THOEQ MCKNEE HARRIS HRS MAYO HAQ VAI 
Reliability: Internal consistency +++ +++ +++ ++ 0 0 0 0 0 0 0 0 0 
Reliability: Test-retest reliability ++ +++ +++ +++ +++ 0 + + 0 +++ 0 0 0 
Validity: Content validity ++ ++ ++ 0 0 ++ 0 ++ 0 0 0 + 0 
Validity: Criterion-related validity 0 0 0 0 0 0 0 0 +++ 0 +++ 0 0 
Validity: Construct validity: 
Within scale analyses 
++ +++ +++ ++ 0 0 ++ 0 0 0 0 0 0 
Validity: Analyses against 
external criteria: Construct 
validity: Convergent/ 
Discriminant 
+++ +++ ++ ++ ++ +++ + 0 ++ ++ 0 0 0 
Validity: Construct validity: 
Known groups 
+++ +++ +++ 0 0 + 0 0 0 0 0 0 0 
Validity: Other hypothesis testing ++ 0 0 0 0 0 0 0 0 0 0 0 0 
Responsiveness +++ +++ +++ 0 +++ ++ 0 ++ 0 + 0 +++ 0 
Interpretability + + + 0 0 + 0 0 + + 0 + 0 
Acceptability ++ + + 0 0 0 0 0 0 0 0 0 0 
Feasibility/burden ++ 0 0 + ++ 0 0 0 0 0 0 0 + 
Figure 3.2: Appraisal of psychometric (shaded) and operation (unshaded) criteria for disease specific PROMs for knee replacement (adapted 
from Smith 2005). The OKS (third column) was chosen as the disease specific metric of choice. Notes: For psychometric criteria 0 = not 
reported or no evidence in favour, + = limited evidence in favour, ++ = some acceptable evidence in favour, but some aspects fail criteria or not 
reported, +++ = acceptable evidence in favour. For operational criteria 0 = no evidence, + =  some evidence. 
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Patient related explanatory variables Time recorded 
Demographic variables 
- Age 
- Gender (M/F) 
- Date of questionnaire completion 
 
Both 
Both 
Both 
Patient health variables 
- History of heart disease  
- History of hypertension  
- History of previous stroke  
- History of circulatory problems 
- History of lung disease 
- History of diabetes 
- History of kidney disease 
- History of nervous system disease 
- History of liver disease 
- History of cancer 
- History of depression 
- History of arthritis 
- General health rating 
- Self-reported disability  
- Living arrangements  
- Duration of symptoms 
 
Pre-operative 
Pre-operative 
Pre-operative 
Pre-operative 
Pre-operative 
Pre-operative 
Pre-operative 
Pre-operative 
Pre-operative 
Pre-operative 
Pre-operative 
Pre-operative 
Both 
Both 
Both 
Pre-operative 
Outcome variables (Further details given in section 3.4) 
- Euroqol-5D index 
- Euroqol-5D visual analogue scale 
- Oxford Knee Score 
- Patient satisfaction rating 
- Patient success rating 
- Operative event (allergy) 
- Operative event (UTI) 
- Operative event (bleeding) 
- Operative event (wound problem) 
- Operative event (reoperation) 
- Operative event (readmission) 
 
Both 
Both 
Both 
Post-operatively 
Post-operatively 
Post-operatively 
Post-operatively 
Post-operatively 
Post-operatively 
Post-operatively 
Post-operatively 
Other 
Number of times attended physiotherapy 
 
Post-operative 
 
Table 3.4: Summary of the variables recorded by the PROMs project which were available 
for the current analyses. 
*Further information relating to the data held in the PROMs database can be accessed via 
the PROMs data dictionary 
(http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=289).  
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3.4.4 Preparation of the NJR-PROMs linked database 
For the current work the Department of Health information centre provided information on 
all completed PROMs episodes up to February 2011. Upon receipt of the PROMs data four 
key identifiers common to both the NJR and PROMs databases were identified. These were 
the NJR index number, the NJR procedure identifier, the episode key and the year of entry 
of that operation onto the Hospital Episode Statistics database. These identifiers were 
extracted from the PROMs database and provided to the NJR data handler who was then 
able to extract the matching NJR records. The two datasets (PROMs and NJR) were then 
merged based on matching of these four variables common to both datasets. Adequacy of 
this merge was assessed by cross checking for discrepancies between these four variables in 
the merged file. Of a total of 51,558 records there were no discrepancies for any of the 
variables and therefore the merge was felt to be successful.  
 
The data held within the linked NJR-PROMs database was a composite of the data outlined 
in tables 3.3 and 3.4. In total the merged NJR-PROMs extract included all 51,558 records. 
Included within this were all patients who had completed either part of the PROMs 
questionnaire (Pre or Post-operative) between 01/04/09 and 01/02/11.  
 
Initial analysis of the NJR-PROMs data revealed a number of data issues. These fell into 4 
categories: 
1. Missing questionnaire data (Either pre or post-operative questionnaires were 
incomplete). 
2. Missing information relating to the data of questionnaire completion meaning the 
time to follow up could not be determined. 
3. Variation in the time of follow up for those records were this information was 
available. 
4. Duplicate records. 
Each of these issues was dealt with in turn to produce a clean, usable dataset. 
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Step 1: Removal of cases with missing questionnaires 
Improvement in scores (OKS and EQ5D) is one of the key outcomes used by HES and local 
health authorities when making comparisons using PROMs. It was also the method of 
comparison used when the initial evaluation and feasibility of using PROMs to compare 
performance was undertaken (Browne 2007). Calculation of the improvement in score at an 
individual level requires knowledge of the pre-operative starting point and the final post-
operative endpoint. It is therefore not possible to calculate the improvement in score if 
either the pre or post-operative questionnaires are missing. A decision was therefore taken 
to remove all cases with missing questionnaires, leaving only those with both the pre and 
post-operative PROMs questionnaires completed. Missing questionnaires were identified 
using a column within the PROMs dataset that records whether the questionnaires had 
been received by the Department of Health. Questionnaires are recorded as received if they 
are returned irrespective of whether all sections have been correctly or adequately 
completed. A received questionnaire may therefore still have some sections missing but will 
have data within it that makes it possible to compare at least one PROMs outcome for that 
individual.  
 
In total this process removed 18,676 cases (Table 3.5). However, of these 10,633 were 
patients who had completed a pre-operative questionnaire but who had not yet reached 
the 6 month post-operative threshold. These patients were therefore not yet eligible to 
complete the post-operative questionnaire.   
 
Questionnaire completion Number Percent 
Neither complete 157 0.3% 
One complete 
- Not yet reached 6 month post-operative 
threshold  
- Missing questionnaire 
18,519 
10,633 
 
7886 
35.9% 
20.6% 
 
15.3% 
Both complete 32,882 63.8% 
Total 51,558 100.0% 
 
Table 3.5: Questionnaire completion rates for the 51,558 NJR-PROMs records. 
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Step 2: Removal of cases for which the date of questionnaire completion could not be 
ascertained  
Information on the date of completion of each of the PROMs questionnaires is required if 
the timing of completion relative to the date of surgery is to be ascertained. This is 
important as if the pre-operative questionnaire is completed well in advance of surgery it is 
possible the clinical picture may have changed and the PROMs recorded may not be an 
adequate reflection of the patient’s status at the time of surgery. Similarly post-operative 
questionnaires completed too early in the post-operative course may not detect 
improvements in PROMs as patients are still in the recovery phase whereas questionnaires 
completed much after much longer follow-up may not be comparable to improvements 
seen earlier in the post-operative course.  It is important that periods of follow-up are equal 
to limit the confounding effects of time to follow-up within any comparative analyses. Cases 
for which the date of questionnaire completion could not be determined, were therefore 
excluded (n=2676) (Table 3.6).  
 
Dates for Questionnaires Number Percent Cumulative Percent 
No date for either 71 0.2% 0.2% 
Date for one questionnaire only 2605 7.9% 8.1% 
Dates for both questionnaires 30,206 91.9% 100.0% 
Total 32,882 100.0%  
 
Table 3.6: Presence of dates on the 32,882 records with both PROMs questionnaires 
 
Step 3: Removal of cases for which the timing of questionnaire completion was out with a 
relevant range 
To produce a homogeneous dataset it was decided to limit the time from the pre-operative 
questionnaire to surgery and the time from surgery to the post-operative questionnaire. 
This posed two questions: 
1. Should the NJR or PROMs date of surgery be used to calculate these time periods? 
2. What should these time periods be? 
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The date of surgery is recorded in both the NJR and PROMs databases. The method of 
collecting this data differs between databases. For the NJR database the date of surgery is 
recorded on the K1/K2 form completed at the time of surgery and is thus likely to be 
accurate. If this data is missing it is verified and added by data clerks at the time of entry 
into the NJR database.  In contrast the PROMs date of surgery is recorded as part of the 
post-operative questionnaire and is recorded by the patients in response to the question 
“Please confirm when you knee operation took place?”. This therefore relies on patients 
completing this section, returning the questionnaire and accurately recalling the date of 
operation. After review the date recorded in the NJR database was chosen as the reference 
for the date of operation based on the following observations: 
1. The NJR dataset had a higher rate of complete surgical date data (NJR = 51,556 vs. 
PROMs = 30,221). 
2. NJR data is less prone to reporting error as its completed on day of surgery by 
surgeon rather than 6 months after surgery by the patient. 
3. All NJR dates for surgery were within a plausible range whereas a number of PROMs 
dates were not (e.g. some dates in the future). 
 
Acceptable ranges for the periods of follow up were then defined. For the pre-operative 
PROMs an arbitrary 90 day cut-off for completion was chosen. This was chosen as it is 
similar to the time patients wait on current NHS waiting lists and should therefore represent 
the symptoms at the time a decision was made to list them for surgery. Questionnaires 
completed at more than 90 days prior to surgery were excluded as symptoms and 
corresponding levels of function may have changed during this period. The distribution of 
time of completion for the post-operative questionnaires is shown in Figure 3.3. Due to the 
design of the PROMs project the majority of post-operative PROMs were collected between 
6 to 8 months. Functional improvements after TKR begin to plateau at 6 months following 
surgery but may continue to improve for up to 12 months (Nerhus 2010). While comparison 
of outcomes after knee replacement are probably best compared at a minimum of 12 
months after surgery it was recognised that unless patient with at least 6 months follow up 
were included then a significant volume of follow up data would be lost. Additionally there 
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is evidence that the functional improvements attained between 6 and 12 months are 
minimal and that comparison of outcome at 6 months is therefore acceptable (Judge 2011).   
 
 
Figure 3.3: Distribution of the time in days of collection for the 30,206 post-operative 
PROMS records with both questionnaire complete and complete information for the dates 
of questionnaire completion.  
 
Based on these criteria the dataset was filtered by the timing of pre- and post-operative 
questionnaire completion (Figure 3.4). In total 25,011 of the remaining 30,206 completed 
their pre-operative questionnaire within 90 days of surgery and their post-operative 
questionnaire within 6 to 12 months of surgery.  
Timing of Post-operative questionnaire (Days)
90 360
0
4000
8000
270180
6000
10000
2000
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Step 4: Removal of duplicate records 
Duplicate data were assessed on the basis of duplicate NJR ID numbers. The number of 
duplicates was small (7 of 25011 records (0.002%)). Where duplicates were found the 
second of the two duplicate records were removed from the dataset.  The process for 
cleaning the data is summarised in figure 3.4. The number of duplicates and the final 
numbers of useable records for each implant type are given in figure 3.5.  
 
 
Figure 3.4: Flowchart summarising the preparation of the linked NJR-PROMs dataset. 
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Figure 3.5: Details of the 7 duplicate records from the cleaned NJR-PROMs linked dataset. 
 
Following removal of the excluded cases the demographics of the patients included and 
excluded were compared to ensure the patients with complete questionnaires were 
demographically comparable to the total PROMs population. The two groups were matched 
for age (p=0.54), gender (p=0.93) and side of operation (p=0.64). However, there were 
differences between the groups for the American Society of Anesthesiologist (ASA) grade 
(p<0.001) with a greater proportion of ASA 1 and 2 patients and a smaller proportion of ASA 
3 patients observed in the group that was used for analysis (ASA grade 1: 10.5% versus 9.1%, 
ASA grade 2:  74.3% versus 73.1%, ASA grade 3: 14.8% versus 17.3%). A possible explanation 
for this may be that patients with significant co-morbidities (ASA 3 or more) had their 
surgery postponed due to these co-morbidities. If this occurred after the pre-operative 
questionnaire was completed then by the time surgery was rescheduled they may have 
been outside the 90 day limit for pre-operative questionnaire completion and they may 
therefore have been excluded.  
 
To ensure that the data we were analysing represented the wider population undergoing 
primary knee replacement, the TKRs (n=23,393) and UKRs (n=505) from the selected NJR-
PROMs cohort was compared with the demographic details for national TKR and UKR 
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patients recorded in the NJR 9th Annual Report (table 3.7). This demonstrated that the 
cohorts were comparable for both groups, suggesting that the patients selected were 
representative of the wider population of patients undergoing these two operations. 
 
Preliminary analysis of the cleaned NJR data revealed that for some of the factorial data 
fields there was one overwhelming level and a number of others for which the numbers 
were relatively small.  Prior to any analysis we therefore we chose to combined data within 
these groups. Consequently the grade of lead surgeon and indication for surgery were 
grouped into their most frequently occurring levels of Consultant and osteoarthritis, 
respectively, versus all other levels combined. This approach also meant that the factors 
could each be treated as covariates during analysis. The demographic and pre-operative 
data available from the NJR-PROMs dataset and a description of this data is given in table 
3.8.  
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 Selected PROMs cohort Comparison  
PROMs cohort 
TKR vs. UKR 
Comparative values for 2010 
from NJR  Annual Report 
Variables
*
 TKR  
(n = 23 393) 
UKR  
(n = 505) 
p-value All TKR  
(n = 69 649) 
All UKR  
(n = 6119) 
Mean (SD) age (yrs)  69.6 (9.0) 63.6 (9.8) < 0.001 70.1 (9.3) 64.0 (9.8) 
Mean (SD) Body Mass Index (kg/m
2
) 31.0 (5.5) 30.1 (5.2) 0.005 30.7 (5.5) 30.0 (5.1) 
Body Mass Index category (n, %)      
- 15 to 25 kg/m
2
 1365 (6) 39 (8)    
- 25 to 40 kg/m
2
 11 600 (50) 284 (56)    
- 40 to 60 kg/m
2
 1036 (4) 17 (3)    
- Data missing 9392 (40) 165 (33)    
Gender (n, %)      
- Female 13 221 (57) 258 (49) 0.001 37 997 (55) 2675 (44) 
- Male 10 172 (43) 247 (51)  28318 (41) 3027 (49) 
- Missing    3334 (5) 417 (7) 
ASA grade (n, %)      
- 1 2362 (10) 112 (22) < 0.001 7455 (11) 1421 (23) 
- 2 17 445 (75) 355 (70)  51 158 (73) 4221 (69) 
- 3 or 4 3586 (15) 38 (8)  11 036 (16) 477 (8) 
Side (n, %)      
- Left 11 186 (48) 242 (48) 0.96   
- Right 12 207 (52) 263 (52)    
Hospital type (n, %)      
- NHS 20 932 (89) 379 (75) < 0.001 48 575 (70) 3645 (60) 
- Independent (private/ISTC) 2461 (11) 126 (25)  21 074 (30) 2474 (40) 
Lead surgeon grade (n, %)      
- Consultant 17 374 (74) 434 (86) < 0.001   
- Other 6019 (26) 71 (14)    
Comorbidities
†
 (n, %)      
- 0 or 1 17 771 (76) 428 (85) < 0.001   
- ≥ 2 5622 (24) 77 (15)    
General health pre-operatively (n, %)      
- Excellent 818 (4) 22 (4) 0.06   
- Very good 5834 (25) 150 (30)    
- Good 10 440 (45) 222 (44)    
- Fair 4983 (21) 85 (17)    
- Poor 745 (3) 14 (3)    
- Data missing 573 (2) 12 (2)    
Self-assessed as ‘disabled’ (n, %) 12 925 (55) 175 (35) < 0.001   
Diagnosis of depression (n, %) 1703 (7) 44 (9) 0.23   
Osteoarthritis as indication (n, %) 22 798 (97) 499 (99) 0.06 67 668 (97) 6048 (99) 
Symptom period (n, %)      
- < 1 year 1166 (5) 40 (8) < 0.001   
- 1 to 5 years 12 151 (52) 307 (61)    
- 6 to 10 years 5020 (22) 87 (17)    
- > 10 years 4969 (21) 71 (14)    
- Data missing 87 (0) 0 (0)    
 
Table 3.7: Comparison of the TKR and UKR cohorts form the final NJR-PROMs dataset with 
the equivalent patients undergoing these procedures described in the NJR 9th annual 
report. p values for the difference in demographics between the selected TKR and UKR 
patients are given to highlight the inherent difference between these two groups of 
patients. *Further details for each of the variables can be found in table 3.8. 
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Variable Data source Data type Additional Information 
PATIENT VARIABLES    
Age (years) NJR/PROMs Continuous/ 
categorical 
Used either as a continuous variable or categorised into age groups (<55/55-64.9/65-74.9/≥75 years) 
determined by the spread of the data 
BMI (kg/m2) NJR Continuous Only BMIs within range 15-60 included  
Number of comorbidities PROMs Continuous Recorded by patients as part of the pre-operative PROMs questionnaire. Total of 10 comorbidities: heart 
disease, hypertension, stroke, circulatory problem, lung disease, diabetes, kidney disease, nervous system 
disease, liver disease, cancer 
History of depression and arthritis excluded as history of depression considered separately (see below) and 
history of arthritis overlapped with indication for surgery. 
Time from operation to post-
operative PROMs questionnaire 
collection (days) 
NJR/PROMs Continuous Calculated from date of operation as recorded on the NJR database to date of post-operative PROMs as 
recorded on the PROMs questionnaire 
Gender PROMs Binary Male/Female 
Side of surgery NJR Binary Right/Left 
Pre-operative disability  PROMs Binary Indicates whether the patients considers themselves to have a disability (Yes/No) 
Pre-operative general health PROMs Ordinal Indicates the patients perception of their own general health with 5 ordered options: 
1. Excellent 
2. Very good 
3. Good 
4. Fair 
5. Poor 
Depression PROMs Binary Indicates whether patients have previously been given a diagnosis of depression   
Anxiety level PROMs Ordinal Derived from the Anxiety/depression component of the EQ5D index. Indicates their current level of 
anxiety/depression with 3 ordered options: 
1. I am not anxious or depressed 
2. I am moderately anxious or depressed 
3. I am extremely anxious or depressed  
ASA grade NJR Ordinal American Society of Anesthesiologist grade 1 to 5  
Indication for surgery NJR Binary Osteoarthritis vs. Other indication – Indication for surgery included >10 different indications. Decision taken to 
re-code this data into a binary grouping based on the observations that a) osteoarthritis was the indication in 
>95% of all operations b) all of the other indication accounted for <1% when considered individually 
Duration of symptoms PROMs Ordinal Indicates the duration of knee symptoms with 4 ordered options:  
1. <1 year 
2. 1-5 years 
3. 6-10 years 
4. >10 years 
SURGICAL VARIABLES    
Lead surgeon grade NJR Binary Consultant vs. Other grade – Lead surgeon information included 10 different surgical grades. Decision taken to 
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re-code this data into a binary grouping based on the observations that a) consultants performed >70% of all 
operations and the numbers for each of the other groups were therefore small b) interest lies in knowing 
whether not having a consultant perform you operation influences outcome, irrespective of the grade of the 
operating surgeon if they are not a consultant 
Hospital type NJR Nominal NHS funded patients either operated in 
 NHS hospital 
 Independent hospital  
 Independent Surgical Treatment Centre (ISTC) 
Type of Knee replacement NJR Nominal 4 broad groups identified 
 Total Knee Replacement (TKR) 
 Unicondylar Knee Replacement (UKR) 
 Patello-femoral Replacement (PFR) 
 Revision Knee Replacement (RKR) 
Bearing NJR Binary Fixed/Mobile bearing – Information obtained from the component codes held within the NJR 
Meniscus  
(For TKR only) 
NJR Nominal Information obtained from the component codes held within the NJR. Information grouped into three groups: 
 Cruciate Retaining 
 Posterior Sacrificed 
 Other 
Patella Resurfaced  
(For TKR only) 
NJR Binary Indicates whether the patella was resurfaced (Yes/No) 
Brand type  
(For TKR only) 
NJR Nominal Information obtained from the component details held within the NJR. The top 5 brands were chosen for 
analysis as they constituted 80% of all TKR alongside an ‘other’ group: 
 PFC® (Depuy) 
 NexGen® (Zimmer) 
 Genesis 2® (Smith and Nephew) 
 AGC® (Biomet) 
 Triathlon® (Stryker) 
 Others 
Minimally invasive surgery NJR Binary Yes/No 
Computer Navigated NJR Binary Yes/No 
PRE-OPERATIVE SCORE DATA    
Pre-operative OKS PROMs Continuous 0 worst to 48 best 
Pre-operative EQ5D PROMs Continuous Max score 1, Scores <0 indicate a state worse than death 
Pre-operative VAS PROMs Continuous Visual analogue scale scored 0 (worst) to 100 (best) 
 
Table 3.8: Summary of the explanatory patient, surgical and score variables available in the NJR-PROMs linked dataset.  
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3.5 Description of the outcome variables used in the current analysis 
Linking the NJR-PROMs datasets meant that a number of different outcome variables 
became available and could be used for as the basis for the current analyses. The variables 
available are described below and include: 
1. Implant revision. 
2. Reason for revision. 
3. Functional outcome scores. 
a. Oxford Knee Score. 
b. Euroqol 5D. 
4. Patient reported satisfaction / success. 
5. Rates of post-operative complications.  
 
3.5.1 Implant Revision 
Implant revision is the cornerstone of registry analysis. The NJR defines revision as 
“exchange of one implant for another or removal of implants as part of a staged procedure”.  
The life of every knee replacement recorded with the NJR is monitored from the time of 
implantation until the implant fails or the patient dies. At any particular point in time the 
period for which an implant has been under observation and its status (implant unrevised, 
implant revised and patient dead with implant in situ) can be determined. For an implant to 
be coded as revised a revision procedure has to be recorded on the NJR database and linked 
to the relevant primary procedure using unique NJR identifiers (NJR-NJR linkage).  In the 
early years of the registry 2003 to 2009 an alternative way of identifying revision was 
employed whereby revisions were identified in the Hospital Episode Statistics (HES) database 
(NJR-HES linkage).  
 
The influence of the different linkage methods on the revision rate was described in the 8th 
NJR Annual Report. This concluded that “while NJR-NJR linkage underestimates revisions to 
some undetermined extent it was likely that HES data is likely to overestimate revisions to 
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some degree because of the inclusion of some re-operations as revisions. It is likely then that 
the “real” revision rate lies somewhere between the two rates”. Therefore it seems that 
neither method is any better than the other as both methods have inherent flaws and, 
because there is no ‘perfect’ way of measuring revision rate it is impossible to quantify if one 
of these methods is any better of worse than the other. Presently, NJR-NJR linkage is the 
method used by the NJR for their outlier analysis of surgeons and centre survival and will be 
the only way revisions are reported from the 9th NJR annual report onwards. It is also the 
method used in a number of recent research papers published using NJR data (Jameson 
2012, Smith 2012).  In line with current NJR policy we have therefore used NJR-NJR linkage 
to identify revision procedures within the analyses presented in this thesis. 
 
3.5.2 Reason for revision 
For those knee replacements that undergo revision it is important to understand why the 
knee was revised. Differences in the mechanism of failure between implants might help to 
explain why one implant fails to a greater or lesser extent than another. It is also important 
to recognise as the mode of failure may influence survival and function of the revised 
implant. Information relating to the reason for revision is recorded on the K2 and is 
therefore available in the NJR database. The K2 form is completed by the surgical team 
immediately following revision surgery. The reason for revision is therefore recorded based 
on pre-operative clinical and radiological investigations alongside per-operative surgical 
findings. This allows the surgeon ample opportunity to determine the exact mode of failure. 
It also allows surgeons to choose more than one option when recording the reason for 
revision if multiple reasons become apparent at the time of surgery.  
 
To overcome the problem of multiple reasons for revision we employed a hierarchical 
strategy for determining the primary reason for revision. This mirrored the hierarchy used by 
the Australian Arthroplasty register (AJR-AR 2009) but was modified to accommodate the 
additional reasons for revision available on the NJRs data collection forms (table 3.7). In the 
situation where multiple reasons were stated the revision was attributed to the highest 
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ranking reason. As an example, it can be seen from table 3.9 that unexplained pain is the 
lowest ranked of the predefined reasons and as such only revisions where unexplained pain 
was stated alone were found in this category. Where unexplained pain was seen in 
combination with an additional higher ranked reason the revision was attributed to this 
additional reason.  
 
Hierarchy Reason for Revision Category 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
 
Tumour 
Infection 
Incorrect side or sizing of component 
Malalignment 
Metal sensitivity 
Loosening / Lysis 
Component dissociation 
Component wear / Polyethylene wear 
Implant breakage 
Dislocation / Instability  
Fracture of bone 
Progression of arthritis/disease 
Synovitis 
Arthofibrosis / Stiffness 
Osteonecrosis/AVN 
Heterotopic bone 
Unexplained pain 
Other (if not listed above) 
No reason stated 
 
Dominant diagnosis independent of prosthesis 
Dominant diagnosis independent of prosthesis 
Related to surgical procedure 
Related to surgical procedure 
Reaction to prosthesis 
Reaction to prosthesis 
Wear and implant breakage 
Wear and implant breakage 
Wear and implant breakage 
Stability of prosthesis/ knee 
Fracture of bone 
Progression of disease in non-operated part of joint 
New disease occurring in association with prosthesis 
New disease occurring in association with prosthesis 
New disease occurring in association with prosthesis 
New disease occurring in association with prosthesis 
Pain 
Remaining diagnoses 
 
 
Table 3.9: Hierarchy of revision used to determine primary reason for revision where more 
than one reason for revision was recorded (adapted from Australian National Register (AJR-
AR 2009)). 
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3.5.3 Functional outcome scores 
A. Oxford Knee Score 
The Oxford Knee Score (OKS) is a disease specific patient administered questionnaire 
exploring the patient’s subjective assessment of pain, function and ability to perform 
activities of daily living (ADL’s) following knee replacement surgery (Dawson 1998). It is a 12-
part questionnaire (table 3.10) assessing patient perspectives of those factors linked to 
outcome. The answer to each question is rated on a scale ranging from 0 to 4 with lower 
scores indicating more severe problems. The scores for each question are added to generate 
an overall score between 0 and 48, with 0 representing the worst possible score, and 48 the 
best possible score. 
 
In a review of health instruments for the assessment of the knee the OKS was found to be a 
reliable (extent to which the items of the instrument measure the entity, stability of the 
instrument over time), valid (extent to which the instrument measures what it is supposed 
to measure) and responsive (ability of instrument to measure significant change over time) 
measurement when compared to other regularly used patient reported outcome measures 
(Garratt 2004). Twinned with the fact that it is simple, easy to administer and suitable for 
following up patients in the longer term it has been recommended as an appropriate disease 
specific tool for assessing outcomes following total knee replacement (Davies 2002). It has 
also been recommended in preference to the WOMAC for large knee arthroplasty databases 
in a cross sectional population (Dunbar 2001). The method by which the OKS was chosen as 
the disease specific metric for the PROMs project is discussed in section 3.4.3. 
 
Possible weakness with the OKS include the influence of coexistent hip or spinal pathology, 
which can significantly alter both the absolute score and any improvement to be expected 
after surgery (Harcourt 2001). Some patients have also identified areas of weakness within 
the score including a lack of question clarity, difficulty in reporting measurements of pain 
and restrictive and irrelevant questions. They also highlighted the influence and effects of 
co-morbidity on response (Wylde 2005). 
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Question number Question 
1 Describe the pain you usually have from your knee?  
2 How much trouble do you have washing and drying yourself?  
3 How much trouble do you have getting in/out car or using public transport?  
4 How long can you walk before pain becomes severe?  
5 After meal how painful has it been to stand up from a chair?  
6 Have you been limping when walking?  
7 Could you kneel down and get up again?  
8 Have you been troubled by pain in bed at night?  
9 How much has pain from your knee interfered with your normal work?  
10 Have you felt your knee might suddenly give way or let you down?  
11 Could you do the shopping on your own?  
12 Could you walk down a flight of stairs?  
Table 3.10: Summary of the component questions of the Oxford Knee Score (Also see 
Appendix iii). 
 
B. Euroqol-5D (EQ5D) 
The EQ5D is a simple, generic measure of health used for clinical and economic appraisal. It 
provides two separate measures of general health, the EQ5D index and the EQ5D VAS. The 
EQ5D index assesses five dimensions of health (mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression) each graded 1 to 3 (Table 3.11 and Appendix III). 
Level 1 represents no problems and Level 2 and 3 represents difficulties, either moderate 
(Level 2) or severe (Level 3). Outcomes of this score can be reported in a table of the 
proportion of patient in each category before and after the intervention under investigation. 
In this method of reporting the final scores do not have arithmetic properties and are 
therefore not suitable for use as a cardinal score. Alternatively the scores can be combined 
using population weighting to produce the EQ5D index, a single measure of health status 
with a maximum possible value of 1 and a score below 0 indicating a state worse than death. 
The EQ5D health VAS (0-100 Visual Analogue Scale) provides an additional assessment of 
patient well-being.   
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EQ5D domain Possible responses 
By placing a tick in one box in each group below, please indicate which statements best describe 
your own health state today. 
Mobility - I have no problems in walking about  
- I have some problems in walking about  
- I am confined to bed 
Self-Care - I have no problems with self-care  
- I have some problems washing or dressing myself  
- I am unable to wash or dress myself 
Usual Activities 
(e.g. work, study, housework, 
family or leisure activities) 
- I have no problems with performing my usual activities  
- I have some problems with performing my usual activities  
- I am unable to perform my usual activities 
Pain/Discomfort - I have no pain or discomfort  
- I have moderate pain or discomfort  
- I have extreme pain or discomfort 
Anxiety/Depression - I am not anxious or depressed 
- I am moderately anxious or depressed 
- I am severely anxious or depressed 
Table 3.11: Component parts of the EQ5D index (Also see Appendix iii). 
 
3.5.4 Patient reported Satisfaction / Success 
The PROMs questionnaire asks about patient satisfaction with their surgery by asking: “How 
would you describe the results of your operation?”. Responses are recorded on a 5 point 
Likert scale with the possible answers: ‘Excellent’, ‘Very Good’, ‘Good’, ‘Fair’ and ‘Poor’.  
Success is assessed by asking patients “Overall, how are the problems now in the knee on 
which you had surgery, compared to before your operation?” with possible responses ‘Much 
better’, ‘A little better’, ‘About the same’, ‘A little worse’, ‘Much worse’. Success measures 
the patient’s perception of whether they have symptomatically improved following surgery 
whereas satisfaction measures the extent to which they are happy with this improvement. 
 
In both of these scales the first category is the best response and the fifth category the worst 
response. The ordinal scales used to assess satisfaction and success have not been validated. 
However, they do mirror similar adjectival scales used for assessing patient reported 
satisfaction in national cohorts (Robertsson 2000, Noble 2006, Howie 2010). The benefit of 
these scales is that they give a simple representation of the patient’s perceptions of the 
results of surgery. In this respect they complement some of the more frequently used 
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validated outcome scores by appreciating the individual patient’s experiences, instead of 
focusing on hard symptomatic endpoints.  
 
3.5.5 Rates of post-operative complications 
As part of their post-operative assessment patients are asked if they developed any of 6 
specific complications following surgery (allergic reaction, urinary problems, wound 
problems, bleeding problems, readmission and need for further surgery). These questions 
form part of the patient’s experience of surgery questionnaire which has previously been 
used to audit complications after day case surgery (Audit Commission 1991, Smith 2005). 
The interpretation of what constitutes a complication is at the discretion of the patient and 
no attempt is made to verify the presence of these complications from the medical records. 
This information is particularly useful when comparing groups for which the interpretation of 
a complication is expected to be similar such as after different type of knee replacement. 
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3.6 Statistical considerations 
To achieve the objectives of each analysis a number of complementary statistical techniques 
were employed. An overview of these techniques is given in the following section. The 
details of the statistical methods used for specific analyses are discussed within the chapters 
relating to those analyses (Chapters 4 to 6).  
 
3.6.1 Basic data analysis and simple comparative analysis 
Prior to analysis the data was interrogated using graphical (scatterplots, histograms, interval 
plots etc.) and tabular summaries along with simple summary statistics (mean, median, 
standard deviation, range). This determined the distributions and characteristics of these 
data so that appropriate statistical analysis could be employed. For example, analysis of the 
Oxford Knee Score data demonstrated that the pre-operative score was approximately 
normally distributed with a slight right skew, the post-operative OKS was heavily skewed to 
the left with an abrupt cut-off at the top end of the scale (score 48), and that the change in 
score was approximately normally distributed (figures 3.6 to 3.8). A similar effect was seen 
for both the EQ5D index and EQ5D VAS. These findings demonstrated that the change in 
score was a much better outcome variable to model that the change in score based on its 
superior distribution characteristics.  For comparative analysis the continuous variables were 
analysed using independent Student’s t-tests, and one-way analysis of variance (ANOVA). 
Within ANOVA post hoc between groups comparisons were performed using the Bonferroni 
method. Categorical data was analysed using Fisher’s exact test and Chi squared tests.  
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Figures 3.6, 3.7 and 3.8: Histograms deonstrating the distibutions of the pre-operative (top), 
post-operative (middle) and change (bottom) in Oxford Knee Score (OKS). 
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3.6.2 Survival analysis 
For all of the survival analyses a revision procedure, as defined and recorded by the NJR was 
considered to be a ‘failure event’. For each implant its status (Revised/Unrevised/Patient 
death with implant in situ) and the period for which it had been under observation was 
determined based on a census date of 31st December 2010.  The time between the index 
procedure and any subsequent revision measured the joint’s survival.  Information on 
patients who had died before the census date was obtained through the United Kingdom 
Office for National Statistics (ONS).   
 
Survival analyses were conducted in accordance with the recommendations of the Nordic 
Arthroplasty Register Association (NARA) study group (Ramstam 2011). Survival analyses are 
often conducted using one of two approaches, the life-table approach (Cutler 1958) and the 
Kaplan-Meier (product-limit) approach (Kaplan 1958). In both methods the survival is 
calculated as the cumulative probability that an implant will survive through a set of time 
points. However, they differ in that life-tables are calculated for a set of pre-defined time 
intervals whereas Kaplan-Meier analysis defines the time intervals to include only one event 
(revision) and is therefore independent of a subjective choice of time intervals (Ramstam 
2011).  While Kaplan-Meier analysis is usually preferred (Ramstam 2011) both methods have 
been advocated for the reporting of arthroplasty data (Murray 1993). Both Kaplan-Meier 
and life-table analysis methods were employed in the reporting of our survival data 
(Armitage 1994). 
 
One issue with survival analysis is the influence of the competing risk of death. This problem 
particularly effects survival analysis performed over longer and longer periods as more and 
more patients are likely to die with time. It has been argued that the presence of a risk of a 
competing event may bias Kaplan-Meier survival estimates (Biau 2007). However, others 
have argued that because standard Kaplan-Meier analysis is based on the assumption that 
patient will be alive until the implant fails it give a more logical, understandable and clinically 
relevant survival estimate (Ramstam 2011). Currently the NARA group recommend that it is 
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appropriate to use Kaplan-Meier methods, however if this method is used the number and 
type of censored observations should be described (Ramstam 2011). For these analyses we 
have therefore used the standard Kaplan-Meier methods in addition to reporting why 
observations were censored (revision or death).  
 
For a number of analyses we were interested in comparing survival between a large 
numbers of groups (up to 900 groups). In this situation conventional Kaplan-Meier plots and 
life tables are impractical. This problem was overcome by calculating the number of 
revisions per 100 component years for each group. This was done by firstly determining the 
cumulative period of observation for all implants within a given group. Knowledge of the 
number of revisions within this group during the period of observation is then used to 
calculate the number of revisions per 100 component years. This information could then be 
graphically represented using funnel plots allowing a visual comparison of the data to be 
made (Spiegelhalter 2005). For the purposes of these analyses funnel plots were constructed 
using +/- 3 standard errors of the mean which can be considered as 99% confidence intervals 
for the mean.  
 
For a number of analyses we were interested in whether there was a difference in survival 
between one or more groups. Survival comparisons were made using the Mantel Hantszel 
Log-rank test (Mantel 1959). The benefit of this test is that it compares survival based on the 
total follow-up rather than at a pre-specified point chosen by the investigator. The choice of 
time point can influence the estimated difference in survival between groups making it a 
possible source of bias and by using the log-rank test this problem is mitigated. 
 
For many comparisons there may be systematic differences in demographics of the groups 
being compared. Patient and surgical factors may influence implant survival. Differences in 
these variables between groups may therefore affect the validity of results by confounding 
bias (Ramstam 2011). This problem was partly overcome using Cox proportional hazard 
models. In these models, the contribution of potential risk factors to the risk of the event 
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occurring can be quantified (Therneau 2000) by determining the extent to which the timing 
of event is explained by the measured patient and surgical factors. The Cox model assumes 
that there is an underlying unspecified baseline hazard that stays constant through time and 
that is influenced by covariates that mitigate or enhance the risk of failure. The model is 
based on the assumption that the hazards of failure for comparative groups are 
proportional. Results obtained using this method are biased if the proportionality 
assumption is violated (Ramstam 2011).  The main reason for non-proportionality is that a 
factor’s effect on survival varies with time.  Prior to modelling we therefore investigated the 
constant proportionality over time assumption by assessing the influence of time on each of 
the factors included within the models. This was achieved by creating time-dependent risk 
factors which were included in the Cox models.  
 
Cox-models were used in two specific ways. Firstly, they were used to investigate which 
factors influence the hazard of failure. This was achieved using forward (from the null 
model) and backward (from the full model) stepwise regression. Having determined the 
factors that influenced survival the model was re-evaluated as a directly entered model 
(non-stepwise) to provide unconditional factor estimates. Secondly, they were used to 
adjust for differences in patient and surgical factors that could potentially confound 
comparison of a pre-specified group. In this situation a directly entered model (non-
stepwise) was created including all of the ‘adjuster’ variables with the comparative group of 
interest added last to provide factor estimate for the group of interest conditional on the 
‘adjuster’ variables. In all of the final models the combined influence of variables was 
determined by exploring 2-way interactions between the included covariates. 
 
3.6.3 Generalised linear modelling 
In similarity to survival comparisons, the validity of PROMs comparisons between groups 
may also be confounded if there are systematic differences in demographics of the groups 
being compared. Generalised linear modelling was therefore used to explore the influences 
of a number of explanatory variables upon our key PROMs outcomes, namely the change in 
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Oxford Knee Score, the change in EQ5D index, the presence of post-operative complications, 
the rates of patient satisfaction. Once the factors influencing the PROMs and the size of their 
effects were known the models could then be used to make adjustments for any differences 
in these factors between the comparative groups of interest.  
 
Generalised linear modelling is a term relating to the unified approach to the analysis of a 
whole host of useful regression models including the normal linear regression model, the 
binary and Poisson regression models and a range of others models (OU 2009). For data that 
was approximately normally distributed (OKS change, EQ5D change) multivariable linear 
regression models were used. For data that was binary or ordinal (complication rate, 
satisfaction) ordinal logistic regression models we used.  
 
For all modelling a standardised procedure was employed: 
Step 1: Graphical analysis of the explanatory and outcome variables to characterise their 
distributions. This enabled appropriate models for the outcomes of interest to be chosen 
and allowed explanatory variables to be entered correctly into the model (either and 
continuous, ordinal, nominal or binary data).  
Step 2: Exploration of the relationships between variables to be included in the model using 
scatterplot matrices and correlation matrices (figure 3.9 and table 3.12). This gives an overall 
impression of the strength of relationship between variables and therefore which variables 
are likely to appear in the final regression models. 
Step 3: The influence of each explanatory variable in isolation was explored by creating 
univariate regression models.  
Step 4: The influence of variables in combination was explored by creating ‘full’ multivariate 
models. 
Step 5: Models were then limited to only the variables with a significant influence using 
backward stepwise regression from the ‘full’ model. The modelling process was repeated 
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using forward stepwise regression from the ‘null’ model to assess the effect of the direction 
of modelling on the variables included in the final model. Where there was discrepancy 
variables were added and removed from the model individually and their influence assessed 
subjectively based on the amount of variation in the outcome variable they explained (Wald 
test statistic) and their significance level (p-value). The significance levels employed varied 
dependent upon the type of analysis and the size of the dataset. p-values of p<0.01 to 
p<0.001 were used given the large number of patients and variables available to ensure a 
parsimonious model was achieved and to limit the effects of type I error.  
Step 6: Having determined the variables that had a significant influence the models were 
then re-evaluated as a directly entered model (non-stepwise) to provide unconditional 
estimates for each variable. These models were then used to make adjusted comparisons 
between groups of interest. 
Step 7:  The influence of interactions between variables within the final models were 
assessed by investigating their 2 way interactions. Significant interactions were investigated 
graphically to quantify their effects.   
Step 8: Linear regression model adequacy was assessed using standard analysis of residuals, 
leverage and Cooks statistics (figure 3.10). Ordinal logistic regression model identifiability 
was assessed on the basis of a condition number of Hessian of <104. Where the condition 
number of the Hessian was in excess of this value the models were rejected on the basis of 
being ill-conditioned. Ordinal logistic regression assumes that the relationship between each 
pair of outcome groups is proportional. This means that the impact of any covariate on each 
step up (or down) the ordinal scale remains the same with equivalent coefficients (and 
hence parallel regression lines across all levels of the ordinal scale). The extent to which the 
proportionality assumption was valid was assessed using the graphical methods described by 
Bender (1997) and Gould (2000) (figure 3.11).   
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Figure 3.9: Scatterplot matrix demonstrating the relationships between the pre, post and 
change in EQ index and the pre, post and change in the OKS 
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 PreEQindex PostEQindex ChangeEQindex PreOKS PostOKS ChangeOKS 
PreEQindex 
 
-      
PostEQindex 0.359 
p<0.001 
-     
ChangeEQindex -0.612 
p<0.001 
0.518 
p<0.001 
-    
PreOKS 0.696 
p<0.001 
0.369 
p<0.001 
-0.326 
p<0.001 
-   
PostOKS 0.344 
p<0.001 
0.781 
p<0.001 
0.347 
p<0.001 
0.408 
p<0.001 
-  
ChangeOKS -0.137 
p<0.001 
0.556 
p<0.001 
0.597 
p<0.001 
-0.280 
p<0.001 
0.762 
p<0.001 
- 
Table 3.12: Correlation matrix demonstrating the correlations between the pre, post and 
change in EQ index and the pre, post and change in the OKS. Values in each box are the 
Pearson correlation co-efficient between the two variables and the associated p-value. Data 
taken from analysis 5.  
 
 
 
Figure 3.10: Example of standard 4 in 1 residuals plots used in the assessment of model 
adequacy. Data taken from analysis 1. 
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Figure 3.11: Example of the graphical plots used to assess the proportionality assumption as 
part of the ordinal regression modeling process. Data taken from analysis 6.  
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3.6.4 Structured equational modelling (SEM) 
SEM investigates relationships among different processes by partitioning relationships 
among variables on the basis of a hypothetical pathway of interactions identified prior to 
analysis. It effectively challenges a prior hypothetical model of a system using observed data 
for that system.  The paths between variables are defined in equation form with response 
variables related to two or more explanatory variables. The response variables in one 
equation then form the explanatory variables in other equations. SEM tests whether the 
variables in the path are interrelated by analysing their variances and co-variances.  
 
Our SEM modeling procedure was first to fit a full model with all hypothesised pathways and 
then to remove all non-significant paths to create the simplest model containing only 
significant pathways. This was determined by two measures of model fit (Root Means 
Square Error of Association (RMSEA) and Goodness of Fit Index (GFI)) (Kline 2003) and the 
paths standard errors with boot-strapped 95% confidence limits. SEM is usually based on 
analysis of a covariance matrix, expressing how each of the drivers and outcomes in the 
system of interest co-vary.   Since our data were a mixture of variable type (categorical, 
ordinal, continuous, binary) we used polychoric correlations to create a correlation matrix 
for analysis in the SEM.  Polychoric correlations allow estimation of correlation between 
ordinal and (when extended to tetrachoric correlations) categorical variables.  These 
correlations are rarely bivariate normal so this means that standard errors on parameter 
estimates derived from a SEM analysis are likely to be biased (Fox 2006).  We therefore used 
a Bootstrapping approach to estimate means and standard errors for the SEM parameter 
estimates.  Bootstrapping was undertaken by running the model 200 times with 200 
separate sets of data. The rationale was that analysing the mean and standard deviations of 
the 200 random subsets of the data this would provide an unbiased estimate of the SEM 
parameter estimates. This non-normality meant that the standard errors of the parameter 
estimates for the SEM are unlikely to be reliable; accordingly we used Monte Carlo 
approaches to assess the SEM. Our rationale was if a model was adequate with a subset of 
the data then we would have very conservative estimates of the impacts of the individual 
pathways in the overall model.   
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3.6.5 Sample sizes 
As part of their PROMs feasibility analysis Browne (2007) calculated the sample sizes needed 
for PROMs comparisons using estimates for the minimally important differences and 
standard deviations for the EQ5D and OKS. These are detailed in table 3.13 and are 
presented for a number of different power and significance levels. The sample sizes used in 
the current analyses were in excess of these minimum numbers suggested by Browne 
(2007). 
 
 Distribution based 
 0.05 significance level 0.002 significance level 
 80% power 95% power 80% power 95% power 
Oxford knee score 103 171 203 294 
EQ5D (for knees) 53 87 104 150 
 
Table 3.13: Distribution based sample size details for the Oxford Knee Score and the EQ5D 
for knees. 
 
3.6.6 Statistical packages used for the current analyses 
Statistical analysis was performed using Genstat 10th Edition (Lawes Agricultural Trust, 
Hemel Hempstead, UK), Minitab version 16 (Minitab Inc., Coventry, UK.) and the Statistical 
Package for the Social Sciences SPSS v19.0 (SPSS Inc., IBM Corporation, Armonk, New York). 
Structured equational modelling analysis was performed using the R statistical package (R 
Foundation for Statistical Computing, Vienna, Austria). 
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Chapter 4: Clinical outcomes after unicondylar knee replacement 
4.1 The on-going debate about the role of the unicondylar knee replacement (UKR) 
The number of unicondylar knee replacements (UKRs) performed in England and Wales 
continues to rise. In 2010, 6995 UKRs were registered with the National Joint Registry (NJR), 
a substantial increase from 2226 recorded in 2003, even allowing for the incomplete 
registration of patients at the inception of the NJR (NJR-AR 2012). Reports from specialist 
centres suggest that UKRs have clinical outcomes and survival equivalent to those of total 
knee replacement (TKR) when followed for 10 to 15 years (Svard 2001, Price 2005, Newman 
2009, Pandit 2011). Independent analysis of the use of UKR in the United Kingdom NHS has 
suggested it to be cheaper, functionally superior and under-used (Willis-Owen 2009). 
However, while some non-specialist centres have been able to replicate the success of these 
specialist centres (Keys 2004, Rajesekhar 2004, Lisowski 2011), others have not (Fehring 
2010, Mercier 2010, Dervin 2011).   
 
The results reported from specialist centres are also not reflected in registry outcomes, 
where revision rates for UKRs are significantly higher than for TKRs (NJR-AR 2012, Koskinen 
2008, Davidson 2009, Lidgren 2009). In the most recent NJR report the seven-year revision 
rate for UKR (16.6% (95% CI 15.3 to 18.1)) was markedly higher than that observed for 
cemented TKR (3.8% (95% 3.7 to 4.0)) (NJR-AR 2012). This finding mirrors the rates reported 
in the Australian registry, where the ten-year revision rates for UKR and TKR are 15.1% and 
5.7%, respectively (Davidson 2009). Recent analysis from the Finnish registry reported that 
UKR was not cost-effective when the overall survival and cost of revision were considered at 
a national level (Koskinen 2008). National registry data also suggests that a unicondylar 
replacement converted to a total knee replacement performs poorly in comparison to a 
primary total knee replacement (Pearse 2010) and is no better in terms of survival than 
revision total knee replacement (Dudley 2008). This has led to additional concern over the 
higher revision rates observed for unicondlyar replacements. The performance of this 
implant in the hands of the ‘average’ orthopaedic surgeon and its wider use in the setting of 
the National Health Service therefore remains a matter of considerable debate.   
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Advocates of UKR defend the differences between UKR and TKR observed in registries by 
arguing that registries simply look at revision rate in isolation without considering the 
greater functional gains, which this implant type should theoretically produce (Goodfellow 
2010, Cobb 2010).  Following any operation, the patient’s perception of the outcome is 
fundamental. Greater improvements in patient-reported outcome measures (PROMs), 
following UKR when compared to TKR may allay some of the concerns about implant survival 
and the cost-effectiveness of the former.  
 
It has also been suggested that discrepancies in the revision rate may also be partly 
explained by differential revision thresholds for these types of implant (Goodfellow 2010, 
Cobb 2010), but nevertheless the data represent a reflection of the reality of current 
practice.  The surgical threshold to proceed to revision may be influenced by the existing 
implant and potential surgical challenges faced. Such surgical selection bias is not currently 
accounted for when using revision as an outcome measure. Indeed, the use of revision as 
the sole endpoint has been challenged as unfairly discriminating against UKR for which 
excellent centre outcomes exist (Murray 1998, Keys 2004, Newman 2009, Lisowski 2011, 
Pandit 2011). Both Cobb (2010) and Goodfellow et al (2010) have highlighted the paradox 
observed in the data published from the New Zealand Registry (NZJR-AR 2010) which 
demonstrates equivalent excellent early and mid-term functional outcome scores for both 
implant types, but a marked difference in survivorship with consistently higher revision rates 
for UKR. Despite equivalent knee scores, a UKR was between four to six times more likely to 
be revised than a TKR with the same outcome.  This suggests that UKR may be more 
susceptible to revision, especially in the case of implants presenting with unexplained pain 
(Cobb 2010, Goodfellow 2010). 
 
A further criticism of registry analysis of UKR data has been a failure to examine medial and 
lateral UKR separately. Survival rates for UKR stratified by implant laterality are not currently 
available in any registry report, as implants are pooled together for the purpose of analysis. 
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The vast majority of UKR (>90%) are implanted in the medial compartment of the knee and if 
laterally inserted implants were to have a high failure rate the pooled analysis used by 
national registries may bias the results of medially inserted implants. This argument is 
supported by a number of small, historical studies which have reported high failure rates of 
82% to 83% at five to ten years in patients undergoing lateral UKR (Heyse 2010, Gunther 
1996, Ashraf 2002). However, recent publications have reported ten-year survival rates of 
92% (Argenson 2008) and 98% (Lustig 2011), with some series reporting 100% survival at a 
mean of 5.2 years (Sah 2007) and 12.4 years, respectively (Pennington 2006). Therefore the 
true survival and the influence of lateral UKRs with registry analyses remains unclear.  
 
UKR is a technically demanding procedure with a long learning curve (Hamilton 2010). This 
has led to concerns about how these implants perform in the hands of surgeons and centres 
that are unable to maintain their surgical experience as they perform small numbers of these 
procedures. The literature suggests that rates of revision are heavily dependent upon the 
reporting institution (Labek 2011), with the best results coming from institutions involved in 
the design of these implants and independent advocates of UKR (Murray 1998, Keys 2004, 
Newman 2009, Lisowski 2011, Pandit 2011), and the worst results coming from registry 
analyses (Koskinen 2008, Davidson 2009, Lidgren 2009, NJR 2012,). Revision rates from the 
best centres are comparable to TKR suggesting that higher operative volumes and surgical 
enthusiasm improve revision outcomes. This contention is supported by registry data from 
Sweden where lower rates of UKR revision were found in centres performing the highest 
operative volumes (>23/year) when compared to all other centres (Robertsson 2001). A 
similar association between revision rate and unit volume have also been reported for TKR 
(Katz 2004, Marlow 2010) and may be an indication of the standards of patient selection and 
operative performance employed in these centres (Robertsson 2001). 
 
Ultimately these concerns need to be addressed to allow the debate regarding the use of 
UKR to move forward.  The HTA funded Total or Partial Knee Arthroplasty Trial (TOPKAT) 
(HTA ref: 08/14/08, grant £2,700,878) is currently the only prospective nationally funded 
trial assessing the role of UKR. The trial aims to “assess the clinical and cost effectiveness of 
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Total Knee Replacements versus Unicompartmental Knee Replacements in patients with 
medial osteoarthritis”.  Recruitment has only recently commenced and it is not expected to 
publish until early 2020. It will therefore be a number of years before this trial can offer 
anything useful to this debate, a debate which may have moved on as newer implants and 
methods of surgery are developed. The scope of this trial is also limited as, due to its design 
and primary aim, it can only assess short and mid-term clinical outcomes (function and 
complications) and cannot assess longer term concerns such as the rate of revision and 
mode of failure. For the same reasons it will also be unable to assess the impact of variables 
such as surgeon volume upon implant survival and will be restricted to the analysis of medial 
UKR.   
 
It may be possible to address a number of the issues raised above using registry data. The 
NJR and PROMs data available was therefore used in an attempt to answer a number of 
questions about UKR. These included: 
1. Do patients undergoing UKR experience greater improvements in knee specific 
function and general health measures and lower rates of complications than patient 
undergoing TKR?  
2. How do the reasons for revision differ between UKR and TKR and are more UKR 
revised for unexplained pain when compared to TKR 
3. What proportions of all UKRs are implanted in the lateral compartment of the knee 
and are UKR survival influenced by implant laterality?  
4. What patient and implant factors influence failure of medial and lateral UKRs and 
does their mode of failure differ? 
5. How many different centres and surgeons are performing UKR and in what amounts?  
6. Is there an association between centre and/or surgeon volume and revision rate for 
UKR?  
7. If surgeons perform high volumes of UKR do they achieve revision rates comparable 
to those seen with cemented TKR? 
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These questions are addressed in the subsequent 4 analyses.  
1. Analysis of functional improvements and rates of complications for UKR and TKR.  
2. Analysis of the reasons for revision and rates of failure for unexplained pain for UKR 
and TKR. 
3. Analysis of the reasons for revision and rates of failure for medial and lateral UKR. 
4. Analysis of the effect of centre and surgeon operative volume on UKR rates of failure. 
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4.2 Analysis 1: Analysis of functional improvements and rates of complications for UKR and 
TKR  
 
Analysis 1: Aim: 
To determine if patients undergoing UKR experience greater improvements in knee specific 
function and general health measures and lower rates of complications than patient 
undergoing TKR.  
 
Analysis 1: Methods:  
This analysis was performed on the NJR-PROMs dataset described in section 3.4.4. All 23,393 
TKR and 505 UKR were used for the analysis (table 3.7 section 3.4.4). PROMs questionnaires 
were collected at medians of 15 days pre-operatively (15 days (0 to 90) and 12 days (0 to 90) 
for TKR and UKR, respectively) and 199 days post-operatively (199 days (180 to 365) and 199 
days (180 to 349) for TKR and UKR, respectively). Comparison of the demographics of the 
two groups demonstrates that there were marked differences between them, with the UKR 
patients being younger and in better overall health. The UKR group also had a greater 
proportion of males, operations performed in independent centres, and operations 
performed by a consultant (table 3.7 section 3.4.4).  
 
Initial comparisons of the patient demographics and PROMs for the TKR and UKR groups was 
undertaken using a combination of independent-samples t-tests for continuous data, 
Fisher’s and chi-squared tests for categorical data, and ordinal logistic regression for ordinal 
data. As with the PROMs feasibility pilot (Browne 2007) we aimed to compare the two 
implant types according to change in disease-specific PROM (OKS), change in generic PROM 
(EQ5D index), presented as both the EQ5D index value and in the tabular format 
recommended by the EuroQol group, and proportion of patients reporting any of the six 
recorded complications (see sections 3.5.3 and 3.5.5). 
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In order to allow a meaningful comparison between UKR and TKR it was important to 
account for differences in case mix (patients’ characteristics), which could be potential 
confounding factors in any comparative analysis. We therefore sought to determine the 
case-mix variables which explained the largest proportion of the variance in each of the 
PROMs outcomes of interest. This was achieved using the standard modeling processes 
described in section 3.6.3. The models included all patient characteristics and clinical factors 
collected routinely by the NJR and pre-operative PROMs questionnaire pertinent to the 
comparison of UKR and TKR (table 3.8). In order to help limit the effects of multiple testing 
and ensure we had a model containing only the most important variables, the final models 
included only those variables that were significant at a p-value of < 0.001. Whereas body 
mass index (BMI) was significant (p < 0.001) in the models relating to the change in OKS and 
EQ5D index, there were sufficient concerns about the quantity of missing data 
(approximately 40%) and the possibility for recording bias that we excluded it from the 
model. Also, within the models BMI was only responsible for a small amount of the 
explained variance, and was correlated with other more influential variables responsible for 
a greater proportion of the explained variance in the model (pre-operative OKS: r = -0.22, p < 
0.001; Age: r = -0.25, p < 0.001).  
 
Using these models we were able to ‘adjust’ the observed PROMs outcomes taking into 
account the inherent background variability associated with each of the two types of 
implant. Adjustment was performed by comparing the differences in final model residuals 
for TKR and UKR. This effectively compares the differences in the residual variation 
associated with the two groups after the variation associated with the factors included in the 
final model has been accounted for. PROMs data for both the ‘unadjusted’ (direct reporting 
of the PROMs without accounting for case-mix variation) and ‘adjusted’ (PROMs adjusted for 
case-mix variation) outcomes for TKR and UKR were reported, so that the effects of 
adjustment for each outcome could be observed.  
 
For the smaller UKR group, power calculations were undertaken to assess the size of effect 
that could be confidently detected, based on the sample size and standard deviations of the 
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change in OKS and EQ5D index. With a power of 80% and significance of p = 0.01 we could 
detect a difference in the change in OKS of 2.1 points and a difference in the change in EQ5D 
index of 0.07 points. These differences were below the effect sizes felt to be clinically 
significant for these two scores. Owing to the effects of multiple statistical testing within this 
analysis, borderline p-values between 0.01 and 0.05 should be interpreted with caution, and 
a p-value of < 0.01 was therefore used to indicate statistical significance. Model residuals 
and other checks of model adequacy were satisfactory and there were no significant 2-way 
interaction between variables included within the final models.  
 
Analysis 1: Results:  
Unadjusted PROMs: There were significant post-operative improvements in knee-specific 
and generic PROMs for both types of implant (table 4.1 and 4.2). Analysis of the unadjusted 
PROMs showed that the improvements in OKS and EQ5D were greater following TKR than 
following UKR, although the post-operative PROMs were better after UKR (table 4.1). These 
differences were largely explained by the differences in the pre-operative baseline scores for 
each of the two groups, emphasising the need to correct for these differences when 
analysing these data. The unadjusted overall rates of complications were similar for the two 
groups, although there was a trend for lower rates of wound complications (p = 0.02), lower 
rates of readmission (p = 0.02) and a higher rate of patients requiring further surgery (p = 
0.02) in the UKR group (Table 4.3). 
 
Outcome measure TKR UKR p-value 
Mean OKS (95% CI)    
Pre-operative 18.9 (18.8 to 19.0) 21.5 (20.8 to 22.2) < 0.001 
Post-operative 34.0 (33.9 to 34.2) 35.5 (34.5 to 36.4) 0.002 
Change 15.1 (15.0 to 15.3) 13.9 (13.1 to 14.8) 0.007 
    
Mean EQ5D (95% CI)     
Pre-operative 0.407 (0.403 to 0.411) 0.470 (0.442 to 0.497) < 0.001 
Post-operative 0.710 (0.707 to 0.714) 0.736 (0.711 to 0.760) 0.04 
Change 0.303 (0.298 to 0.307) 0.266 (0.236 to 0.296) 0.02 
Table 4.1: Comparison of the unadjusted patient reported outcome measures for total knee 
replacement (TKR) and unicondylar knee replacement (UKR) Key:  OKS, Oxford knee score; 
EQ5D, EuroQol-5D. 
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 Pre-operative  Post-operative  
EQ5D dimension TKR UKR p-value TKR UKR p-value 
Mobility (n, %)       
Level 1 1383 (6) 43 (9) 0.07 10 713 (46) 260 (52) 0.009 
Level 2 21 582 (92) 455 (90)  11 909 (51) 224 (44)  
Level 3 47 (0) 0 (0)  31 (0) 0 (0)  
Not recorded 381 (2) 7 (1)  740 (3) 21 (4)  
Self-care (n, %)       
Level 1 15 934 (68) 369 (73) 0.06 17 839 (76) 400 (79) 0.04 
Level 2 6917 (30) 122 (24)  4734 (20) 81 (16)  
Level 3 142 (1) 3 (1)  135 (1) 2 (0)  
Not recorded 400 (2) 11 (2)  685 (3) 22 (4)  
Usual activities (n, %)       
Level 1 2000 (9) 55 (11) 0.07 9554 (41) 238 (47) 0.03 
Level 2 17 885 (77) 391 (77)  11 958 (51) 228 (45)  
Level 3 3065 (13) 50 (10)  1104 (5) 20 (4)  
Not recorded 443 (2) 9 (2)  777 (3) 19 (4)  
Pain/discomfort (n, %)       
Level 1 224 (1) 6 (1) < 0.001 7294 (31) 188 (37) 0.01 
Level 2 13 604 (58) 343 (68)  13 850 (59) 263 (52)  
Level 3 9003 (39) 144 (29)  1337 (6) 31 (6)  
Not recorded 562 (2) 12 (2)  912 (4) 23 (5)  
Anxiety/depression (n, %)       
Level 1 14 343 (61) 312 (62) 0.67 17 270 (74) 362 (72) 0.30 
Level 2 7652 (33) 162 (32)  4783 (20) 111 (22)  
Level 3 798 (3) 21 (4)  509 (2) 8 (2)  
Not recorded 600 (3) 10 (2)  831 (4) 24 (5)  
Table 4.2: Comparison (%) of the pre- and post-operative responses for each of the five 
EuroQol (EQ5D) domains (Level 1, no problems; Level 2, moderate problems; Level 3, severe 
problems; NR, not recorded; TKR, total knee replacement; UKR, unicondylar knee 
replacement). 
 
Post-operative complications (n, %) TKR 
(n = 23,393) 
UKR 
(n = 505) 
p-value 
Allergy 3870 (17) 65 (13) 0.03 
Urinary tract infection  2525 (11) 50 (10) 0.52 
Bleeding problems 1533 (7) 27 (5) 0.28 
Wound problems 2808 (12) 43 (9) 0.02 
Readmission 2290 (10) 33 (7) 0.02 
Further surgery 848 (4) 28 (6) 0.02 
Patients stating ≥ 1 of the above complications (n, %) 8985 (38) 177 (35) 0.12 
Table 4.3: Comparison of patients’ reported post-operative complications following total 
knee replacement (TKR) and unicondylar replacement (UKR). 
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Development of risk-adjustment model: Regression models were generated for each of the 
response variables of interest (change in OKS, change in EQ5D index, and rate of 
complications). Initial univariate analysis of the effect of the implant type on the PROMs 
outcomes showed there was a relationship for the change in OKS (p = 0.007) and EQ5D index 
(p = 0.02) but not the rate of complications (p = 0.12). This is consistent with the preliminary 
unadjusted analysis. However, once all other variables were entered into the model the 
effect of implant type diminished and was no longer significant. 
 
The variables included in the final models are given in table 4.4. For the change in OKS and 
EQ5D index, the most important variable in the models was the relevant pre-operative 
score. In both cases there was a greater change in score as the pre-operative score 
decreased, so that patients who were worst to begin with had the best improvement. This 
highlights the influence of the baseline score on the ability to improve post-operatively, and 
the possible ceiling effects of these two scores, whereby patients with better pre-operative 
scores are unable to improve to the same extent as those with poorer scores, owing to the 
inability of these scores to detect top-end differences. This further emphasises the 
importance of appropriate adjustment when comparing PROMs. Two variables appeared in 
all three models: pre-operative general health and anxiety level. For these variables, along 
with pre-operative disability, number of comorbidities and depression, the observed 
relationship with the response variable was for smaller improvements in score with greater 
levels of anxiety, depression, pre-operative disability and worsening pre-operative general 
health.  
 
Adjusted PROMs: After adjustment, the mean difference between the change in OKS for the 
TKR and UKR groups was 0.0 (95%CI -0.9 to 0.9; p = 0.96). The adjusted change in EQ5D 
index was similar for both UKR and TKR (mean difference of 0.09 (95%CI -0.015 to 0.034; p = 
0.37) (table 4.5). The odds of developing a complication were also similar for the two groups 
(odds ratio (OR) TKR versus UKR = 1.17 (95% CI 0.92 to 1.37); p = 0.24). 
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  Response variable 
Variables included in the final risk-adjustment models Change in 
OKS 
Change in 
EQ5D 
Complication 
rate 
Age X X  
Gender  X X 
Anxiety level X X X 
Depression  X  
Hospital type X   
Indication for surgery X   
Number of comorbidities X   
Pre-operative disability X X  
Pre-operative general health X X X 
Pre-operative OKS X X  
Pre-operative EQ5D index  X  
Pre-operative EQ5D health VAS  X X 
Variance explained by the risk adjustment models (%)    
Full model (all 19 variables) 22 52 - 
Chosen model (variables listed above) 21 51 - 
Pre-operative PROM of response variable 15 45 - 
Table 4.4: The risk adjustment models for the change in Oxford knee score (OKS) (multiple 
regression model), change in EuroQol (EQ5D) index (multiple regression model) and 
complication rate (logistic regression model). VAS, visual analogue score. Variables included 
were significant at p < 0.001.  
 
 TKR versus UKR p-value 
Change in OKS   
Unadjusted difference +1.2 (95% CI 0.3 to 2.1) 0.007 
Adjusted difference 0.0 (95% CI -0.9 to 0.9) 0.96 
Change in EQ5D   
Unadjusted difference +0.037 (95% CI 0.006 to 0.067) 0.02 
Adjusted difference -0.009 (95% CI -0.034 to 0.015) 0.37 
Complications   
Unadjusted odds ratio 1.16 (95% CI 0.96 to 1.39) 0.12 
Adjusted odds ratio 1.17 (95% CI 0.92 to 1.37) 0.24 
Table 4.5: Unadjusted and adjusted mean differences in patient reported outcome measures 
for the total knee replacement (TKR) and unicondylar knee replacement (UKR) groups. For 
change in Oxford knee score (OKS) and EuroQol (EQ5D), positive differences favour TKR, and 
negative differences favour UKR. For complications odds ratios are given for TKR relative to 
UKR. 
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Analysis 1: Discussion 
This analysis has shown that although unadjusted improvements in PROMs were greater for 
TKR than for UKR, once adjustments had been made for differences in case mix and baseline 
scores, there were no statistically significant or clinically important differences in the 
improvements in either knee-specific, generic outcomes or complication rates between 
these two implant types. 
 
There is only one other registry study comparing clinical outcomes of UKR and TKR. Lygre et 
al (Lygre 2010) interrogated the Norwegian registry and compared 372 UKRs and 972 TKRs 
at a mean of 6.5 years post-operatively. Their analysis included only post-operative knee 
injury and osteoarthritis outcome (KOOS) (Roos 1998) and EQ5D scores, and comparisons 
with pre-operative scores were not possible. Whereas some statistically significant 
differences were found between UKR and TKR for the KOOS subscales of symptoms, function 
in sport and recreation and function in daily living, these differences decreased with 
adjustment, and were below the accepted level for a minimal perceptible clinical difference 
in outcome. They therefore concluded that the two implants demonstrated similar levels of 
pain and function and questioned the use of UKR, given the reported higher rates of revision 
(Lygre 2010). Both the NJR and the Swedish registry investigated patient satisfaction 
following knee arthroplasty (Robertsson 2000, Baker 2007). The Swedish study found no 
difference between the implant types for general satisfaction (Robertsson 2000), whereas 
the NJR study found a higher level of satisfaction after TKR, despite the UKR group having a 
better post-operative OKS (Baker 2007). 
 
As in this analysis, Pearse et al (2010) found in their analysis of the New Zealand registry that 
the unadjusted mean post-operative OKS was better for UKR (39.2) than for TKR (37.2), but 
they provided no further analysis nor attempted to account for the potential confounding 
differences in case-mix. The clinical results of Newman, Pydisetty and Ackroyd (Newman 
2009) also suggest that there are no significant differences in pain scores between TKR and 
UKR in the longer term. Pandit et al (2011) reported on the first 1000 phase-3 Oxford UKRs 
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from the originating centre. The mean OKS at five years was 41.3 (SD 7.2), compared with 
24.7 (SD 8.7) pre-operatively, a mean rise of 16.6 points. These excellent results are superior 
to those in this analysis, where we found a mean unadjusted OKS improvement of 13.9 for 
UKR, suggesting that the Oxford experience cannot be extrapolated to the national scale. 
 
The final outcome of interest was the overall complication rate, which was very high for both 
groups. This was probably due to the fact these were patients’ reports rather than verified 
hospital data, and included complications such as allergy and urinary infection, which cannot 
be directly attributed to the implant type and may be difficult for patients to define. 
Whereas there was no difference in the overall complication rates, there was variation 
between the implants in the rates of wound infection, readmission and reoperation. 
 
Analysis 1: Summary 
This analysis has shown that there are no differences in the improvements in either knee-
specific or general health PROMs between UKR and TKR in a large cohort of registry patients. 
Given the on-going concerns about the significantly higher revision rates for UKR observed in 
registries worldwide, this information about the expected improvements in function for UKR 
relative to TKR should be of prime interest to the orthopaedic community.  
 
Analysis 1: Limitations and Reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
While it was possible to adjust the UKR and TKR groups for differences in a range of patient 
characteristics one key variable for which we were unable to correct for was the severity and 
distribution of pre-operative arthritis. UKR are designed for people for isolated medial or 
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lateral compartment disease and are not used in patients in whom both of these 
compartments are involved. In contrast, TKR can be used for patients with either medial or 
lateral or combined disease. The cohorts of patients being compared were therefore not 
directly comparable. This is important as the ‘real world’ clinical problem relates to which 
treatment is best for isolated medial or lateral compartment disease. There is wide 
agreement that the best treatment for combined compartment disease is TKR and so these 
patients should ideally be excluded from any comparison of the two procedures. This was 
not possible due to the confines of the current datasets. The models developed for analysis 1 
included variables such as age, pre-operative OKS and general health, which were correlated 
with disease severity and were probably acted as surrogate markers for it. This allowed us 
to, in part, adjust for differences in the severity of disease between the groups and gain the 
best possible representative comparison of these implants using registry data. However 
despite the inclusion of these variables the data we have presented is only able to give an 
indication of the answer and does not definitively answer the question posed. Capture and 
inclusion of additional data (e.g. radiographic data) may have overcome some of these 
problems as it would allow specific groups of patients (e.g. patients with isolated medial 
compartment disease) to be identified and directly compared. However, as with all 
observational research a lack of information about the clinician’s rationale for choosing one 
implant over another would remain. The only way to adequately answer this question is by 
using defined inclusion / exclusion criteria and randomisation to take the surgical decision 
out of the hands of the clinician as is being done in the TOPKAT Trial. 
 
This analysis revealed a possible issue relating to the representativeness and coverage of the 
PROMs data collection, specifically for UKR procedures. The numbers of UKR in this analysis 
were smaller than might be expected (505 of 23,898 (2%)), given that UKRs represent 
approximately 8% of all primary knee arthroplasties performed in England and Wales (NJR-
AR 2012). The reasons for this are unclear but may in part relate to the observation that the 
collection of PROMs data is currently only from NHS-funded operations, and that more UKRs 
than TKRs are privately funded and performed in non-NHS hospitals. While the patient 
characteristics were similar, this observation raises the question of whether the surgeon, 
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centre and operative characteristics of these procedures are representative of national 
practice.  
 
Despite the large numbers of explanatory variables available to us our models only explained 
a small proportion of the variation in the PROMs improvements for both the OKS (full model 
22%) and EQ5D (full model 52%). This meant that between 48% and 78% of the variation in 
these outcomes was unexplained. A proportion of this unexplained variation would be due 
to the ‘natural’ variation observed with any outcome measure but it raises the concern that 
a variety of other unmeasured variables are influencing these outcomes and acting as 
sources of confounding. Variables such as mental health scores, education status and patient 
expectation are known to influence functional outcome after knee replacement and were 
not available for this analysis. It is possible that if these variables were available we could 
have produced more robust models or possibly that we might have observed a difference in 
outcome between the UKR and TKR procedures.  
 
This comparison might also have been limited by the functional outcome measures chosen 
by the PROMs project. Advocates of UKR believe this procedure is better at restoring high 
end function, and cite this as a benefit of this procedure.  Due to the ceiling effect observed 
with the OKS this score may not detect differences at the top end of the score, between the 
highest functioning individuals. This may be a source of bias against UKR procedures which 
could be reduced if different outcome measures were employed.   
 
Analysis 1 was based on functional data from all the UKR for whom PROMs records were 
available. Later analysis (analysis 3) determined the laterality (medial versus lateral) of the 
NJR UKR cohort, allowing us to also determine the laterality of the NJR-PROMs UKR cohort. 
This revealed that there were 484 medial and 21 lateral UKR within the NJR-PROMs UKR 
group. As the number of lateral UKRs were small we were unable to determine whether the 
lack of difference in the PROMs between the medial and lateral UKRs was a valid 
observation, or simply a function of low statistical power (type II error). Given this 
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uncertainty it would probably have been better if the lateral UKR had been excluded and the 
analysis had been based exclusively upon the medial UKRs.  
 
If it were to be repeated, this analysis would benefit from the inclusion of radiological data 
to ensure groups were matched for disease severity, inclusion of a greater number of 
explanatory variables to assist with the creation for more robust models, restriction of the 
UKR group to include only medial UKR and the use of outcomes measures that are better 
suited to detecting differences in high end function. Trying to determine the relative merits 
of UKR and TKR based on observational data is always likely to encounter methodological 
limitations and the best way to address this problem is through pragmatic well constructed 
clinical trials such as the TOPKAT trial.    
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4.3 Analysis 2: Analysis of the reasons for revision and rates of failure for unexplained pain 
for UKR and TKR 
 
Analysis 2: Aim: 
To determine how the reasons for revision differ between UKR and TKR and establish 
whether more UKR revised for unexplained pain when compared to TKR. 
 
Analysis 2: Methods: 
The NJR data set described in section 3.4.2 was used for this analysis. All 366,965 TKR and 
35,749 UKR were included in the analysis irrespective of the indication for surgery. 
Demographic details for the TKR and UKR cohorts are given in table 4.6. Significant 
differences were seen for a number of the demographic variables reflecting the differing 
populations that undergo TKR and UKR respectively. 
 
As of December 2010, 6,075 implants had undergone a revision procedure according to 
registry records (figure 3.1 section 3.4.2). For those cases that underwent revision both the 
institution performing the revision and the reason for revision were available for analysis. To 
overcome the problem of multiple reasons for revision we employed the hierarchical 
strategy for determining the primary reason for revision described in section 3.5.2 (table 
3.9). This meant the primary reason for revision could be determined for all TKR and UKR 
revisions.  
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Group TKR UKR p value 
PRIMARY SURGERY    
Number 366,965 35,749  
Mean Age (Years) 70.4 (S.D 9.2) 64.5 (S.D 9.6) <0.001 
Gender (Female:Male) 210,769F:156,196M 17,231F:18,518M <0.001 
Primary indication 
osteoarthritis 
355,692 (97%) 35,345 (99%) <0.001 
REVISION SURGERY    
Number 4503 1572  
Mean Age (Years) 68.2 (S.D 9.4) 64.0 (S.D 9.8) <0.001 
Gender (Female:Male) 2371F:2132M 806F:766M 0.34 
Table 4.6: Summary of the primary and revision demographics for the unicondylar and total 
knee replacement groups.  
 
After determining the primary reason for each revision we specifically analysed the 
proportion of TKR and UKR undertaken for unexplained pain to see if there was any support 
for the supposition of Cobb (Cobb 2010) and Goodfellow (Goodfellow 2010) that there is a 
differing threshold for revision in the face of the implant presenting with unexplained pain. 
The two implant types were compared using Cox regression to adjust for differences in age, 
gender, American Society of Anaesthesiologists (ASA) grade and indication for primary 
surgery. Analyses were based on three different endpoints: revision for all indications; 
revision for unexplained pain; and revision for any other reason as endpoints. A p value of 
<0.05 was deemed to be statistically significant. For the Cox regression analysis 
proportionality assumptions were broadly met.  
 
Analysis 2: Results 
A breakdown of the primary reason for revision stated on the data collection form for both 
groups are given in table 4.7. The percentage of patients revised for unexplained pain was 
23% (364 of 1572 revisions) in the UKR compared to 9% (408 of 4503) in the TKR group 
(p<0.001). The corresponding odds of revision for unexplained pain was 3.0 (95%CI 2.6 to 
3.5) greater for UKR when compared to TKR.  Of interest is the finding that, of the UKR 
revised, only 67 patients (4%) had arthritis progression as an indication for revision which is 
lower than previously reported (Gioe 2003). This may, however, be a reflection of the modes 
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of failure observed with shorter term follow up where progression of arthritis does not have 
a chance to develop, combined with the observation that progression of arthritis was only 
introduced as a specific option on the revision data collection form in later versions (1056 of 
1572 revisions). 
 
Reason for Revision TKR 
n=366,965 
UKR 
n=35,749 
 Number of 
revisions (%) 
% risk of 
revision 
Number of 
revisions (%) 
% risk of 
revision 
Infection 1295 (29%) 0.35% 90 (6%) 0.25% 
Malalignment 382 (8%) 0.10% 86 (5%) 0.24% 
Loosening / Lysis 1069 (24%) 0.29% 477 (30%) 1.33% 
Component Dissociation 35 (1%) 0.01% 44 (3%) 0.12% 
Component wear / Polyethylene wear 73 (2%) 0.02% 29 (2%) 0.08% 
Implant breakage 15 (0%) 0.00% 2 (0%) 0.01% 
Dislocation / Instability 579 (13%) 0.16% 144 (9%) 0.40% 
Fracture of bone 75 (2%) 0.02% 36 (2%) 0.10% 
Progression of arthritis / disease 34 (1%) 0.01% 67 (4%) 0.19% 
Arthrofibrosis / Stiffness 265 (6%) 0.07% 22 (1%) 0.06% 
Unexplained pain 408 (9%) 0.11% 364 (23%) 1.02% 
Other (if not listed above) / No reason 273 (6%) 0.07% 211 (13%) 0.59% 
Total 4503 (100%) 1.23% 1572 (100%) 4.40% 
Table 4.7: Frequency of each reason for revision for the total and unicondylar knee 
replacement groups. In cases where multiple reason were stated the dominant reason for 
revision was determined using the hierarchy in Table 3.9 (section 3.5.2). 
 
The mean time to revision was similar for the two groups with an overall mean of 2.0 years 
(UKR 2.0 years, TKR 2.0 years, (p= 0.19)). The mean time to revision was not different when 
unexplained pain was stated as the reason for revision (UKR 2.1 years, TKR 2.0 years, (p= 
0.61)). In total 295 centres and 570 surgeons performed revisions of failed UKR implanted 
within the lifespan of the registry (April 2003 to December 2010). The median number of 
UKR revised per centre was 3 (Range 1 to 56) and per surgeon was 2 (Range 1 to 35). The 
centres and surgeons performing the lowest numbers of revisions were those that 
performed the lowest numbers of primaries. In comparison to TKR, UKR revisions were more 
likely to be performed in the same institution that undertook the primary procedure (UKR 
1162 of 1572 revisions (74%), TKR 3047 of 4503 revisions (68%) (p<0.001)) and be performed 
by the same surgeon (UKR 1019 of 1572 (65%), TKR 2189 of 4503 (49%), p<0.001).  
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Kaplan Meier survival curves for UKR and TKR using the endpoints of all revisions, revision 
for unexplained pain and revisions for all other reasons are given in figures 4.1, 4.2 and 4.3. 
At 5 years the failure rates for all revisions (UKR 6.9% and TKR 2.0%) and revisions for 
unexplained pain (UKR 1.6%, TKR 0.2%) were significantly greater following UKR (both 
p<0.001). After adjustment using Cox regression the risk of revision was greater for UKR for 
all revisions (Hazard Ratio (HR) = 2.82 (95%CI 2.66 to 2.99, p<0.001) and revisions for 
unexplained pain (HR = 6.76 (95%CI 5.84 to 7.83), p<0.001). After removal of those 
replacements revised for unexplained pain the risk of revision for all other reasons was still 
greater for UKR (HR = 2.39 (95%CI 2.27 to 2.56), p<0.001) suggesting proportionately more 
UKR were also revised for other reasons. 
 
 
Figure 4.1: Kaplan-Meier survival plot for unicondylar (UKA) and total knee replacement 
(TKA) groups: Endpoint all revisions. Analysis adjusted for age, gender, ASA grade and 
operative indication.  
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Figure 4.2: Kaplan-Meier survival plot for unicondylar (UKA) and total knee replacement 
(TKA) groups: Endpoint revision for unexplained pain. Analysis adjusted for age, gender, ASA 
grade and operative indication. 
 
 
 
Figure 4.3: Kaplan-Meier survival plot for unicondylar (UKA) and total knee replacement 
(TKA) groups: Endpoint revision for all other reasons. Analysis adjusted for age, gender, ASA 
grade and operative indication. 
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Analysis 2: Discussion 
This analysis found that the risk of revision for unexplained pain is greater following UKR and 
that proportionally more UKR were revised for this reason. These findings mirror those from 
other registries in which data on “pain” as a reason for revision is available (AJR-AR 2010, 
NZJR-AR 2010). The proportion of revisions for “pain” is greater after UKR in the registries of 
New Zealand (NZJR-AR 2010) (121 of 284 UKR revisions (43%) versus 271 of 835 TKR 
revisions (32%, p=0.002) and Australia (AJR-AR 2010) (331 of 2882 UKR revisions (12%) 
versus 736 of 8155 TKR revisions (9%) (p<0.001). The reported percentages vary between 
registries because of different methods of data collection. Previous analysis from the 
Norwegian Registry is limited by a small sample size but also suggests that UKR are more 
commonly revised for unexplained pain (Furnes 2007). The findings of this analysis are 
specific to the cause of revision and therefore clarify the consistent finding in all registries 
that UKR is more often revised for unexplained pain.  
 
Reliance solely upon revision rate as an endpoint, whilst a definitive event, is highly 
subjective (Wylde 2011). Surgeon preference and the perceived ease of revision influence 
the decision to revise a particular implant type. It is therefore important to consider the 
reason for revision alongside the rate of revision if the behaviour of specific implant types is 
to be understood.  Revision for unexplained pain represents a relatively small proportion of 
all revisions and once it is accounted for, there still remains a much greater revision rate for 
UKR from other causes when compared to TKR. It therefore seems unlikely that a low 
threshold for revising the implant with unexplained pain is biasing the overall revision rate 
for UKR.  
 
It has been suggested that, in the hands of less experienced surgeons, there is a tendency 
towards earlier revision for UKR when compared to an equivalently performing TKR 
(Goodfellow 2010). This could be an additional source of bias against UKR. While the 
majority of UKR revisions were carried out by centres and surgeons which may be 
considered infrequent revisers the time to revision for UKR and TKR revised for unexplained 
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pain were equivalent. This finding is also supported by data from the New Zealand registry 
(NZJR-AR 2010).  
 
There are a number of potential explanations for these findings. Firstly, if UKR revision is 
perceived as an easy procedure, with likely benefit to the patient, surgeons may have a 
lower threshold for revising the UKR with unexplained pain. Secondly, there may be more 
patients with a painful UKR than those with a painful TKR. Thirdly, UKR may produce less 
consistent outcomes than TKR, meaning they are either very good or very bad. This might 
explain the paradox between statistically equivalent functional outcomes, but higher 
revision rates with UKR. Fourthly, unexplained pain may be caused by subtle problems that 
the surgeon is unable to detect and/or document on a standardised form such as that used 
by the NJR. 
 
Analysis 2: Summary 
This analysis demonstrates that unexplained pain is a reason for revision more commonly 
with UKR than TKR. The reasons for this remain unclear. It suggests that using revision rates 
in isolation to compare these two implants is misleading. This supports the conclusions of 
others that more detailed analysis is required when using registry data to compare implants 
(Goodfellow 2010, Cobb 2010, Horan 2010).  
 
Analysis 2: Limitations and reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
The reason for revision is related to the time from primary surgery. Early revisions 
performed in the first year following primary surgery are more likely to be due to infection 
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or issues relating to component malalignment. Late revisions performed more than 10 years 
following primary surgery are more likely to be due to loosening, lysis and component wear. 
As such the distribution of reasons for revision will change dependent upon the duration of 
follow up. Currently the NJRs follow up is limited to 7 years. As the registry matures it is 
likely that the distribution in the reasons for revision will change. Comparison of the reasons 
for revision for the UKR and TKR groups is valid as the duration of follow up is similar for 
both. However, one must be careful when interpreting the number of revisions and 
associated risk of revision for each individual group as these may change with increased 
follow up. 
 
The hierarchy used within this analysis is based upon the hierarchy used by the Australian 
Joint Registry for their registry analyses (AJR-AR 2012). This hierarchy is based on expert 
consensus without supportive evidence.  As such one could make a case for an alternative 
hierarchy which could alter the observed numbers of revisions within each group. This is 
particular important when one considers that, for the majority of cases (approx. 60%), two 
or more reasons for revision were recorded on the NJR K2 form. Alteration of the hierarchy 
therefore has the potential to significantly alter the results. This problem could be resolved if 
the K2 form were to explicitly ask the surgeon what they felt to be the main cause for 
revision, as this would allow one primary cause to be linked to each revision procedure.  
 
This analysis was based on information recorded about the reason for revision. No 
information was available relating to the surgical decision making process. We therefore 
have no way of adequately determining why patients underwent revision and whether there 
was a differing threshold to revision based upon the primary implant type. The UKR group 
was younger than the TKR group. This difference could have had an equal if not greater 
bearing on the decision to proceed to revision. We have therefore only been able to surmise 
that the discrepancy in revision rate for UKR and TKR is not related to a differing threshold 
for revision. This is based on the observation that once revisions for unexplained pain are 
excluded the number of revisions performed for more objective reasons (e.g. loosening, 
infection, wear, instability etc.) were still significantly greater in the UKR group. This suggests 
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that more UKR fail in a manner that necessitates and justifies revision irrespective of the 
revising surgeon feelings about the ease of revision. This is, however, just one possible 
explanation for the results observed in this analysis and is by no means conclusive.   
 
It is difficult to imagine how any trial could adequately assess something as subjective as the 
decision to proceed to revision surgery. As such it is unlikely that this argument will be 
resolved in the near future. 
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4.4 Analysis 3: Analysis of the reasons for revision and rates of failure for medial and 
lateral UKR 
 
Analysis 3: Aims 
To determine: 
1. What proportion of all UKRs are implanted in the lateral compartment of the knee.  
2. Whether UKR survival is influenced by implant laterality.  
3. Which patient and implant factors influence failure of medial and lateral UKR. 
4. Whether the mode of failure differs between medial and lateral UKR. 
 
Analysis 3: Methods 
The 35,749 UKR recorded in NJR dataset described in section 3.4.2 were used as the basis for 
analysis.  For each record an attempt was made to determine whether the implant was used 
in the medial or the lateral compartment by combining information for the side of operation 
with details held within the description of the components. The descriptions were assessed 
for keywords, including ‘RIGHT MEDIAL/LEFT LATERAL’, ‘RIGHT’, ‘RM/LL’, ‘R MDL/ L LAT’, 
‘MRT/LLT’ and ‘RM’, which specified that the component was designed for use in the medial 
side of a right knee or the lateral side of a left knee. Similar keywords were sought for 
components designed for use in the medial side of a left knee or the lateral side of a right 
knee. This information was then used alongside the side of operation (right or left knee) to 
establish whether the implant was used in the medial or the lateral compartment of the 
knee.  
 
From the original cohort, 125 UKRs were excluded as they could not be accurately classified. 
In total, 20 different brands of UKR were implanted, and for 13 of these laterality could be 
determined from either the femoral or the tibial component description. Four of the 
remaining seven brands totaled only 21 UKRs, and the other three totaled 1649 (AMC 
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Uniglide (Corin, Cirencester UK)), 625 (Sled (Waldemar Link, Hamburg, Germany)) and 219 
(UC-PLUS (Endo Plus, Rotkreuz, Switzerland)) implants. For these latter three brands the 
manufacturers were contacted to determine whether they could provide additional 
information that would allow component laterality to be determined. Both Corin and 
Waldemar Link confirmed that no such information was available. In addition, the laterality 
of 263 (1%) of the 26,294 Oxford UKRs (Biomet, Warsaw, Indiana, USA) could not be 
determined because of unique component descriptions. In total, laterality could therefore 
be determined for 32,847 of 35,624 UKRs (92.2%) (figure 4.4) 
 
Using revision for any reason as the endpoint, implant survival was calculated for both the 
medial and lateral UKR groups using Kaplan-Meier and life table analysis. Survival rates were 
compared using the log rank (Mantel-Cox) test. Supplementary comparison of the medial 
and lateral groups was performed after adjustment for any differences in patient age group 
(< 55 versus 55 to 65 versus 65 to 75 versus > 75 years), gender, American Society of 
Anesthesiologists (ASA) grade, indication for surgery (osteoarthritis/other) and implant 
design (fixed bearing with all-polyethylene tibial component/fixed bearing with metal-
backed one-piece tibial component/fixed bearing with modular tibial component/mobile 
bearing with modular tibial component) between the groups using Cox’s proportional 
hazards method. This method was then employed to determine which of these covariates 
influenced the rates of failure for medial and lateral UKRs separately. These covariates were 
chosen as they mirror the factors used by other registries when stratifying the risk of 
revision for specific types of implant (Davidson 2009, Lidgren 2009). The design of the 
implant was included as a covariate as there was interest in establishing whether the 
performance of different bearing types and tibial designs varied according to laterality. 
Information relating to design was obtained from the component codes and descriptions for 
all but 947 medial and 95 lateral implants. Information for all of the other covariates was 
available for all implants in both the medial and the lateral groups.  
 
Finally the reasons for revision for both medial and lateral UKR were examined using the 
hierarchy described in section 3.5.2 (table 3.2). The analysis also considered the effect of 
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bearing type (fixed versus mobile) on the reason for revision within each group. A p-value 
<0.05 was considered statistically significant. 
 
 
Figure 4.4: Flowchart demonstrating the preparation of the unicondylar knee replacement 
(UKR) dataset. 
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Analysis 3: Results 
In total, 2052 of the 32,847 (6.2%) UKRs for which laterality could be determined were 
implanted on the lateral side of the knee (figure 4.4). The demographic and implant 
characteristics of the medial and lateral UKR groups are given in Table 4.8. The use of fixed-
bearing implants was significantly higher in the lateral compartment (590 of 2052 UKRs; 
29%) than in the medial compartment (5611 of 30 795 UKRs; 18%) (p<0.001). 
 
Patient characteristics Medial UKR 
(n = 30,795) 
Lateral UKR 
(n = 2052) 
Mean age (yrs) (range) 64.6 (24 to 96) 63.1 (19 to 92) 
Male (n, %) 16,223 (52.7) 900 (43.9) 
ASA grade (n, %)   
    1 7757 (25.2) 614 (29.9) 
    2 20,574 (66.8) 1302 (63.5) 
    3 and 4 2464 (8.0) 136 (6.6) 
Indication (n, %)   
    Osteoarthritis 30,485 (99.0) 2025 (98.7) 
    Other 310 (1.0) 237 (1.3) 
Implant design (n, %)   
    Fixed bearing/all PE 3127 (10.2) 248 (12.1) 
    Fixed bearing/metal-backed 77 (0.3) 156 (7.6) 
    Fixed bearing/modular 2407 (7.8) 186 (9.1) 
    Mobile bearing/modular 24,237 (78.7) 1367 (66.6) 
    Not available 947 (3.1) 95 (4.6) 
Table 4.8: Demographics of the medial and lateral unicondylar replacement (UKR) groups 
Key: ASA, American Society of Anesthesiologists; PE, polyethylene. 
 
Survival analyses: 
The survival rate for the entire cohort at five years (all 35,749 UKRs) was 92.9% (95%CI 92.5 
to 93.3) and at seven years was 90.6% (95%CI 89.9 to 21.3). Kaplan-Meier graphs and life 
tables for both the medial and the lateral groups are given in figure 4.5 and tables 4.9 and 
4.10. The rates of survival at five years were 93.1% (95%CI 92.7 to 93.5) for medial and 
93.0% (95%CI 91.1 to 94.9) for lateral UKRs. There was no statistically significant difference 
in the survival distributions (log rank chi-squared test = 0.48 (1 df); p=0.49).
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Years since operation Number at start Number revised Number withdrawn Number at risk Annual failure rate 
(%) 
Survival rate 
(%, 95% CI) 
0 to 1 30,795 320 4957 23,316.5 1.1 98.9 (98.7 to 99.0) 
1 to 2 25,518 421 5335 22,850.5 1.8 97.0 (96.8 to 97.3) 
2 to 3 19,762 262 5370 17,077.0 1.5 95.6 (95.3 to 95.8) 
3 to 4 14,130 157 4776 11,742.0 1.3 94.3 (93.9 to 94.6) 
4 to 5 9197 92 3656 7369.0 1.2 93.1 (92.7 to 93.5) 
5 to 6 5449 54 2760 4069.0 1.3 91.9 (91.3 to 92.4) 
6 to 7 2635 22 1812 1729.0 1.3 90.7 (90.0 to 91.4) 
 
Table 4.9: Life table analysis for the medial unicondylar replacement group. Three implants were revised after the end of year 7 (CI, confidence interval). 
 
 
 
Years since operation Number at start Number revised Number withdrawn Number at risk Annual failure rate 
(%) 
Survival rate (%, 95% 
CI) 
0 to 1 2052 25 448 1828.0 1.4 98.6 (98.1 to 99.2) 
1 to 2 1579 21 410 1374.0 1.5 97.1 (96.3 to 98.0) 
2 to 3 1148 8 388 954.0 0.8 96.3 (95.3 to 97.3) 
3 to 4 752 10 265 619.5 1.6 94.8 (93.4 to 96.1) 
4 to 5 477 7 202 376.0 1.9 93.0 (91.1 to 94.9) 
5 to 6 268 0 149 193.5 0.0 93.0 (91.1 to 94.9) 
6 to 7 119 0 88 75.0 0.0 93.0 (91.1 to 94.9) 
 
Table 4.10: Life table analysis for the lateral unicondylar replacement group (CI, confidence interval). 
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In order to account for differences in patient and implant covariates between the two 
groups, the influence of laterality was further assessed using Cox’s proportional hazards. In a 
model including all covariates the risk of failure for medial and lateral UKRs was equivalent 
(hazard ratio (HR) for lateral relative to medial UKR=0.88 (95 CI 0.69 to 1.13); p=0.32). 
 
 
Figure 4.5: Kaplan-Meier survival curve for medial and lateral unicondylar knee 
replacements. 
 
The factors influencing the risk of failure: 
The full Cox models, including the influences of all the covariates on the risk of failure for 
both medial and lateral UKRs, are given in table 4.11. The only covariates found to influence 
the risk of failure for medial UKRs were patient age (p < 0.001) and ASA grade (p=0.03). The 
risk of failure decreased with increasing age (figure 4.6). Patients categorised as ASA grade 3 
or 4 had a greater risk of failure than patients graded ASA 1 (HR 1.30 (95%CI 1.05 to 1.60); 
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p=0.02) and ASA 2 (HR 1.31 (95%CI 1.08 to 1.59); p = 0.01). Analysis of the effects of bearing 
on the risk of failure demonstrated no differences between mobile- and fixed-bearing 
implants (HR 1.05 (95%CI 0.91 to 1.20); p=0.51) (figure 4.7). There were also no differences 
in the risk of failure dependent upon tibial design for the fixed-bearing implants (p=0.52). 
 
Following a similar process for the lateral UKRs, only age (p=0.01) had a significant effect in 
the final model. Similarly to the medial group, the risk of failure decreased with increasing 
age (figure 4.8). For lateral UKRs there was again no difference in the risk of failure between 
mobile- and fixed-bearing implants (HR 0.86 (95%CI 0.52 to 1.44); p=0.57) (figure 4.9) and 
the different fixed-bearing tibial designs (p=0.96).  
 
 Medial UKR  Lateral UKR  
Covariate* HR (95% CI) p-value HR (95% CI) p-value 
Age group     
    < 55 years Reference - Reference - 
    55 to 65 years 0.75 (0.65 to 0.86) < 0.001 0.57 (0.33 to 1.00) 0.05 
    65 to 75 years 0.57 (0.49 to 0.67) < 0.001 0.36 (0.17 to 0.73) 0.005 
    > 75 years 0.42 (0.34 to 0.52) < 0.001 0.35 (0.14 to 0.85) 0.02 
     
Gender     
    Female Reference - Reference - 
    Male 0.90 (0.81 to 1.00) 0.06 0.67 (0.41 to 1.10) 0.12 
     
ASA grade     
    1 Reference - Reference - 
    2 0.99 (0.87 to 1.12) 0.89 0.62 (0.38 to 1.02) 0.06 
    3 and 4 1.30 (1.05 to 1.60) 0.02 0.76 (0.23 to 2.51) 0.65 
     
Indication     
    Osteoarthritis Reference  Reference - 
    Other 0.83 (0.44 to 1.54) 0.54 NA† -† 
     
Implant design     
    Fixed bearing/all PE 0.99 (0.84 to 1.17) 0.91 0.96 (0.50 to 1.82) 0.89 
    Fixed bearing/metal-backed 1.46 (0.61 to 3.51) 0.40 0.76 (0.30 to 1.93) 0.57 
    Fixed bearing/modular 1.14 (0.93 to 1.42) 0.21 0.78 (0.31 to 1.97) 0.60 
    Mobile bearing/modular Reference - Reference - 
Table 4.11: Predictors of medial and lateral unicondylar replacement (UKR) revision included 
in the Cox’s proportional regression model (HR, hazard ratio; CI, confidence interval). Key: 
ASA, American Society of Anesthesiologists; PE, polyethylene, † there were no revisions in 
this group, so HR and p value could not be calculated. 
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F 
Figure 4.6: Hazard plot for the risk of failure for medial unicondylar knee replacements 
dependent upon patient age group after adjustment for significant covariates in the final 
Cox’s proportional hazard model. 
F  
 
Figure 4.7: Hazard plot for the risk of failure for medial unicondylar knee replacements 
dependent upon implant bearing (fixed versus mobile) after adjustment for significant 
covariates in the final Cox’s proportional hazard model. 
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Figure 4.8: Hazard plot for the risk of failure for lateral unicondylar knee replacements 
dependent upon patient age group after adjustment for significant covariates in the final 
Cox’s proportional hazard model. 
 
Figure 4.9: Hazard plot for the risk of failure for lateral unicondylar knee replacements 
dependent upon implant bearing (fixed versus mobile) after adjustment for significant 
covariates in the final Cox’s proportional hazard model. 
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Reason for revision: 
The reasons for revision for the 71 lateral and 1331 medial UKRs are given in table 4.12. The 
distributions of the reasons were similar for the two groups, the commonest reasons being 
aseptic loosening/lysis (417 of 1402 revisions, 29.7%) and unexplained pain (342 of 1402 
revisions, 24.4%). Of interest was the finding that the patients revised for unexplained pain 
were younger (mean age 60.9 years (SD 9.2)) than those revised for all other reasons (mean 
age 62.3 years (SD 9.8)) (p=0.02). Although the hazard of revision for mobile- and fixed-
bearing implants was similar for both lateral and medial UKRs, there were noticeable 
differences in the reasons for which those revisions were performed. On both sides of the 
knee mobile bearings were associated with a significantly greater proportion of failures for 
component dissociation/disability/instability than were fixed bearings (medial: mobile 137 of 
1046 (13%) revisions versus fixed 12 of 272 (4%), p<0.001; and lateral: mobile 14 of 46 (30%) 
revisions versus fixed two of 23 (9%), p=0.04).  However, this discrepancy was offset by 
higher rates of loosening/lysis and unexplained pain for the medial fixed-bearing UKRs, and 
progression of arthritis and unexplained pain with the lateral fixed-bearing UKRs. 
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  Medial UKR Lateral UKR 
  Mobile Fixed Not 
known 
Total Mobile Fixed Not known Total 
Hierarchy Reason for revision n=24,237 n=5611 n=947 n =30,795 n=1367 n=590 n=95 n=2052 
1 Tumour - - - - - - - - 
2 Infection 53 (5) 19 (7) 1 (8) 73 (5) 4 (9) 3 (13) - 7 (10) 
3 Incorrect side/sizing of component - - - - - - - - 
4 Malalignment 58 (6) 15 (6) 1 (8) 74 (6) 1 (2) - - 1 (1) 
5 Metal sensitivity - - - - - - - - 
6 Loosening/lysis 300 (29) 97 (36) 3 (23) 400 (30) 12 (26) 4 (17) 1 (50) 17 (24) 
7 Component dissociation 33 (3) 2 (1) - 35 (3) 5 (11) - - 5 (7) 
8 Component/polyethylene wear 20 (2) 5 (2) - 25 (2) - - - - 
9 Implant breakage 2 (0) - - 2 (0) - - - - 
10 Dislocation/instability 104 (10) 10 (4) 2 (15) 116 (9) 9 (20) 2 (9) - 11 (15) 
11 Fracture of bone 23 (2) 6 (2) - 29 (2) - 2 (9) - 2 (3) 
12 Progression of arthritis/disease 47 (4) 12 (4) 1 (8) 60 (5) - 3 (13) - 3 (4) 
13 Synovitis - - - - - - - - 
14 Arthrofibrosis/stiffness 14 (1) 5 (2) - 19 (1) - 1 (4) - 1 (1) 
15 Osteonecrosis/avascular necrosis - - - - - - - - 
16 Heterotopic bone - - - - - - - - 
17 Unexplained pain 247 (24) 75 (28) 5 (38) 327 (25) 8 (17) 7 (30) - 15 (21) 
18 Other (if not listed above) 145 (14) 26 (10) - 171 (13) 7 (15) 1 (4) 1 (50) 9 (13) 
          
 TOTAL REVISIONS 1046 272 13 1331 46 23 2 71 
Table 4.12: Reasons for revision for the 1331 medial and 71 lateral unicondylar knee replacement (UKR) revisions dependent upon bearing 
type. Figures in brackets represent the column percentages (%) for each implant type. 
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Analysis 3: Discussion 
This analysis demonstrates that approximately 6% of UKRs are implanted on the lateral side 
of the knee, and that the mid-term survival rates of lateral and medial UKRs are equivalent. 
Medial and lateral UKRs have a similar pattern of failure, with aseptic loosening/lysis and 
unexplained pain the predominant reasons for revision. The main factor influencing the risk 
of failure was patient age, and this finding was consistent for both medial and lateral UKRs.  
 
Approximately one in 15 UKRs were implanted laterally, slightly less than the one in ten 
suggested by Scott (Scott 2005). Owing to the failure to report medial and lateral UKRs 
separately, it is difficult to obtain an idea of lateral UKR usage from other registry reports. 
No information is available from the current Australian (AJR-AR 2010) New Zealand (NZJR-
AR 2010) and Norwegian (Norwegian registry-AR 2010) registries. Data from the Swedish 
knee register suggest that their usage is significantly lower (three of 683 UKRs (0.4%)) 
(Lidgren 2009) than was seen in this analysis, and has declined substantially from the 1336 
(9%) of 14 772 UKRs reported by the same registry in the mid-1990s (Lewold 1998). 
  
The overall seven-year survival rate for all UKRs, including those for which laterality could 
and could not be determined, was 90.6%. This is similar to the 88.9% seven-year survival 
rate reported by the Australian registry (AJR-AR 2010) but significantly lower than the 97.3% 
at seven years reported by the originating centre for the Oxford UKR (Pandit 2011). This 
highlights the discrepancy in the literature between outcomes from registries, independent 
studies and inventor studies for UKR. In a recent literature review Labek et al (Labek 2011) 
found that, compared with studies from the originating centre, the reported rates of failure 
were 2.5 times higher in independent clinical studies and over four times higher in national 
arthroplasty registers. At five years, the rates of survival for medial and lateral UKRs were 
equivalent. This remained the case at seven years, although there were no further failures 
of lateral UKRs between years five and seven. The rates of survival for lateral UKRs were 
lower than those seen in other contemporary series, in which survival rates of 92% (38 
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UKRs) and 98% (54 UKRs) at ten years (Ashraf 2002, Argenson 2008) and 100% at a mean of 
5.2 years (49 UKRs) (Sah 2007) and 12.4 years (28 UKRs) (Pennington 2006) have been 
reported.  
 
For both medial and lateral UKRs the key determinant of failure was the patient’s age at 
primary surgery. A decline in revision rate with increasing age had been reported by a 
number of registries across a range of types of UKR (Lidgren 2007, AJR-AR 2010). For medial 
UKR the risk of failure was greater for patients graded ASA 3 or 4 than for those with ASA 
grades 1 and 2. This is likely to be related to a combination of factors, including an elderly 
population which puts less demand on their replacement and an increasing unwillingness of 
surgeons and patients to commit to revision surgery for the failing implant as age and 
comorbidity increase (Goodfellow 2010). Although the groups were well matched for 
patient demographics, there were differences in the proportions of fixed and mobile 
bearings used in the medial and lateral compartments, with more fixed bearings being 
implanted laterally (29% versus 18% medially). Mobile-bearing UKRs have better kinematics 
than fixed-bearing UKRs (Li 2006), with different patterns of wear and modes of failure 
(Kretzer 2011). However, this study found that the failure of both medial and lateral UKRs at 
seven years was not influenced by the type of bearing or, for fixed-bearing implants, the 
design of the tibial component. A number of registries have reported variations in UKR 
revision rates depending on implant brand (AJR-AR 2010, NZJR-AR 2010, NJR-AR 2012). Our 
analysis did not examine the effect of brand, as brand and design are not independent of 
one another and therefore cannot be examined together. Nevertheless, it is likely that any 
analysis of brand would have mirrored the results found in the NJR (NJR-AR 2012). 
 
The distribution of the reasons for revision was similar for both medial and lateral UKRs, 
with aseptic loosening/lysis and unexplained pain being the main causes. Patients whose 
UKR was revised for unexplained pain were on average 1.4 years younger than those whose 
UKR was revised for any other reason. This finding is reflected in the New Zealand (NZJR-AR 
2010) and Norwegian (Norwegian registry-AR 2010) registries, where aseptic loosening and 
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pain are the predominant reasons for revision. Analysis of the Norwegian registry has also 
shown that UKRs have a greater risk of revision due to aseptic loosening and pain than TKRs 
(Furnes 2007). Although the overall rates of revision were similar for fixed- and mobile-
bearing UKRs, more revisions were performed for dissociation/dislocation/instability in the 
mobile-bearing group. This difference was particularly marked in the lateral UKR group, 
where 30% of mobile-bearing implants were revised for this reason. This may reflect the 
differential kinematics of the medial and lateral compartments (Freeman 2005) and 
emphasises the importance of correct positioning of the components and soft tissue 
balancing when using mobile-bearing UKRs.  
 
Analysis 3: Summary 
This analysis demonstrates that the rates of survival and reasons for revision for medial and 
lateral UKR are similar. There is no evidence to suggest that the performance of either type 
is adversely affecting the results seen for the other when the results are pooled for the 
purposes of registry analysis of UKRs.  
 
Analysis 3: Limitations and reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
Within the NJR the majority of UKRs (>70%) are Oxford brand implants. Any generic analysis 
of UKR, such as undertaken here, is therefore likely to be overwhelmed by the influence of 
this implant type and may not be a true reflection of the behaviour of other UKRs that 
represent a much smaller percentage of the total UKRs performed. Because of this we 
wanted to perform a sub analysis in which the effects of the different types of UKR could be 
assessed. Unfortunately the NJR did not permit this level of analysis.  
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This may have compromised certain elements of the analysis, specifically the analysis of the 
impact of bearing (fixed versus mobile) upon the risk of revision. The mobile bearing group 
almost exclusively consisted of Oxford UKRs, whereas the fixed bearing group comprised a 
variety of different implant types. When these fixed bearing implants were pooled the risk 
of revision was equivalent to that seen with the mobile bearing implants. However, the NJR 
(NJR-AR 2012) reports a wide variation in the mid-term survival of the fixed bearing implants 
with some having very low failure rates and some having very high failure rates. By including 
information on implant type we could have determined which implants worked best in each 
compartment of the knee. Instead by pooling implants with differing performance we have 
lost the necessary detail to address this issue. This highlights an ongoing problem with 
registry data, namely that “the devil is in the detail”. Broadly pooling implants into groups 
for convenience and simplification can miss important associations within the data that 
might have been evident if a greater level of detail had been employed.  
 
The NJR does not currently record whether a UKR is implanted in the medial or lateral 
compartment. Consequently we had to use implant data combined with the side of surgery 
to determine implant laterality. Using this method we were able to determine laterality for 
the majority (92%) but not all of the UKR implants. A solution to this problem would be for 
the NJR K1 form to be amended so that the surgeon can indicate UKR laterality at the time 
the form is completed.  This data would then be stored within the dataset, ensuring higher 
levels of data completion and accuracy and avoiding the need to combine data from a 
number of different data fields.   
 
Unfortunately we were unable to perform a meaningful comparison of functional outcomes 
for the lateral and medial UKRs using the NJR-PROMs dataset. Having determined the 
laterality of each UKR in the NJR dataset we were then able to determine the laterality of 
the UKR in the NJR-PROMs dataset. However, of the 505 UKR within the PROMs dataset 
only 21 were lateral UKR and the small numbers of lateral implants precluded any 
meaningful comparison with the medial UKR group. As the PROMs project matures and 
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more PROMs become available it is likely that the number of PROMs records linked to 
medial and lateral UKR will increase. This issue could therefore be re-visited in the future, 
allowing the function of medial and lateral UKR to be directly compared.  
 
The identification of the lateral UKR group opens up the possibility of further work into this 
group of patients. We could identify which surgeons are undertaking lateral UKRs, allowing 
us to better understand when and why they are being performed. It could allow us to 
determine how many procedures the average surgeon undertakes each year. By directly 
contacting these surgeons we could determine whether they employ different selection 
criteria when selecting patients and employ different surgical processes for their medial and 
lateral UKR patients.  
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4.5 Analysis 4: Analysis of the effect of centre and surgeon operative volume on UKR rates 
of failure  
 
Analysis 4: Aim: 
To determine: 
1. How many different centres and surgeons are performing UKR in England and Wales 
and what volumes of these procedures are they undertaking.  
2. Is there an association between centre and/or surgeon volume and revision rate for 
UKR. 
3. If centres/surgeons perform high volumes of UKR do they achieve revision rates 
comparable to those seen with the ‘gold standard’ cemented TKR. 
 
Analysis 4: Methods 
The 35,749 UKR recorded in NJR dataset described in section 3.4.2 were again used as the 
basis for analysis. The rates of UKR failure vary dependent upon implant type (NJR-AR 2012, 
AJR-AR 2010) and as such this variable could be a source of confounding in any comparison 
of centre and surgeon revision rates. A decision was therefore made to limit the analysis to 
the Oxford UKR (Biomet) as it is the most commonly registered UKR within the NJR 
comprising (n=26,293) 74% of all available implants. From this group we selected all 
cemented UKRs implanted in the medial compartment for osteoarthritis. This was done 
because, despite the previous analysis suggesting that when all implants were pooled the 
overall rates of failure for medial and lateral UKR were similar, we could not be certain that 
this was the case for the Oxford UKR. The method for determining implant laterality (medial 
versus lateral) is discussed in section 4.4. The additional data relating the type of fixation 
(cemented/uncemented/hybrid) and indications for surgery was available within the NJR 
dataset. Details of the numbers of UKR excluded from the initial 35,749 cohort are given in 
figure 4.10. In total 23,400 Oxford UKRs satisfied these criteria.  
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Figure 4.10: Relevant exclusions for Analysis 4. 
 
The effect of operative volume was analysed by considering volume as both a continuous 
and categorical variable. For the categorical analysis both centre and surgeon volumes were 
grouped based upon the volume of primary procedures performed during the period of 
observation. Centres were grouped to produce 5 categories containing approximately equal 
number of primary procedures while maintaining rounded category boundaries (1-50, 51-
100, 101-200, 201-400, >400). Surgeons were similarly grouped into 5 approximately sized 
groups (1-25, 26-50, 51-100, 101-200, >200). As these groups contained larger numbers it 
was then possible to construct Kaplan Meier plots and life tables to supplement the funnel 
plots examining the number of revisions per 100 component years for each individual centre 
and surgeon. 
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Analysis 3 (section 4.4) demonstrated that patient factors including age and ASA grade 
independently influence UKR failure rates. Adjustments were therefore made for 
differences in these factors between the volume groups using Cox’s proportional hazards. 
Independence of centre and surgeon volume cannot be assumed and it is therefore 
inappropriate to include them in the same hazard model. Initial analyses were therefore 
performed with centre and surgeon volume modeled separately using hazard analyses that 
also included age group (<55/55-64.9/65-74.9/>75 years), gender (Male/Female) and ASA 
grade (ASA 1/2/3 and 4). As we were interested in whether higher volumes were associated 
with improved outcomes we chose the highest centre/surgeon volume category as the 
reference within each of the hazard models.  To supplement the analysis of the grouped 
volume data we constructed additional models in which centre and surgeon volume were 
entered as continuous explanatory variables based on their total volume over the period of 
study. Other than entering volume data as a continuous rather than a categorical variable 
these models were identical.  
 
The individual centre and surgeon volume analyses were then supplemented by a further 
analysis that considered these variables simultaneously. Centres and surgeons were 
categorised as low volume or high volume based on volumes of ≤100/>100 as determined 
by the initial analyses. This gave four groups (low centre volume/low surgeon volume, low 
centre volume/high surgeon volume, high centre volume/low surgeon volume, high centre 
volume/high surgeon volume) which were then modelled using Cox’s proportional hazards 
adjusting for age, gender and ASA grade. 
 
Analysis 4: Results 
The demographic characteristics of study cohort are given in table 4.13. Even with the 
exclusions imposed the study cohort was a well matched, representative sample of the 
wider population undergoing UKR.  For the entire study cohort the 5-year and 7-year 
survival rates were 93.2% (95%CI 92.8 to 93.7%) and 90.7% (95%CI 89.9 to 91.5%) 
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respectively. The overall rate of revisions per 100 component years was 1.40 (95%CI 1.31 to 
1.49). 
 
Demographic variable Study Cohort 
(Medial cemented Oxford UKR) 
(April 2003 to December 2010) 
n=23,400 
NJR 8th Annual report 
(All UKR) 
(2010 data only) 
n=6,119 
Gender 
Female 
Male 
 
11,207 (48%) 
12,193 (52%) 
Gender data available for 5,702 
2,675 (47%) 
3,027 (53%) 
ASA grade 
ASA 1 
ASA 2 
ASA 3/4 
 
5,797 (25%) 
15,681 (67%) 
1,922 (8%) 
 
1,421 (23%) 
4,221 (69%) 
477 (8%) 
Age groups 
<55 years 
55-64.9 years 
65-74.9 years 
>75 years 
Mean Age (S.D) 
 
3,379 (14%) 
8,668 (37%) 
7,723 (33%) 
3,630 (16%) 
65.0 (9.3) 
Age data available for 5,702 
1072 (19%) 
2,051 (36%) 
1,800 (32%) 
779 (14%) 
64.0 (9.8) 
Table 4.13: Patient demographics for analysis 4.  
 
Centre and surgeon volumes 
In total 366 centres performed at least 1 primary procedure during the period of analysis. 
The median number of primary procedures was 33 with a range of 1 to 1097 (figure 4.11). In 
total 303 (82.8%) performed 100 or less primary procedures. The rate of revisions per 100 
component years varied widely between institutions ranging from 0.00 to 41.49. The 
variability in this measure and the number of centres above 3 standard errors of the mean 
value increased as centre volume decreased (figure 4.12). In total 46 of the 303 centres 
(15.2%) that performed ≤100 primary procedures, 6 of the 39 centres (15.4%) that 
performed 100-200 and 2 of the 24 centres (8.3%) that performed >200 procedures were 
above 3 standard errors of the mean. 
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Nine-hundred and nineteen surgeons performed at least 1 primary procedure during the 
period of analysis. The median number of primary procedures was 8 with a range of 1 to 423 
(figure 4.13). In total 787 (85.6%) performed 50 or less primary procedures. The rates of 
revisions per 100 component years for individual surgeons ranged from 0.00 to 833.33. In 
similarity to centre volume the variability in this measure and the number of centres above 
3 standard errors of the mean value increased as surgeon volume decreased (figure 4.14). 
Of the 787 surgeons that performed ≤50 procedures 128 (16.3%) were above the 3 standard 
error threshold compared to 5 of 81 (6.2%) and 4 of 51 (7.8%) surgeons who performed 50-
100 and >100 respectively. 
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Figure 4.11: Volume for each of the 366 centres undertaking procedures between (April 
2003 and December 2010). 
 
 
 
Figure 4.12: Funnel plot of revisions per 100 component years against centre volume: April 
2003 to December 2010 (Dotted lines represent +/-3 standard errors from the mean) (Only 
centres performing ≥50 procedures included for clarity). 
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Figure 4.13: Volume for each of the 919 surgeons undertaking procedures between (April 
2003 and December 2010). 
 
 
 
 
Figure 4.14: Funnel plot of revisions per 100 component years against surgeon volume: April 
2003 to December 2010 (Dotted lines represent +/-3 standard errors from the mean) (Only 
surgeons performing ≥10 procedures included for clarity). 
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Volume grouping analysis 
The number of revisions per 100 component years, ratio of revision:primary cases and the 5- 
and 7-year survival rates were calculated for each of the 5 centre (1-50, 51-100, 101-200, 
201-400, >400) and surgeon (1-25, 26-50, 51-100, 101-200, >200) volume categories (tables 
4.14 and 4.15). Kaplan-Meier survival plots for each analysis are shown in figures 4.15 and 
4.16. Comparison of failure rates for the 5 groups confirmed that there were significant 
differences in the rates of failure between one or more groups (p<0.001). Kaplan Meier 
analysis (figure 4.15) demonstrated that the rates of failure were similar for the lowest two 
volume categories (<50 and 51-100) and that the rates for these two groups were higher 
than the rates of failure for the highest two volume categories (201-400, >400). The early 
failure rate in the intermediate volume group (101-200) mirrored that of the lowest volume 
groups before “crossing over” to the highest volume groups between years 2 to 4. After year 
4 the failure rates for this group was similar to that seen for the two highest volume groups.  
 
In similarity to the centre volumes there were significant differences between one or more 
of the surgeon volume groups (p<0.001). However, in contrast to the survival plots for 
centre volume the volume groups within the surgeon volume analysis were not clustered. 
They instead showed an additive pattern with each additional increase in volume associated 
with a better rate of survival when compared to the previous volume group (figure 4.16). 
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Volume of 
primaries 
(Apr 03 to Dec 10) 
Number 
of 
centres 
No. of 
primary 
cases 
No. of 
revision 
cases 
Revisions/
primaries 
(%) 
Observed 
component 
years 
Revisions per 100 
observed 
component years 
Range 5 year survival 7 year survival 
1 to 50 239 4689 245 5.2% 15076.9 1.62 
(95%CI 1.42 to 1.82) 
0.00 to 41.49 92.3% 
(95%CI 91.2 to 93.3%) 
89.5% 
(95%CI 87.8 to 91.1%) 
51 to 100 64 4648 242 5.2% 14207.4 1.70 
(95%CI 1.49 to 1.92) 
0.00 to 6.28 92.0% 
(95%CI 90.9 to 93.1%) 
89.2% 
(95%CI 87.3 to 91.1%) 
101 to 200 39 5164 210 4.1% 16213.1 1.30 
(95%CI 1.12 to 1.47) 
0.00 to 4.25 94.2% 
(95%CI 93.4 to 95.1%) 
92.3% 
(95%CI 90.8 to 93.6%) 
201 to 400 17 4567 164 3.6% 13862.4 1.18 
(95%CI 1.00 to 1.36) 
0.11 to 2.79 93.5% 
(95%CI 92.4 to 94.6%) 
90.8% 
(95%CI 88.6 to 93.0%) 
>400 7 4332 139 3.2% 11943.1 1.16 
(95%CI 0.97 to 1.36) 
0.51 to 1.86 94.1% 
(95%CI 93.0 to 95.2%) 
91.5% 
(95%CI 89.0 to 94.0%) 
Total 366 23400 1000 4.3% 71302.9 1.40 
(95%CI 1.31 to 1.49) 
0.00 to 41.49 93.2% 
(95%CI 92.8 to 93.7%) 
90.7% 
(95%CI 89.9 to 91.5%) 
 
Table 4.14: Revision outcome grouped by centre volume. 
 
 
Volume of 
primaries 
(Apr 03 to Dec 10) 
Number 
of 
surgeons 
No. of 
primary 
cases 
No. of 
revision 
cases 
Revisions/
primaries 
(%) 
Observed 
component 
years 
Revisions per 100 
observed 
component years 
Range 5 year survival 7 year survival 
1 to 25 671 4511 287 6.4% 13296.2 2.16 
(95%CI 1.19 to 2.41) 
0.00 to 
833.33 
90.1% 
(95%CI 88.8 to 91.3%) 
87.1% 
(95% CI 85.1 to 89.0%) 
26 to 50 116 4269 234 5.5% 13310.0 1.75 
(95%CI 1.53 to 1.98) 
0.00 to 7.89 91.7% 
(95%CI 90.5 to 92.8%) 
88.5% 
(95%CI 86.4 to 90.6%) 
51 to 100 81 5841 225 3.9% 17469.8 1.29 
(95%CI 1.12 to 1.46) 
0.00 to 6.29 93.4% 
(95%CI 92.4 to 94.4%) 
91.3 
(95%CI 89.8 to 92.9%) 
101 to 200 39 5442 177 3.3% 17596.7 1.01 
(95%CI 0.86 to 1.15) 
0.00 to 4.58 95.2% 
(95%CI 94.4 to 95.9%) 
92.9% 
(95%CI 91.3 to 94.4%) 
>200 12 3337 77 2.3% 9630.2 0.80 
(95%CI 0.62 to 0.98) 
0.12 to 1.46 96.0% 
(95%CI 95.0 to 97.0%) 
94.3% 
(95%CI 92.3 to 96.2%) 
Total 919 23400 1000 4.3% 71302.9 1.40 
(95%CI 1.31 to 1.49) 
0.00 to 
833.33 
93.2% 
(95%CI 92.8 to 93.7%) 
90.7% 
(95%CI 89.9 to 91.5%) 
 
Table 4.15: Revision outcome grouped by surgeon volume. 
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Figure 4.15: Kaplan Meier survival for UKR grouped by centre volume. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16: Kaplan Meier survival for UKR grouped by surgeon volume. 
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Hazard analysis 
The models for which the volume measures were entered as continuous variables 
demonstrated that as centre (Wald = 8.479 (1df), HR 1.000 (95%CI 0.999 to 1.000), p=0.004) 
and surgeon (Wald = 68.231 (1df), HR 0.996 (95%CI 0.996 to 0.997), p<0.001) volumes 
increased the risk of revision decreased. The observation that the Wald test statistic was 
comparatively larger for surgeon volume in comparison to centre volume in identically 
constructed models suggests surgeon volume is the more important of these two variables. 
 
The analysis of the grouped centre volume data demonstrated that the risk of failure was 
higher in the lowest (1-50, p=0.005) and second lowest (51-100, p=0.001) volume groups 
when compared to the highest (reference) volume group (table 4.16). The rates of failure in 
these two lowest volume groups were also higher than those observed for the 101-200 (HR 
vs. 1-50 = 1.23 (95%CI 1.02 to 1.48), p=0.03; HR vs. 51-100 = 1.30 (95%CI 1.08 to 1.56), 
p=0.006) and 201-400 (HR vs. 1-50 = 1.30 (95%CI 1.07 to 1.59), p=0.009; HR vs. 51-100 = 
1.38 (95%CI 1.13 to 1.67), p=0.002) groups. There were no differences between the three 
highest volume groups within this model.  
 
 Unadjusted (Univariate) Adjusted (Multivariate)* 
 Hazard 
ratio 
95.0% CI for HR p value Hazard 
ratio 
95.0% CI for HR p value 
Total volume 
-1 to 50 
-51 to 100 
-101 to 200 
-201 to 400 
->400 
 
1.40 
1.47 
1.11 
1.02 
Ref 
 
1.14 to 1.73 
1.19 to 1.81 
0.90 to 1.38 
0.81 to 1.28 
Ref 
 
0.001 
<0.001 
0.33 
0.88 
- 
 
1.35 
1.42 
1.10 
1.03 
Ref 
 
1.10 to 1.66 
1.16 to 1.76 
0.88 to 1.36 
0.83 to 1.30 
Ref 
 
0.005 
0.001 
0.40 
0.77 
- 
Table 4.16: Influence of centre volume on the risk of revision (*Adjusted for Age group, ASA 
grade and gender). 
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For surgeon volume the risk of failure was significantly higher for the three lowest volume 
groups (1-25, 26-50, 51-100) when compared to the highest (reference) volume group 
(>200) (all p<0.001) (table 4.17). The rates of failure were also significantly higher for the 
three lowest volume groups when compared to the 101-200 group (HR vs. 1-25 = 2.04 
(95%CI 1.69 to 2.47), p<0.001; HR vs. 26-50 = 1.69 (95%CI 1.39 to 2.6), p<0.001; HR vs. 51-
100 = 1.26 (95%CI 1.03 to 1.53), p=0.02). There were no differences between the two 
highest volume groups within this model.  
 
 Unadjusted (Univariate) Adjusted (Multivariate)* 
 Hazard 
ratio 
95.0% CI for HR p value Hazard 
ratio 
95.0% CI for HR p value 
Total volume 
-1 to 25 
-26 to 50 
-51 to 100 
-101 to 200 
->200 
 
2.72 
2.20 
1.61 
1.25 
Ref 
 
2.12 to 3.50 
1.70 to 2.85 
1.24 to 2.09 
0.96 to 1.64 
Ref 
 
<0.001 
<0.001 
<0.001 
0.10 
- 
 
2.54 
2.11 
1.56 
1.24 
Ref 
 
1.97 to 3.27 
1.63 to 2.72 
1.21 to 1.63 
0.95 to 1.63 
Ref 
 
<0.001 
<0.001 
<0.001 
0.11 
- 
Table 4.17: Influence of surgeon volume on the risk of revision (*Adjusted for Age group, 
ASA grade and gender). 
 
The combined effect of centre and surgeon volume was assessed by categorising 
centres/surgeons as high (>100 primaries) or low (≤100 primaries) volume (table 4.18). In 
total 7,282 primaries were performed by the high centre volume/high surgeon volumes 
group. Compared to the rates for the entire cohort the rate of revisions per 100 component 
years (0.91, 95%CI 0.79 to 1.04) was lower, and the 5- (95.6%, 95%CI 94.9 to 96.3%) and 7-
year (93.2%, 95%CI 91.8 to 94.7%) survival rates were higher (all p<0.001) in this “best case” 
group. The hazard of revision was significantly higher for the low centre volume/low 
surgeon volume (HR 1.87 (95%CI 1.58 to 2.22), p<0.001) and the high centre volume/low 
surgeon volume (HR 1.66 (95%CI 1.39 to 1.98), p<0.001) groups when compared to the 
“best case” high volume group. There was no difference between the low centre 
volume/high surgeon volume group and the “best case” high volume group (HR 1.10 (95%CI 
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0.81 to 1.50), p=0.55). These findings are further evidence that surgeon volume is the more 
important of these two variables. 
 
 
Volume Surgeon volume 
Centre volume Low volume 
(n=14,621) 
High volume 
(n=8,779) 
 
Low volume 
(n=9,337) 
 
n=7,840 
 
5-year survival = 91.6% 
(95%CI 90.7 to 94.4%) 
 
7-year survival = 88.6% 
(95%CI 87.2 to 90.0%) 
 
n=1,497 
 
5-year survival = 94.9% 
(95%CI 93.3 to 96.4%) 
 
7-year survival = 93.6% 
(95%CI 91.5 to 95.7%) 
 
 
High volume 
(n=14,063) 
 
n=6,781 
 
5-year survival = 92.2% 
(95%CI 91.3% to 93.2%) 
 
7-year survival = 90.0% 
(95%CI 88.3 to 91.6%) 
 
n=7,282 
 
5-year survival = 95.6% 
(95%CI 94.9 to 96.3%) 
 
7-year survival = 93.2% 
(95%CI 91.8 to 94.7%) 
 
Table 4.18: 5 and 7-year survival rates when centre and surgeon volume are considered 
simultaneously. High volume = >100 primary UKR between April 2003 and December 2010, 
Low volume = ≤100 primary UKR over same period.  
 
Analysis 4: Discussion 
This analysis demonstrates there is substantial variation in the volumes of cemented medial 
Oxford UKRs performed by centres and surgeons in England and Wales. A large number of 
centres and surgeons undertook these procedures, the majority of which did so at low 
volumes (<100 over lifespan of the registry). While the risk of revision decreased as both 
centre and surgeon increased the effect was more pronounced for surgeon volume. The risk 
of revision was significantly greater for centres and surgeons who had performed less than 
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100 procedures over the period of observation when compared to those performing greater 
than 100. This equates to approximately 13 procedures per year during this time period. For 
centres and surgeons performing greater than this number the failure rates were less than 
1% per year at a maximum of 7 years. 
 
The associations between volume and outcome found in this analysis have previously been 
reported for centre volume (Robertsson 2001, Hamilton 2010, Labek 2011) but not for 
surgeon volume for which the association with revision outcome was more pronounced. 
Increasing volume decreased both revision rate and reoperation rate in the 445 patients 
reviewed by Hamiton et al. (Hamilton 2001). For the first half of UKR performed the 2-year 
revision rate was 5.0% compared to 2.7% for the second half. Reoperation rates similarly fell 
from 8.1% to 5.4%. As previously discussed revision rates vary dependent upon the 
publishing institution (Labek 2011). Our overall rate of revisions per 100 component years 
(1.40, 95%CI 1.31 to 1.49) was comparable to that from other registries (1.60, 95%CI 1.43-
1.80). The revision rate for centres performing the highest volumes, which included the 
inventing centre (1.16 (95%CI 0.97 to 1.36), was significantly higher than the pooled results 
from independent clinical studies including “inventor” studies (0.70, 95%CI 0.60 to 0.82) 
reported by Labek et al. (Labek 2011). The results for this group were instead in keeping 
with the pooled results from independent clinical studies excluding “inventor” studies (1.22, 
95%CI 1.99 to 1.50). This suggests disparity in the reported results from the inventing centre 
for this implant type.  
 
National analysis of UKR cost-effectiveness suggests TKR may be a more cost-effective 
option given the high rates of revision associated with UKR (Koskinen 2008). However, the 
calculations on which these conclusions are based are derived from registry revision rates 
and not those centres and surgeons undertaking high volumes for which the results are 
substantially better. One hundred and thirty seven of the 919 (14.9%) surgeons undertaking 
UKR fell outside the 3 standard error limit for revisions per 100 component years, the 
majority of whom (133) performed ≤100 procedures. If surgical workload was performed by 
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fewer higher volume surgeons and concentrated in higher volume centres then the cost-
benefit of UKR may more become more favourable. To produce a safe and sustainable 
service and improve outcomes for patients, consideration should be given to whether this 
service should be centralised with fewer centres and surgeons undertaking a higher volume 
of procedures, mirroring the restructuring of other surgical specialties (NHS specialised 
services 2011).  
 
This analysis indicates a threshold value for centre and surgeon volume of 100 procedures 
over the 8 years of observation, equating to approximately 13 procedures per year. 
However, this figure is likely to be a conservative estimate. A centre/surgeons volume is 
likely to be greater than that recorded for this analysis owing to the fact that we only 
analysed medial cemented Oxford implants performed for osteoarthritis and there may 
have been a failure to report procedures in the early years of the registry. Reported volume 
thresholds for TKR are higher with suggested minimum volumes of 50-100 TKRs per surgeon 
per year (Norton 1998, Katz 2004). Previous analysis of UKR and centre volume 
demonstrated better outcomes for Oxford UKR if >23 were performed per year (Robertsson 
2001). As such a threshold of 13/year could be considered a minimum value for the number 
of medial cemented Oxford UKRs performed annually. Surgeon volume would also appear 
to be more important than centre volume and caution is advised if centres are undertaking 
>13 UKR/year based on the combined input of several low volume surgeons. Altogether 303 
of the 366 centres (82.8%) and 868 of the 919 surgeons (94.5%) performed less than 100 
primary cases, emphasising the large numbers doing inadequate volumes. 
 
Analysis 4: Summary 
The UKR debate has previously focussed on if and when these procedures should be 
performed. Specialist, high volume centres and surgeons produce superior results so a more 
pertinent question may be to ask “where should these procedures be performed?”. 
Improving the cost effectiveness of UKR relies on revision rates and functional outcomes 
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that approach those seen after TKR. One way to achieve this would be to concentrate the 
UKR workload, allowing centres and surgeons to undertake the necessary volumes required 
to improve patient outcomes and drive up standards of care. 
 
Analysis 4: Limitations and reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
The biggest problems encountered when undertaking an analysis such as this are 
determining how to measure volume and subsequently how to categorise surgeons and 
centres based upon their volume. There is currently no consensus on the best way to 
measure surgical volume. Possible approaches to determining volume include using the 
previous years workload, totaling or averaging out the work undertaken over a pre-specified 
period, or examining each year over a pre-specified period individually (i.e. surgeons can be 
high volume one year and low volume the next within the analysis). Operative volume is a 
very simplistic way of assessing surgical performance. Performance is influenced by a 
number of factors which are difficult to measure and even more difficult to quantify. 
Aspects of prior surgical training such as the institution in which training took place, the 
experience of the trainer, the duration of training, the intensity of training and the 
individual’s ability to be trained are all likely to impact on subsequent performance. These 
factors may have a significant bearing upon surgical outcome but their role is poorly 
understood.  
 
For this analysis volume was determined by observing the number of procedures performed 
over an 8 year period. It was felt this was the best way of measuring volume using the 
available data as it includes some measure of prior experience rather than simply using the 
most recent year’s volume in isolation. It takes into account unexpected departures from 
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the usual output, which may misrepresent true volume, due to centres and surgeons being 
busier or quieter than anticipated during the previous year. It also makes some correction 
for the newly appointed surgeon who is doing high volumes at the end but may not have 
built up the wealth of experience of more senior colleagues over a prolonged period. We 
accept that others may have approached this problem differently. Interest in the effects of 
surgical volume upon outcome within a range of surgical specialties is increasing. To assist in 
future work it would be useful to review how volume has been measured in the past and 
whether there are specific methodological advantages to one method over the rest.  
 
We chose to categorise volume into 5 groups roughly based on the quintile distribution of 
the data. This allowed us to identify 100 procedures in 8 years (approx. 13/year) as a 
threshold below which poorer revision rates were observed. The size of the dataset would 
have allowed us to use a greater number of groups but it was felt this would over-
complicate the analysis. If a greater number of groups had been used it might have been 
possible to refine this threshold further and gain a greater insight into the relationship 
between surgical volume and revision.  
 
The effects of centre volume are difficult to quantify as they are dependent upon the 
“pooled” results of a variable number of surgeons with a range of experience. This is 
emphasised in the Kaplan-Meier plot for centre volume in which the two highest and two 
lowest groups showed a similar pattern of failure but the intermediate volume group 
showed a unique failure pattern with an initial high rate of failure which improved over 
time. This pattern of failure may be partly explained by the observation that in contrast to 
the low and high volume centres, in which procedures were almost exclusively performed 
by low and high volume surgeons respectively, the intermediate centre volume group was 
highly heterogeneous for both surgeon numbers and experience. For this reason one must 
be cautious when interpreting information relating to centre volume from this and other 
analyses. This limitation, taken in combination with the finding that surgeon volume was the 
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most important influence upon revision, suggest that future work in this area should focus 
primarily upon the impact of individual surgeon volume upon outcome.  
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Chapter 5: Clinical outcomes after total knee replacement 
5.1 Current issues surrounding Total Knee Replacement (TKR) 
Total Knee Replacement (TKR) has now surpassed hip replacement as the commonest joint 
replacement procedure in the world (Kurtz 2007). Approximately 80,000 such procedures 
are performed in England and Wales each year at an estimated annual cost of £500million 
(DoH 2012, NJR-AR 2012). The demand for knee replacement is predicted to increase six-
fold between 2005 and 2030 as we service an increasingly elderly, yet functionally 
demanding population (Kurtz 2007). This poses something of a problem for health care 
commissioners with demand likely to outstrip supply. Allied to this are the significant costs 
associated with these procedures which must be considered given the fact that they aim to 
improve quality of life rather than save or sustain it. Despite widespread adoption the 
reported rates of patient satisfaction with TKR are <85% (Robertsson 2000, Noble 2006, 
Baker 2007, Bourne 2010) and up to 20% of patients fail to demonstrate improvements in 
health scores post-operatively (Browne 2007). This places TKR in a precarious position, at 
the mercy of health purchasers who have to balance the needs of their patients, ever 
tightening budgetary constraints and a lingering concern about a significant subgroup of 
patients who remain dissatisfied following surgery.  
 
In the context of these developments it is increasingly important for surgeons and centres 
performing TKR to demonstrate the procedures they are performing are effective. The 
operations performed should bring about tangible improvements in function and quality of 
life. This reflects current NHS reform which aims to “put quality at the heart of everything it 
does” (Darzi 2008). Patient Reported Outcome Measures (PROMs) offer a way to measure 
these improvements and are being increasingly used to supplement more traditional 
methods of assessing outcome such as patient safety and implant survival (Darzi 2008, DoH 
2009). They are now an integral part of the evaluation of the clinical quality of providers of 
elective procedures, and are increasingly being used to benchmark provider performance, 
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assess the efficacy and cost-effectiveness of different approaches to care, empower 
commissioners contracting services and drive patient choice (Darzi 2008, DoH 2009). 
     
Another recent development has seen a number of NHS trusts introduce guidance for 
primary care physicians on the type of patient suitable for referral to secondary care for 
consideration of TKR. These criteria have focused on limiting access to surgery in patients 
who are either deemed to not have severe enough disease (based on their pre-operative 
PROMs), or who have what is felt to be undesirable patient characteristics (smokers, 
obesity) (NHS North Lincolnshire 2011, NHS Warwickshire 2011). TKR is therefore effectively 
being rationed based on these factors in an attempt to control budgets and contain NHS 
spending. 
 
This is a major issue. If we consider the example of obesity we discover that in 2009 22 per 
cent of men and 24 per cent of women in the United Kingdom were classified as obese 
(Body Mass Index (BMI) ≥30kg/m2) (NHS Information centre 2012). The upward trend in the 
proportion of the population classified as obese is expected to increase further over the 
next 10 years (Zaninotto 2012). Obesity is an independent causative factor in the 
development of knee osteoarthritis (Lohmander 2009) and the average patient presenting 
for TKR is now classified as obese (NJR-AR 2012). Growth in the proportion of the population 
with obesity, combined with an increased demand for knee arthroplasty as we service an 
increasingly elderly population, will inevitably lead to a rise in the number of obese patients 
requesting TKR. Introducing referral barriers based on BMI thresholds will therefore deny 
TKR to an increasing proportion of the population. It is therefore important that we are 
certain that these barriers are evidence based.  
 
Historically both obese (BMI ≥30 kg/m2) and morbidly obese (BMI ≥40 kg/m2) patients have 
suffered a higher incidence of complications (Dowsey 2008, Samson 2010) and lower rates 
of implant survival (5-year survival rates = 74%) following TKR (Amin 2006). This view has, 
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however, been challenged by contemporary reports of equivalent rates of complications 
(Suleiman 2012) and mid-term survival (Yeung 2011, Dalury 2012) irrespective of the 
patient’s pre-operative BMI. Two recent reviews on the subject concluded that complication 
rates are higher in the obese and the morbidly obese, and survivorship is inferior (Dowsey 
2008, Samson 2010). However, insufficient evidence is currently available neither to 
definitively determine the effect on functional and quality-of-life outcomes in obese 
patients undergoing TKA (Samson 2010) nor to determine if there is a threshold above 
which the risks of surgery outweigh the benefits. This raises questions about the validity of 
the barriers to surgery and the arbitrary thresholds on which they are based. It also directly 
conflicts with NICE guidance that “patient-specific factors (including age, gender, smoking, 
obesity and comorbidities) should not be barriers to referral for joint replacement surgery.” 
(NICE (CG59)2007). Without further supportive evidence the use of these barriers is highly 
questionable.  
 
The impact of patient factors and pre-operative PROMs upon post-operative function and 
patient satisfaction are poorly understood and their discriminative capacity in predicting 
which patients are likely to be satisfied following TKR has yet to be established. Recent 
examination of the condition specific metric (Oxford Knee Score (OKS)) recorded within the 
PROMs demonstrated that it had no predictive accuracy in relation to post-operative 
satisfaction (Judge 2011). The use of these tools for limiting and/or prioritising access to 
surgery is therefore also unclear.  
 
Given the current vogue for using PROMs to evaluate the quality of clinical care and also to 
limit access to surgery it is of paramount importance that the orthopaedic community 
understands how PROMs are influenced by a range of patient and surgeon related factors.  
By understanding PROMs clinicians and managers can instigate strategies to optimise 
outcomes and improve standards. While it is well known that a variety of patient factors 
influence outcome (Fortin 1999, Baker 2007, Bourne 2010), there may be little the surgeon 
can do to influence them apart from improved patient selection. Failure to appreciate these 
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effects could lead certain centres to be unfairly penalised by the case-mix of the populations 
they serve. However surgeons may mitigate this risk by exercising greater autonomy over a 
number of factors and techniques employed at the time of surgery 
 
The surgeon has an array of potentially modifiable factors available to them at the time of 
surgery. He has a degree of choice over the brand of knee replacement he uses and 
thereafter the specifics of the bearing type, meniscal design, and patella resurfacing. He also 
decides how the operation will be performed, by what surgical approach and whether 
specialist equipment such as computer navigation will be employed.  The impact of a 
number of these factors upon functional outcome has been investigated using randomised 
trial designs previously (Wylde 2008, Burnett 2009, Johnston 2009, Choi 2010). However, 
these publications have all failed to demonstrate any significant benefit deriving from these 
surgical factors. The relative influence of surgeon determined factors upon the PROMs 
outcomes that are now so important remains unclear.  
 
The on-going Knee Arthoplasty Trial (KAT) (HTA ref: 95/10/01, finding £1,381,371) 
commenced in 1998 and is due for completion in later 2013. It aims to clarify the role of 
different approaches to surgery by asking 1) Should the inner surface of the knee cap be 
resurfaced? 2) Should the tibial component have a metal back? and 3) Should the knee 
replacement have a mobile bearing?. When completed this study will have taken 15 years to 
answer these questions but will not have addressed other pertinent questions relating to 
the surgery performed such as is there any role for computer navigation?, is there any 
benefit to minimally invasive surgical techniques?, does it make a difference if you use a 
cruciate retaining or a posterior stabilised knee design?, how does the brand of knee 
replacement and where you have your surgery performed influence post-operative 
functional outcomes and patient satisfaction?.  The results of this trial are therefore likely to 
answer some of the many questions surgeons are asking but leave them scratching their 
heads about others.   
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It may be possible to address a number of the issues raised above using registry data. The 
NJR and PROMs data available was therefore used in an attempt to answer a number of 
questions about TKR. These included: 
1. Which surgical factors influence improvements in PROMs following TKR and what is 
their influence relative to patient related factors? 
2. How do pre- and post-operative factors influence patient satisfaction and the 
perception of symptom improvement following TKR?   
3. What is the nature of the relationship between pre-operative, post-operative and 
the improvements in PROMs and obesity?  
4. Is there evidence to support the idea of an obesity “cut off” as a basis for 
withholding surgery based on functional outcomes? 
 
These questions are addressed in the subsequent 3 analyses.  
1. Analysis of the influence of surgical factors on PROMs. 
2. Analysis of the relationship between pre- and post-operative factors and patient 
satisfaction with TKR. 
3. Analysis of the relationship between Body Mass Index and PROMs. 
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5.2 Analysis 5: Analysis of the influence of surgical factors on PROMs 
 
Analysis 5: Aims 
To determine: 
1. Which surgical factors influence improvements in PROMs following TKR. 
2. What is the relative influence of surgical factors in comparison to a number of 
patient related factors. 
 
Analysis 5: Methods 
This analysis was performed on the NJR-PROMs dataset described in section 3.4.4. From this 
dataset data was extracted on all patients for whom the primary indication for TKR was 
osteoarthritis. In total 22,691 NJR-PROMs records were available for analysis. The 
demographic, surgical and implant variables available for analysis are listed in table 3.8 
(section 3.4.4). These included a number of clinically important operative (lead surgeon 
grade, hospital type, minimally invasive surgery, computer navigation) and implant variables 
(meniscal type, bearing type, patella resurfacing, implant brand) whose impact of the 
improvements in PROMs could be assessed. The improvement in the OKS and EQ5D were 
again used as the primary outcomes for this analysis.  
 
The standard modeling process described in section 3.6.3 was used for this analysis. Initial 
analysis to establish the relationship between the individual explanatory variables and 
magnitude of the OKS/EQ5D improvements was undertaken using one-way analysis of 
variance (ANOVA) and univariable regression. Multiple regression was then employed to 
account for the significant variations in case-mix (patients’ characteristics), pre-operative 
scores and implant usage which could potentially confound any comparative analysis. A p 
value of p<0.001 was used to indicate statistical significance given the large number of 
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patients and variables available. This was done to limit the effects of type I error and help 
produce a parsimonious regression model.  Initial analysis revealed there was a significant 
amount of missing data for Body Mass Index (BMI) (9100 cases (40%)). While the patients 
with and without BMI data were reasonably matched for patient factors there were 
significant differences in the surgical factors (hospital type, lead surgeon grade, navigated 
surgery, meniscus type, implant brand and bearing type (all p<0.05)) between these groups. 
This suggested that patients with BMI data might not be representative of the total 
population and that the recording of BMI may be related to the type of surgery performed. 
As such inclusion of BMI might bias any analysis of the influence of surgical factors upon 
outcome.  Models were therefore produced that did not include BMI as an explanatory 
variable.  
 
For the final models the model estimates with 95% confidence limits are provided to allow 
comparison of the adjusted effect size between variables. Estimates effectively represent 
the predicted changes in the OKS and EQ5D for that variable once the effect of all other 
variables included in the model are considered. For continuous variables (age, BMI, OKS and 
EQ5D scores) these estimates relate to the expected changes in the response outcome 
(OKS/EQ5D) for a unit change in the explanatory variable. For categorical variables the 
estimates are given relative to the base reference category.  Model residuals and other 
checks of model adequacy were satisfactory. There was one significant 2-way interaction 
between variables included within the final models which is discussed within the results 
section.  
 
Analysis 5: Results 
Univariable analysis  
Surgical factors that influenced the magnitude of the OKS and EQ5D improvements included 
implant brand and hospital type (Both OKS/EQ5D), and bearing type (OKS only) (all p<0.001) 
(table 5.1). For implant brand there was a noticeably greater improvement in both OKS and 
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EQ5D with the NexGen implant when compared to other groups (p<0.001) (table 5.2). The 
effect of hospital type was related to differences between NHS hospitals (20,288 cases) and 
Independent hospitals (1491 cases)/ Independent Sector Treatment Centres (ISTCs) (912 
cases), with greater improvements seen in latter two institutions. There was also an 
association between the magnitude of the OKS improvement and bearing type which 
indicated an advantage for fixed over mobile bearing implants. No other surgical factors 
individually influenced the outcomes for either score. 
 
Predictor variable Dependent variable 
 OKS improvement EQ5D improvement 
Patient factors 
Age (years) 0.007 0.65 
Pre-operative OKS <0.001 <0.001 
Pre-operative EQ5D index <0.001 <0.001 
Number of comorbidities <0.001 0.97 
Time from operation to post-operative 
PROMs questionnaire collection (days) 
0.45 0.36 
Gender <0.001 <0.001 
Side of surgery 0.58 0.59 
Pre-operative disability  <0.001 <0.001 
Pre-operative general health <0.001 <0.001 
Depression <0.001 <0.001 
Anxiety level 0.52 <0.001 
ASA grade 0.007 0.85 
Duration of symptoms  <0.001 0.007 
Surgical factors 
Lead surgeon grade 0.20 0.24 
Minimally invasive surgery 0.29 0.84 
Computer Navigated 0.08 0.62 
Bearing <0.001 0.23 
Meniscus 0.51 0.03 
Patella Resurfaced 0.77 0.64 
Brand type  <0.001 <0.001 
Hospital type <0.001 <0.001 
Table 5.1: Summary of the p values for univariable analysis with improvement in OKS and 
EQ5D index as the response variables. 
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In addition a number of patient factors were seen to influence the PROMs improvements. 
Most notably there was an inverse relationship between the magnitude of the 
improvements observed and the corresponding pre-operative PROMs for both the OKS and 
EQ5D. Patients who start off worse had a greater chance of improving presumably because 
they have greater scope for improvement. Better overall health (pre-operative general 
health, ASA code, pre-operative disability, anxiety/depression) was also related to a greater 
PROMs improvement. These findings were consistent with the associations seen in analysis 
1 (section 4.2).  
 
  Pre op Post op Change 
NexGen® 
(n=3283) 
OKS 
 
EQ5D 
18.9 
(95% CI 18.6 to 19.1) 
0.409 
(95% CI 0.398 to 0.420) 
35.1 
(95% CI 34.8 to 35.5) 
0.730 
(95% CI 0.722 to 0.739) 
16.2 
(95% CI 15.9 to 16.6) 
0.323 
(95% CI 0.310 to 0.333) 
PFC® 
(n=8287) 
OKS 
 
EQ5D 
18.7 
(95% CI 18.5 to 18.8) 
0.396 
(95% CI 0.389 to 0.403) 
33.9 
(95% CI 33.7 to 34.1) 
0.708 
(95% CI 0.702 to 0.714) 
15.2 
(95% CI 15.0 to 15.4) 
0.312 
(95% CI 0.305 to 0.320) 
Genesis 2® 
(n=1818) 
OKS 
 
EQ5D 
19.3 
(95% CI 18.9 to 19.6) 
0.425 
(95% CI 0.410 to 0.440) 
33.6 
(95% CI 33.2 to 34.1) 
0.707 
(95% CI 0.694 to 0.719) 
14.3 
(95% CI 13.9 to 14.8) 
0.282 
(95% CI 0.266 to 0.299) 
AGC® 
(n=2398) 
OKS 
 
EQ5D 
19.4 
(95% CI 19.1 to 19.7) 
0.429 
(95% CI 0.416 to 0.442) 
34.2 
(95% CI 33.8 to 34.6) 
0.715 
(95% CI 0.704 to 0.726) 
14.9 
(95% CI 14.5 to 15.2) 
0.286 
(95% CI 0.272 to 0.300) 
Triathlon® 
(n=1896) 
OKS 
 
EQ5D 
19.6 
(95% CI 19.2 to 19.9) 
0.436 
(95% CI 0.422 to 0.451) 
34.4 
(95% CI 34.0 to 34.9) 
0.725 
(95% CI 0.713 to 0.737) 
14.8 
(95% CI 14.4 to 15.3) 
0.289 
(95% CI 0.274 to 0.304) 
Other 
(n=5009) 
OKS 
 
EQ5D 
19.1 
(95% CI 18.9 to 19.3) 
0.407 
(95% CI 0.398 to 0.416) 
33.6 
(95% CI 33.3 to 33.9) 
0.702 
(95% CI 0.694 to 0.709) 
14.5 
(95% CI 14.2 to 14.8) 
0.294 
(95% CI 0.285 to 0.304) 
Total 
(n=22,691) 
OKS 
 
EQ5D 
19.0 
(95% CI 18.9 to 19.1) 
0.409 
(95% CI 0.405 to 0.414) 
34.1 
(95% CI 33.9 to 34.2) 
0.712 
(95% CI 0.708 to 0.716) 
15.1 
(95% CI 14.9 to 15.2) 
0.303 
(95% CI 0.298 to 0.307) 
Table 5.2: Improvement in the OKS and EQ5D scores analysed by implant brand. 
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Multiple regression analysis 
Once the influence of other variables was considered the only surgical factors seen to 
influence outcome were implant brand and hospital type (table 5.3). The effect of bearing 
type (p=0.003) did not appear within the final OKS model as it did not reach the criteria 
(p<0.001) for inclusion. The NexGen implant remained the best performing implant within 
these models. The variation in PROMs ascribed to brand type is given in the estimate 
columns of table 5.3. The difference between the best (NexGen) and worst (“Others”) 
brands within these models was 1.7 (95%CI 1.4 to 2.2) for the OKS and 0.034 (95%CI 0.023 
to 0.045) for the EQ5D. The statistical significance seen between brands has been facilitated 
by the large numbers available for analysis and the associated precision of the estimates for 
the mean PROMs improvement. However, the variation in improvement for each brand 
remains large with significant overlap in the distribution of improvements between the 
different brands (figure 5.1).  
 
 
Figure 5.1: Distributions of the improvement in OKS and EQ5D after adjustment using the 
regression models for the best (NexGen®: Black) and worst (Others: Red) brands. The 
reference lines represent the mean for each brand in relation to the overall mean for all 
patients (zero line on horizontal axis). 
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For hospital type the improvements in both OKS and EQ5D were again greater for ISTCs 
when compared NHS hospitals (OKS 1.8 (95% CI 1.2 to 2.5), EQ5D 0.040 (95%CI 0.024 to 
0.057)). There was no significant difference between independent hospitals and ISTCs. The 
only significant interaction between either surgical factor with other variables in the final 
models was between depression and implant type for the magnitude of the EQ5D 
improvement. However, on further graphical investigation the effect of this interaction was 
not found to be important.  
 
While both brand and hospital type were seen to influence PROMs improvements the effect 
sizes of these factors were modest compared to those attributable to a number of patient 
factors. The effect sizes (the predicted effect of each variable on the magnitude of the 
change in PROMs) for all of the variables included in the final models are given as the model 
estimates for that variable in table 5.3. Within both models the most important variables 
were the relevant pre-operative PROMs score, the patient’s ratings of their pre-operative 
general health, and the presence of anxiety and depression. For example, table 5.3 shows 
that a for every one point increase in the pre-operative OKS the change in OKS is predicted 
to decrease by -0.66 points, thus an increase in the pre-operative OKS of 10 points predicts 
a reduction of -6.6 points in the OKS improvement. The corresponding size effects for 
patients with the best and worst general health is 8.1 points. This puts into context the 
differences seen between the best and worst implant brands (1.7) and hospital types (1.8). 
It must, however, be noted that the effect of each variable on the predicted improvement in 
PROMs are additive, meaning the effects of brand and hospital type are the same 
irrespective of changes in the other variables.  
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 OKS improvement EQ5D improvement 
Predictor Variable Estimate 95% CI p value Estimate 95% CI p value 
Patient variables       
Age 0.06 0.04 to 0.07 <0.001 0.002 0.002 to 0.002 <0.001 
Pre-operative OKS -0.66 -0.67 to -0.64 <0.001 0.003 0.003 to 0.003 <0.001 
Pre-operative EQ5D index - - - -0.891 -0.905 to -0.876 <0.001 
Number of Co-morbidities -0.25 -0.39 to -0.12 <0.001 - - - 
Pre-operative disability  
No 
Yes 
 
Reference 
-1.49 
 
 
-1.75 to -1.23 
 
 
<0.001 
 
Reference 
-0.049 
 
 
-0.056 to -0.042 
 
 
<0.001 
Pre-operative general health 
Excellent 
Very Good 
Good 
Fair 
Poor 
 
Reference 
-1.12 
-2.78 
-5.23 
-8.13 
 
 
-1.78 to -0.45 
-3.42 to -2.12 
-5.93 to -4.53 
-9.09 to -7.16 
 
 
<0.001 
<0.001 
<0.001 
<0.001 
 
Reference 
-0.038 
-0.076 
-0.152 
-0.243 
 
 
-0.056 to -0.020 
-0.093 to -0.058 
-0.171 to -0.133 
-0.269 to -0.217 
 
 
<0.001 
<0.001 
<0.001 
<0.001 
Depression 
No 
Yes 
 
Reference 
-0.95 
 
 
-1.44 to -0.46 
 
 
<0.001 
 
Reference 
-0.066 
 
 
-0.079 to -0.054 
 
 
<0.001 
Anxiety level 
No anxiety/depression 
Moderate anxiety/depression 
Severe anxiety/depression 
 
Reference 
-1.17 
-2.78 
 
 
-1.45 to -0.90 
-3.48 to -2.07 
 
 
<0.001 
<0.001 
 
Reference 
-0.041 
-0.097 
 
 
-0.048 to -0.033 
-0.117 to -0.077 
 
 
<0.001 
<0.001 
ASA grade 
Grade 1 
Grade 2 
Grade 3/4 
 
Reference 
-0.27 
-1.00 
 
 
-0.67 to 0.13 
-1.52 to -0.49 
 
 
0.19 
<0.001 
 
Reference 
-0.011 
-0.037 
 
 
-0.021 to -0.000 
-0.051 to -0.024 
 
 
0.046 
<0.001 
Surgical variables       
Brand type 
NexGen® 
PFC® 
Genesis 2® 
AGC® 
Triathlon® 
Other  
 
Reference 
-0.98 
-1.50 
-1.20 
-0.94 
-1.74 
 
 
-1.35 to -0.62 
-2.02 to -0.98 
-1.68 to -0.72 
-1.46 to -0.43 
-2.16 to -1.36 
 
 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
 
Reference 
-0.015 
-0.023 
-0.023 
-0.011 
-0.034 
 
 
-0.025 to -0.005 
-0.037 to -0.009 
-0.036 to -0.010 
-0.024 to 0.003 
-0.045 to -0.023 
 
 
0.003 
0.001 
<0.001 
0.11 
<0.001 
Hospital Type 
NHS Hospital 
Independent Hospital 
ISTC 
 
Reference 
0.83 
1.84 
 
 
0.35 to 1.31 
1.23 to 2.45 
 
 
0.73 
<0.001 
 
Reference 
0.017 
0.040 
 
 
0.004 to 0.029 
0.024 to 0.057 
 
 
0.01 
<0.001 
Table 5.3: Summary of the variables significant in the final multiple linear regression models. 
Estimators with 95% CI are presented to allow comparison of the effect size of each 
variable. For categorical variables the estimators are given as differences relative to the first 
category. For continuous variables the estimate describes the effect on the change in score 
if the predictor variable was increased by one point.  
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Analysis 5: Discussion 
This analysis found that of the variables considered the only surgical factors influencing 
PROMs improvements were implant brand and hospital type. However, the effects 
attributable to these factors were small in comparison to those associated with a range of 
patient factors whose influence upon PROMs improvements was more pronounced.  
 
PROMs are becoming an established means of assessing and comparing Trusts and 
surgeons. In the current climate of transparency and accountability, results of the NJR and 
PROMS are within the public domain. Patients are becoming far more educated, particularly 
with the ability to access internet resources and are thus becoming more selective with 
regard to who will perform their joint replacement (Marcario 2003). This environment 
provides the motivation to drive quality improvement, track productivity and foster inter-
unit competition. In addition PROMs data is soon to be used for ranking, re-imbursement 
and the identification of outliers with individual surgeon’s outcomes displayed alongside 
other surgeons’ performing the same procedure (Fairley 2008). Consequently, these 
measures wield potentially substantial financial weight. Should PROMs data be used for 
benchmarking and comparison, any advantage (even theoretical) becomes desirable, 
regardless of change in patient function. However, incentivising institutions and individuals 
based on outcome measures becomes more difficult to defend if the gain in clinical benefit 
is unclear (Kay 2011).  
 
A number of previous studies have assessed the impact of surgical factors upon functional 
outcomes. Surgical factors studied include patella resurfacing (Nizard 2005, Burnett 2009), 
bearing type (mobile vs. fixed bearing) (Jacobs 2004, Wylde 2008), tibial component design 
(metal backed vs. all polyethylene) (Najibi 2003), meniscus type (cruciate retaining vs. 
posterior stabilised) (Tanzer 2002), computer navigation (Bauwens 2007, Luring 2011), 
minimally invasive surgery, high flexion knee systems (Choi 2010), gender specific knee 
systems (Kim 2010) and implant type (Koskinen 2010, Scott 2010, Endres 2011). None of 
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these has demonstrated a clear functional advantage. Implants and their corresponding 
design traits are surrounded by a massive advertising framework and a strong 
representative presence. It can be hard to separate out performance in terms of patient 
outcome measures due to the number of confounding variables that accompany the varied 
patient mix. The NJR provides a wealth of information with which we have been able to 
examine the impact of surgical factors, after adjustment for important patient factors, on 
PROMs improvements.  
 
Papers specifically comparing implant brands have failed to show improved outcomes for 
one particular brand (Scott 2010, Endres 2011). However, these analysis are based on small 
numbers and limited data. This analysis has the benefit of large numbers (n=22,691) and a 
robust statistical analysis, allowing for the identification of significant relationships 
unappreciated in smaller analyses.  
 
Previous reports have suggested that ISTC’s achieve higher patient satisfaction rates when 
compared to NHS institutions (97.5% versus 89%) (DoH 2007). A thorough evaluation of 
their performance, quality of care and equality of access has not been possible due to poor 
compliance with data submission to the Hospital Episode Statistics (HES) database and a lack 
of enforcement of this contractual requirement. The Healthcare Commission of 2007 did, 
however, note ISTCs had fewer post-operative readmissions and shorter lengths of stay 
(DoH 2007), reflecting the case-mix for ISTCs which is self-selecting and by its very nature, 
excludes patients with complex co-morbidities. This analysis made adjustments for case-mix 
and as such the observed differences in PROMs cannot be attributed to case-mix variation.  
The findings may, however, be partly due to the inclusion of one high volume ISTC with 
particularly good results which contributed 44% (402 of 912 cases) of the procedures for the 
ISTC group (11 ISTCs). This is likely to bias the results for ISTCs, with the results reflecting 
outcomes for this institution rather than for ISTCs as a whole.  
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While surgical factors were important in the final models, the factors demonstrating the 
greatest influence on PROMs outcomes were predominately patient related. This is 
consistent with a number of other studies that have demonstrated significant associations 
between outcome and a variety of patient factors (Fortin 1999, Baker 2007, Bourne 2010). 
In all models the most important and consistent predictor of outcome was the relevant pre-
operative PROMS score. Better outcomes were also seen in patients with the best levels of 
pre-operative general health, disability and depression/anxiety, which is consistent with the 
literature (Lingard 2004, Chang 2010). While the best post-operative scores were seen in 
patients with the best pre-operative scores, patients with lower pre-operative scores 
demonstrated the greatest improvements. This observation is likely related to the larger 
potential improvements available to these patients and PROMs ceiling effects due to the 
inability for these scores to adequately detect top end differences. The absolute post-
operative score is thus arguably an unfair measure, as patients with low pre-operative 
scores have lower post-operative scores and as such are unlikely to achieve pre-determined 
target scores designated as the bookmark of success. Instead, the overall change in score, 
adjusted for the pre-operative starting point, should be used a more accurate reflection of 
the patient’s experience.   
 
Difficulty lies in establishing the relationship between the amount of change required in the 
scoring system and the perceptible clinical difference. For a difference to be important, it 
has to make a difference to the patient. In many units, it has become part of the usual 
surgical pre-assessment and follow-up to complete standardised and validated scores. The 
minimal clinically important difference (MCID) for the OKS has not been published, but is 
has been demonstrated that the MCID  for TKR using the Western Ontario and McMaster 
Universities Osteoarthritis index (WOMAC) score is 15 points and the Short Form 36 (SF-36) 
at least 10 points (Escobar 2007). It is unlikely therefore that the differences of less than 2 
OKS points seen between implants and institutions will be clinically relevant. This 
demonstrates that patient factors are more important than anything we as surgeons can 
control at the time of surgery.  It is, however, differences of this magnitude that are 
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monitored by managers and politicians and considered as evidence of performance with far-
reaching implications for both the surgeon and their organisation.  
 
These findings highlight the fundamental importance of adequate case-mix adjustment 
when comparing institutions and surgeons. Without adequate correction surgeons could 
potentially become PROMs outliers dependent solely upon the population they serve and 
the cases they undertake. In a climate of financial incentives, failure to recognise and make 
allowance for these factors could result in surgeons cherry-picking cases to obtain the best 
results. The danger could be that patients with significant co-morbidities, poor mental 
health scores or reduced functional ability for whom arthroplasty could potentially be life-
changing, may be denied surgery. Therefore, it is vital that discussion of PROMs for payment 
by results includes detailed analysis of case-mix and pre-operative scores before the less 
tangible effect of the individual surgeon’s skills can be teased out. Whilst the surgeon can 
influence the implant choice and timing of surgery, he/she has little sway on case-mix and 
like it or not, the outcome, or change in outcome is what the commissioning bodies will use 
to determine workload choice. 
 
Analysis 5: Summary 
This analysis found that of the surgical factors analysed only implant brand and hospital type 
were associated with PROMs improvements. However the effects of these categorically 
collected surgical factors were small when compared to patient factors, and in particular the 
pre-operative PROMs and general health status.  The influence attributable to the pre-
operative PROMs also highlights the importance of collecting both pre and post-operative 
data when comparing groups, and the significance of the change in score versus the 
absolute outcome score. Given these findings, it would seem to be inappropriate to base 
decisions about the effectiveness of surgical interventions on post-operative scores alone. 
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Analysis 5: Limitations and reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
The ‘surgical factors’ used for this analysis were those that could be extracted from the NJR 
dataset. Implant coding within the NJR dataset is complex. In many cases there are greater 
than 20 columns of data relating to each implant which makes it difficult to effectively 
assimilate implant data. We therefore had to simplify the way in which we grouped surgical 
data particularly for factors such as implant brand, meniscus and bearing. Given more time 
and a greater understanding of the coding structure it might have been possible to extract a 
greater level of detail for these factors.   
 
This analysis suffered the same problem as analysis 1, namely that the final models 
produced only explained a small amount of the observed variation in the response variables 
(OKS and EQ5D improvement). The influence and significance of variables within the 
regression models naturally change as variables are added or removed. The addition of 
information relating to ‘missing’ variables such as patient expectation or mental health 
might change the model so that variables that were initially significant are no longer so. This 
is concerning, particularly when there is a commercial interest in the results of the analysis 
due to the inclusion of implant brand data.  
 
The minimally clinically important difference (MCID) for the OKS is not yet known. It is, 
however, likely to be greater than the size effects of many of the variables included in the 
final regression models. A clinical study examining, for example, the influence of implant 
brand upon the OKS would use information on the distribution of this measure in 
combination with the MCID to perform a power calculation and sample size analysis. 
Recruitment would be based on this analysis and would not exceed it. Due to the size of the 
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NJR-PROMs dataset the analysis has been able to identify variables that have an influence at 
a level below the MCID. Reporting these associations relies on the readership understanding 
the concept of the MCID and applying the findings within this context. Unfortunately this is 
not always the case as many clinicians focus primarily on high significance (p values) even if 
it is associated with a marginal, clinically irrelevant outcome. Given these concerns it may 
have been better to model and report this data based not only on the p value but also on 
the model estimate, with variables only included if they reached statistical significance and 
their model estimate was in excess of the MCID. If these criteria were applied to this 
analysis only the pre-operative OKS, pre-operative general health and possibly the anxiety 
level would have made it into the final model for the OKS improvement. For the EQ5D 
improvement only the pre-operative EQ5D score would have made it into the final model. 
These simplistic models highlight only the most important explanatory variables and help 
avoid over-interpretation. 
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5.3 Analysis 6: Analysis of the relationship between pre- and post-operative factors and 
patient satisfaction with TKR 
  
Analysis 6: Aim 
1. To establish how pre- and post-operative factors influence patient satisfaction and 
the perception of symptom improvement following TKR. 
 
Analysis 6: Methods 
This analysis was performed on the NJR-PROMs dataset described in section 3.4.4. From this 
dataset data was extracted on all patients for whom the primary indication for TKR was 
osteoarthritis. In total 22,691 NJR-PROMs records were available for analysis. The primary 
outcome for this analysis was the patient’s rating of their surgery (“patient satisfaction”) 
described in section 3.5.4. Within this scale the first category was the best response and the 
fifth category the worst response meaning the scale was inversely related to the OKS and 
EQ5D scores. A satisfaction rating was available for 22,373 (99%) of the 22,691 patients 
analysed. 
 
A structured literature review was undertaken to determine which factors had previously 
been shown to influence satisfaction following knee replacement. All of the identified 
reports focused solely on the direct relationships between a variety of explanatory factors 
and satisfaction without consideration for any interactions between these factors. Reported 
associations with satisfaction included both demographic characteristics / other 
preoperative conditions (patient age (Noble 2006, Baker 2007), gender (Ethgen 2004, Baker 
2007), underlying diagnosis (Bullens 2001, Baker 2007), a lower level of education (Bourne 
2010), increasing Body Mass Index (BMI) (Bourne 2010), mental health status/depression 
(Anderson 1996, Scott 2010, Blackburn 2012), general health status (Anderson 1996, Noble 
2006)) and factors measured postoperatively (need for revision surgery (Hawker 1998, 
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Robertsson 2000, Bourne 2010), post-operative patient reported outcome scores/symptom 
improvement (Hawker 1998, Baker 2007, Bourne 2010) and fulfillment of patient 
expectations (Bourne 2010)). Descriptions of the factors available for this analysis are given 
in table 5.4. 
 
Predictors  Details 
Age (Years)  
Gender - Female / Male  
Diagnosis Analysis restricted to only those procedures performed for 
osteoarthritis as this group comprises >98% of all knee 
replacements performed. Other indications excluded 
Need for revision surgery PROMs recorded at 6 months post-operatively. The number 
of revisions at this time-point is small limiting the ability to 
analyse this variable 
Level of education Not recorded in the NJR-PROMs dataset 
Body Mass Index (BMI) Data only available for 9,874 (42%) patients. Patients with 
missing BMI data differed from those with recorded BMI 
data in relation to reported levels of satisfaction and 
success. This data was therefore excluded from the analysis.  
Mental health status/ Depression Patient reported. Indicates whether the patient has 
previously been given a diagnosis of depression   
- No / Yes 
Pre-operative  General Health Patient reported: Indicates the patients perception of their 
own general health with 5 ordered options: 
- Excellent 
- Very good 
- Good 
- Fair 
- Poor 
Patient reported outcomes 
Euroqol index (EQ5D)  
 
Oxford Knee Score (OKS)  
 
Operative Success 
The patients perception of surgical 
success 
 
Described in section 3.5.3 
(Pre-operative, post-operative and change in score) 
Described in section 3.5.3 
(Pre-operative, post-operative and change in score) 
Described in section 3.5.4 
“Overall, how are the problems now in the knee on which 
you had surgery, compared to before your operation?”  
- Much better 
- A little better 
- About the same 
- A little worse 
- Much worse 
Patient expectation Not recorded in the NJR-PROMs dataset 
Table 5.4: Explanatory variables identified from the structured literature review and their 
availability within the NJR-PROMs dataset. 
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Initial tabular and graphical summaries of the relationship between satisfaction and each of 
the explanatory variables were supplemented by ordinal logistic regression and structural 
equation modelling. Ordinal logistic regression was used to analyse the effects of the 
explanatory variables individually and in combination as satisfaction was measured using a 5 
point ordinal scale. Structural equation modelling was then used to investigate the direct 
and indirect effects of the different factors upon patient satisfaction. Logistic regression 
models were constructed to assess the relationship between variables available both pre-
operatively (age, gender, depression, general health status, pre-operative OKS/EQ5D) and 
post-operatively (post-operative OKS/EQ5D, ‘operative success’) with satisfaction. Model 
identifiability was assessed on the basis of the condition number of Hessain of <104. Where 
the condition number of Hessain was in excess of this value the models were rejected on 
the basis of being ill-conditioned. Initial models including both the OKS and EQ5D in addition 
to the other patient characteristics were rejected as they did not converge. Models with the 
OKS alone were also inadequate for the same reason. A resampling exercise using 200 
random subsets of 94% of the data showed that all models including the OKS were not 
identifiable as the condition number for all replicates was in excess on 105 (mean 6.5 × 105  
SD 4332). However as the OKS and EQ5D were correlated (Preoperative OKS:EQ5D 
Spearman rank r=0.70, Post-operative OKS:EQ5D Spearman rank r=0.76), and prior analysis 
had demonstrated the pre-operative OKS and satisfaction were poorly correlated 
(Spearman Rank correlation 0.04 (95%CI -0.01 to 0.08)) (Judge 2011) a decision was made to 
proceed using only the EQ5D in addition to the other patient characteristics. Variables were 
removed using a two-stage stepwise reduction until only significant variables were left in 
the model.  
 
As the explanatory variables have the potential to influence each other structured 
equational modelling (SEM) was used to investigate their direct and indirect effects on the 
satisfaction outcome. SEM is described in section 3.6.4. In summary it is a method for 
investigating the impacts of variables in systems where there are multiple pathways to the 
final effect. The approach is used to challenge a hypothetical representation of the system 
pathways using data. In the present context we hypothesised that patient satisfaction is 
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driven by patient characteristics, pre- and post-operative function and the perception of 
symptom improvement (‘operative success’). For example, this model is able to recognise 
that post-operative function is dependent upon preoperative function which in turn is 
dependent on patient age and gender. Thus there are a set of driving variables that have 
both direct and indirect effects on satisfaction that are themselves related. The pathway of 
hypothesised effects for this analysis is shown in figure 5.2. Males and females patients 
were modeled separately as a grouping index in the analysis.  
 
 
 
Figure 5.2: Hypothetical model developed to explain the relationship between the available 
explanatory factors and satisfaction and success 
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Analysis 6: Results 
Initial examination of the relationship between satisfaction and ‘operative success’ 
demonstrated that 15,882 (71%) patients perceived their knee symptoms to be ‘much 
better’ following surgery. However despite symptomatic improvement only 4,959 (22%) 
gave their surgery the top satisfaction rating of ‘excellent’. Instead the majority of patients 
rated their surgery as either ‘very good’ or ‘good’ (table 5.5). In total there were 1,592 (7%) 
patients who rated their surgery as ‘fair’ or ‘poor’ despite reporting symptomatic 
improvements (red shaded). This group were on average a year younger (mean age: 68.8 vs. 
69.7 years), had higher levels of depression (11% vs. 7%) and ‘Fair/Poor’ general health (43% 
vs. 24%), and had lower pre-operative knee (mean OKS score: 16.9 vs. 19.0) and general 
health (mean EQ5D score: 0.329 vs. 0.407) scores than the total population undergoing TKR. 
There was also a smaller group of 40 (0.2%) patients who reported high levels of satisfaction 
despite a worsening of their symptoms (blue shaded). 
 
Satisfaction Success  
Much 
better 
A Little 
better 
Much the 
same 
A little 
worse 
Much 
worse 
TOTAL 
Excellent 4,886 59 3 7 4 4,959 
(22%) 
Very Good 7,344 474 36 18 11 7,883 
(35%) 
Good 3,374 2,002 313 119 23 5,831 
(26%) 
Fair 272 1,251 646 476 122 2,767 
(12%) 
Poor 6 63 111 199 459 838 
(4%) 
TOTAL 15,882 
(71%) 
3,849 
(17%) 
1,109 
(5%) 
819 
(4%) 
619 
(3%) 
22,278 
(100%) 
Table 5.5: Distribution of satisfaction and success following total knee replacement. 
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Ordinal logistic regression 
Patient satisfaction was significantly and positively related to ‘operative success’. As the 
success in operative outcome declined, the odds ratio of a poor satisfaction score increased. 
A ‘much worse’ operative outcome had an odds ratio of 845 (95%CI 652 to 1097) of a low 
satisfaction score relative to a case with ‘much better’ operative success.  Similarly, poor 
health had a higher odds ratio of low satisfaction (3.3, 95%CI 2.6 to 4.2) relative to a patient 
in good health. Satisfaction was also related to the pre- and post-operative function as 
represented by the EQ5D scores (OR = 1.52, 95%CI 1.38 to 1.68 and OR = 0.09, 95%CI 0.08 
to 0.10 respectively). In addition being male led to a lower risk of dissatisfaction relative to 
being female (OR = 0.86. 95%CI 0.81 to 0.91), as did not having a previous diagnosis of 
depression (OR = 0.83, 95%CI 0.74 to 0.92) (table 5.6). Age was not a significant predictor of 
satisfaction within the ordinal regression model. The regression diagnostics indicated that 
post-operative variables had a larger influence upon satisfaction than preoperative 
variables. For the regression models proportionality assumptions were broadly met except 
where the number of cases in a class was low, specifically the ‘much worse’ success group. 
 
Structured equational modelling (SEM) 
Full models including all hypothesised explanatory variables and pathways did not 
adequately describe the variation in satisfaction observed in the data. Z values for all 
variables included in the final SEM path model (figure 5.3) were significant at p<0.001 with 
the exception of the pathway from age to satisfaction in females where significance was 
marginal (Z=1.81, p=0.07). The variable was kept in the final model however, as it was more 
significant for males (Z=2.60, p=0.009). Whilst these data show levels of significance for key 
covariates the coefficients are not standardised in relation to each other so are difficult to 
compare across pathways. Standardised coefficients for the best fit models for males are 
shown in figure 5.3. The coefficients on the path lines represent the proportional change in 
standard deviation of the response in relation to a unit standard deviation change in the 
hypothesised driving variable.  
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Covariate Estimate SE of 
Estimate 
Z p Odds 
Ratio 
Lower 
95%CI 
Upper 
95%CI 
Pre-operative variables        
Gender 
(Reference: Female) 
       
Male -0.15 0.028 -5.4 <0.001 0.9 0.8 0.9 
Pre-operative EQ5D 0.42 0.049 8.5 <0.001 1.5 1.4 1.7 
Depression 
(Reference: Diagnosis of depression) 
       
No diagnosis of depression -0.19 0.056 -3.4 <0.001 0.8 0.7 0.9 
General health 
(Reference: Excellent) 
       
Very Good 0.67 0.088 8.5 <0.001 2.0 1.6 2.3 
Good 1.07 0.078 13.7 <0.001 2.9 2.5 3.4 
Fair 1.28 0.082 15.5 <0.001 3.6 3.1 4.2 
Poor 1.20 0.116 10.4 <0.001 3.3 2.6 4.2 
        
Post-operative variables        
Success 
(Reference: Much better) 
       
A little better 2.79 0.048 58.6 <0.001 16.3 14.8 17.9 
About the same 4.10 0.078 52.3 <0.001 60.3 51.8 70.3 
A little worse 4.98 0.096 51.7 <0.001 145.5 120.5 175.6 
Much worse 6.74 0.133 50.7 <0.001 845.6 651.5 1097.4 
Post-operative EQ5D -2.39 0.075 -31.9 <0.001 0.1 0.1 0.1 
Table 5.6: Regression diagnostics for the ordinal regression analysis for the satisfaction 
response. Note: Caution is advised when interpreting odds ratios >10 such as those seen 
within the success group. 
 
The final models and model path coefficients for females were similar to those for the males 
and are therefore not shown. The Root Means Square Error of Association (RMSEA) for the 
TKR model was 0.064; the Comparative Fit Index (CFI) was 0.97 and the Bollen-Stine 
bootstrap probability (PBS) for this model was 0.0 indicating that the model was a very good 
fit for the data. Patient satisfaction was strongly dependent on ‘operative success’. Higher 
levels of satisfaction and ‘operative success’ were related to higher levels of post-operative 
function as represented by the EQ5D score. Pre-operative function had a positive impact on 
postoperative function and both pre-operative function and age had slight but significant 
impacts on satisfaction, with older patients being more satisfied. In the context of these 
relationships the level of pre-operative general health and a diagnosis of depression were 
not found to be important.  
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The direct and indirect contributions of pre-operative and post-operative covariates on 
patient satisfaction were estimated by the product coefficient method (table 5.7). Thus, the 
indirect effect of the post-operative EQ5D on satisfaction was the sum of the products of 
coefficients for its relationship with ‘success‘ and that for ‘success’ with satisfaction (i.e. 
0.55×0.57) (figure 5.3). Using these method pre-operative variables (age and pre-operative 
EQ5D) contributed little direct or indirect effect up on patient satisfaction. In contrast, the 
post-operatively measured ‘success’ and EQ5D score contributed much more to the 
perceived satisfaction, with a unit change in ‘success’ resulting in a >0.55 unit change in 
patient satisfaction for both males and females. These results further demonstrate the 
greater influence of post-operative variables upon satisfaction when compared to 
preoperative variables and highlight the significant role indirect effects have upon this 
outcome. 
 
 
 
Figure 5.3: Final SEM model for male total knee replacement patients after removal of all 
non-significant variables and pathways. Values in () represent the proportion of the 
observed variability which is explained by the suggested model. 
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 Male Female 
 Direct Indirect Direct Indirect 
Pre-operative variables     
- Pre-operative EQ5D 0.029 -0.115 0.033 -0.126 
- Age 0.018 -0.024 0.014 -0.061 
Post-operative variables     
- Post-operative EQ5D -0.214 -0.315 -0.259 -0.313 
- Success 0.573  0.552  
Table 5.7: Direct and indirect pathways to effect from the SEM analysis. The values 
represent the impact of units standard deviation change in the driving variables on the 
patient’s satisfaction with total knee replacement. 
 
Analysis 6: Discussion 
This analysis examined the relationships, interactions and predictive capacity of pre- and 
post-operative variables on post-operative patient satisfaction. While preoperative variables 
such as gender, a diagnosis of depression, pre-operative general health status and pre-
operative EQ5D scores were related to patient satisfaction they were not as strongly related 
as a number of post-operative factors such as the post-operative EQ5D score and the 
perception of operative success when both their direct and indirect effects upon satisfaction 
were modelled.  
 
By using the NJR- PROMS data, with a cohort of patients in excess of 22,000, we have been 
able to use analytical approaches that are not suitable for the analysis of smaller datasets. 
This analysis has quantified the relationships between satisfaction, operative success, 
functional capacity and patient characteristics. It found that only 22% of patients gave the 
top ‘excellent’ rating when asked to describe the results of their knee replacement. This 
occurred despite 71% of patients perceiving their knee to be ‘much better’ following 
surgery. This demonstrates the inherent differences between satisfaction and operative 
success. Success measures the patient’s perception of whether they have symptomatically 
improved following surgery whereas satisfaction measures the extent to which they are 
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happy with this improvement. Patient expectation is a key determinant of satisfaction 
(Bullens 2001, Bourne 2010). There were a significant number of patients (1,592) who were 
dissatisfied despite reporting symptomatic improvements, possibly because their 
expectations had not been fulfilled. This group was on average younger, had poorer mental 
and physical health and had poorer pre-operative function that the total population 
undergoing knee replacement, a finding that is consistent with previous studies analysing 
the direct effects of these factors upon satisfaction (Anderson 1996, Hawker 1998, Noble 
2006, Baker 2007, Bourne 2010, Scott 2010, Blackburn 2012). It is likely that within this 
analysis ‘operative success’ was a surrogate marker for the fulfillment of expectation. This 
may explain why this variable was such a strong predictor of satisfaction and confirms the 
important role patient expectation has upon outcome. 
 
The modeling techniques employed, allowed us to examine the combined direct and 
indirect effects of factors upon satisfaction. These approaches confirmed that primary 
determinant of a patient’s level of satisfaction was their post-operative perception of 
whether their operation was a success. While a number of other factors were also 
significant in the final models their effects upon satisfaction occurred through an indirect 
influence upon the ‘operative success’ variable. In effect this means that these ‘preliminary’ 
factors have a greater role in determining whether a patient perceives their surgery as 
successful, which then in turn determines their level of satisfaction, rather than any effect 
directly upon satisfaction itself. The findings of the ordinal regression and SEM differed in 
respect to the presence of age, depression and general health which were significant in one 
model but not the other. This probably reflects the interdependence between variables. 
While gender was significant in the ordinal regression, with females having lower levels of 
satisfaction than males in keeping with previous analyses (Ethgen 2004, Baker 2007), the 
SEM analysis which was performed separately for males and females demonstrated that the 
pathways and variables influencing satisfaction are similar irrespective of gender.  
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The pre-operative OKS has previously been shown not to predict post-operative satisfaction 
(Judge 2011). Similarly, the analyses based on pre-operative variables alone did not 
adequately explain the variability in the satisfaction outcome and as such would not be 
suited to making predictions. It was only when both pre- and post-operative variables were 
considered together that any prediction of satisfaction could be made. There is clearly merit 
in attempting to predict which patients are likely to exhibit high levels of satisfaction 
following surgery to help support patient selection and clinical decision making. However, 
the findings in this study suggest that this process is complex and simplistic interpretations 
of small datasets should be treated with caution. Any predictions of satisfaction based on 
pre-operative variables alone are likely to be heavily modified by the outcome of surgery. 
This must be appreciated before these predictive models are used in clinical practice.  
 
This analysis and the predictions obtained from the models employed highlights three 
important findings. Firstly, even in the ‘best’ patient with the most favourable patient 
characteristics and a large functional improvement a highly successful operation does not 
guarantee the highest levels of satisfaction. Secondly, in the ‘worst’ patient with the most 
unfavourable patient characteristics and poor functional improvement a failure to produce a 
successful operation will almost certainly result in a dissatisfied patient. Thirdly, there is a 
spectrum of satisfaction after knee replacement which varies significantly dependent upon 
both pre- and post-operative factors. 
 
Analysis 6: Summary 
Patient satisfaction is increasingly being used as a comparative measure when assessing the 
quality of care following joint replacement in European healthcare systems (Danish registry-
AR 2010). Surgeons must now not only produce technically proficient outcomes but these 
must also translate into high levels of patient satisfaction. The most important determinants 
of satisfaction are the patient’s perception of the success of their operation and post-
operative function. Pre-operative variables have a minimal influence upon post-operative 
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satisfaction bringing into question the appropriateness of restricting access to care based on 
arbitrary pre-operative thresholds. 
 
Analysis 6: Limitations and reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
In contrast to the rest of the analyses undertaken as part of this thesis, the majority of this 
analysis (ordinal regression; structured equational modelling) was undertaken by Prof 
Stephen Rushton.  By comparing this analysis to the others one notices appreciable 
differences in the analyses undertaken by myself, a clinician with an interest in statistics, 
and by Prof Rushton who is a biological modeler and statistician. This analysis is more 
statistically complex, using methods that are difficult for the average clinician to understand 
and interpret. How the findings might be applied to everyday clinical practice is not as clear 
as those presented elsewhere.  The reader has to trust the analysis and its interpretation 
rather than being able to follow it and ‘see it with their own eyes’. This highlights the need 
for clinical experts to be involved in the design and analysis of projects using registry data. 
These projects must be understandable and relevant to orthopaedic clinicians for there 
findings to be accepted and incorporated into everyday practice. Clinicians, and especially 
those with an understanding of registry research methodology, can help guide this process 
and must continue to be an integral part of the ongoing analysis of registry data.  
 
Due to the complexity of the structured equational modelling we were only able to consider 
a small number of variables within these preliminary models.  The addition of additional 
variables, such as those identified with the structured literature review, may have improved 
the model further. We had difficulty modelling with the OKS and EQ5D and it may be that 
the inclusion of other general health metrics which were more sensitive might have been 
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better suited to these types of analytical techniques. The inclusion of additional / alternative 
variables may have yielded different results. I do not, however, think it would have changed 
the major finding of this analysis, namely that post-operative factors such as the success of 
surgery and the final health outcomes were much more important than pre-operative 
‘demographic’ factors in determining the level of post-operative satisfaction.   
  
Unfortunately the ordinal scales used to assess satisfaction and success within the PROMs 
project have not been validated. They do, however, mirror similar scales used for assessing 
patient reported satisfaction in national cohorts (Robertsson 2000, Bourne 2006, Noble 
2010). While the content of these scales differs, their construct is similar with patients asked 
to rate their experience ranging from bad to good with responses presented as an ordered 
Likert scale. The benefit of these scales is that they give a simple representation of the 
patient’s perceptions of the results of surgery and offer an alternative to the large number 
of frequently used validated outcome scores that fail to appreciate an individual patient’s 
experiences and instead focus on hard symptomatic endpoints. There is undoubted value in 
measuring patient satisfaction, but work needs to be done to validate these measures and 
standardise reporting of this metric.  
  
What makes a patient satisfied with their surgery is still poorly understood. In similarity to 
previously published work this analysis has focused on investigating how defined 
measurable variables influence satisfaction. However, it may well be that there are a range 
of unmeasured or difficult to quantify variables (e.g. how expectation is handled, rapport 
between patient and surgical team, level of nursing care, processes of surgical care, hospital 
environment, post-operative after care and support etc.) that are equally, if not more, 
important. Future work needs to focus on defining what makes patients satisfied and what 
patients mean when they say they are satisfied. This will probably require a qualitative 
approach to research, in contrast to the quantitative approaches used previously. Only by 
understanding what satisfaction is can we design validated outcome tools to assess it and 
then make strides to improve levels of satisfaction.  The ultimate goal has to be able to 
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tailor our approach to surgery based on a variety of patient, hospital, surgical, 
environmental factors so that patients at high risk of dissatisfaction can be identified and 
offered additional input and support to subvert the risk of a poor outcome.  
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5.4 Analysis 7: Analysis of the relationship between Body Mass Index and PROMs 
 
Analysis 7: Aims 
1. To determine the nature of the relationship between pre-operative, post-operative 
and the improvements in PROMs and obesity.  
2. To establish if there evidence to support the idea of an obesity “cut off” as a basis for 
withholding surgery based on functional outcomes. 
 
Analysis 7: Methods 
This analysis was performed on the NJR-PROMs dataset described in section 3.4.4. From this 
dataset data was extracted on all patients for whom the primary indication for TKR was 
osteoarthritis. In total 22,691 NJR-PROMs records were available for analysis. From this 
cohort a further 9,018 records were excluded because BMI data was either missing or 
outside the range 15-60kg/m2. This range in line with the policy of BMI analysis used by the 
NJR as part of their annual reporting as it is felt BMIs outside this range may represent 
erroneously entered data. In total 13,673 cases fulfilled these criteria and were used as the 
basis for analysis. The demographic details of those patients who had their BMI recorded 
and those who did not are given in table 5.8. As previously discussed in analysis 5 (section 
5.2) the two groups were similar in respect to their patient characteristics but differed in 
respect to their surgical characteristics.  
 
 
  
 169 
 
 Study Cohort 
n=13,673 
Missing BMI data 
n=9018 
Mean BMI 31.0 kg/m2 (S.D 5.5) 
(95% CI 30.9 to 31.1) 
NA 
Patients with BMI >30 kg/m2 7771 (57%) NA 
Mean Age 69.7 years (S.D 8.8) 69.7 years (S.D 8.9) 
Gender 
- Male 
- Female 
 
6117 (45%) 
7556 (55%) 
 
3896 (43%) 
5229 (57%) 
ASA grade  
- 1 
- 2 
- 3/4 
 
1424 (10%) 
10,077 (74%) 
2172 (16%) 
 
883 (10%) 
6981 (76%) 
1261 (14%) 
Pre-operative general health 
- Excellent 
- Very Good  
- Good  
- Fair 
- Poor 
- Missing 
 
483 (4%) 
3433 (25%) 
6112 (45%) 
2899 (21%) 
385 (3%) 
361 (3%) 
 
322 (4%) 
2315 (25%) 
4070 (45%) 
1914 (21%) 
304 (3%) 
200 (2%) 
Number of Co-morbidities 
- 0 
- 1 
- 2 or more 
 
4933 (36%) 
5480 (40%) 
3260 (24%) 
 
3332 (36%) 
3541 (39%) 
2252 (25%) 
Mean Pre-operative OKS 18.9 
(95% CI 18.8 to 19.0) 
18.9 
(95% CI 18.7 to 19.1) 
Mean Pre-operative EQ5D index 0.389 
(95% CI 0.384 to 0.394) 
0.387 
(95% CI 0.381 to 0.393) 
Mean Pre-operative EQ5D VAS 69.0 
(95% CI 68.7 to 69.3 
68.9 
(95% CI 68.5 to 69.3) 
Table 5.8: Demographics for the Patient Reported Outcome Measures (PROMs) cohorts with 
and without Body Mass Index (BMI) data.  
 
 
For this analysis the primary outcome variables were 1) the pre- and post-operative OKS and 
EQ5D index 2) the change in the OKS and EQ5D index 3) the rates of post-operative 
complications. To help determine the relationship between BMI and these three outcomes 
it was analysed as both a continuous and categorical variable. Initial analysis involved the 
construction of scatterplots plotting BMI against the pre-operative, post-operative and 
change from baseline score or each of the PROMs outcomes. Scatterplots were stratified by 
age (≤ and >65 years) and gender and for each plot the associated linear regression 
equation was calculated.  
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Additional statistical analysis was undertaken by categorising the data into 3 groups (15-
24.9kg/m2, 25-39.9kg/m2, 40-60kg/m2) based on the World Health Organization (WHO) 
upper cut off for normal weight (BMI 25kg/m2) and the lower cut off for morbid obesity 
(BMI 40kg/m2) (WHO 2011). To limit the confounding effect of patient variables known to 
influence PROMs (age, gender, American Society of Anesthesiologists (ASA) grade, number 
of co-morbidities and general health rating) multiple linear regression was used to adjust for 
differences in these variables when comparing the three BMI groups. This “adjustment” 
effectively accounts for any differences in the distribution of these covariates and their 
respective influences upon the changes in the PROMs within each of the groups. Model 
diagnostics were satisfactory for the regression models used.  
 
Analysis 7: Results 
The mean BMI for the 13,673 patient identified was 31.0kg/m2 (S.D 5.5) and 7771 (57%) had 
a BMI of ≥30kg/m2 (table 5.8). Scatterplots of BMI plotted against the pre-operative, post-
operative and change in OKS and EQ5D index stratified by age and gender are given in 
figures 5.4, 5.5, 5.6 and 5.7. Initial analysis of the EQ5D health scale demonstrated patients 
reported only minimal improvements, which were not felt to be clinically significant, using 
this assessment modality (mean improvement 3.0 points (95% CI 2.7 to 3.3) on a scale 0-
100). The graphical output this variable is therefore not presented.  
 
For all PROMs a consistent trend for decreasing pre and post-operative scores as BMI 
increased was observed irrespective of age and gender. Overall the gradient of the linear 
regression line for the OKS (+0.028, p=0.08), EQ5D index (+0.001, p=0.005) and EQ5D VAS 
(+0.033, p=0.35) were positive indicating that whilst the pre and post-operative scores 
decreased with BMI the trend was for the change in score to improve, albeit minimally, as 
BMI increased. 
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Figure 5.4: Scatterplot by gender with corresponding linear regression lines for Body Mass 
Index (BMI) against the pre-operative, post-operative and change from baseline for the 
Oxford Knee Score (OKS) in patients aged ≤65 years. 
 
 
Figure 5.5: Scatterplot by gender with corresponding linear regression lines for Body Mass 
Index (BMI) against the pre-operative, post-operative and change from baseline for the 
Oxford Knee Score (OKS) in patients aged >65 years. 
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Figure 5.6: Scatterplot by gender with corresponding linear regression lines for Body Mass 
Index (BMI) against the pre-operative, post-operative and change from baseline for the 
Euroqol (EQ5D) index in patients aged ≤65 years. 
 
 
Figure 5.7: Scatterplot by gender with corresponding linear regression lines for Body Mass 
Index (BMI) against the pre-operative, post-operative and change from baseline for the 
Euroqol (EQ5D) index in patients aged >65 years. 
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The PROMs for the categorised BMI groups prior to adjustment are given in table 5.9. These 
mirrored the findings observed in figures 5.4, 5.5, 5.6 and 5.7 with the higher BMI group 
(40-60kg/m2) having lower pre and post-operative OKS and EQ5D index scores but a greater 
change in score compared to the other two groups. The changes for the EQ5D VAS were 
similar for all three groups. 
 
Unadjusted 
PROMs 
BMI 15-24.9kg/m2 
n = 1292 
BMI 25-39.9kg/m2 
n = 11,363 
BMI 40-60kg/m2 
n = 1018 
p value 
(ANOVA) 
OKS 
Pre op 
 
Post op 
 
Change 
 
20.9 
(95%CI 20.4 to 21.3) 
36.5 
(95%CI 36.0 to 37.1) 
15.7 
(95%CI 15.2 to 16.2) 
 
19.1 
(95%CI 19.0 to 19.3) 
34.2 
(95%CI 34.0 to 34.3) 
15.0 
(95%CI 14.8 to 15.2) 
 
15.1 
(95%CI 14.6 to 15.5) 
31.1 
(95%CI 30.4 to 31.7) 
16.0 
(95%CI 15.4 to 16.6) 
 
<0.001 
 
<0.001 
 
0.002 
EQ5D Index  
Pre op 
 
Post op 
 
Change 
 
0.457 
(95%CI 0.440 to 0.475) 
0.766 
(95%CI 0.752 to 0.779) 
0.309 
(95%CI 0.291 to 0.327) 
 
0.416 
(95%CI 0.410 to 0.422) 
0.718 
(95%CI 0.713 to 0.723) 
0.303 
(95%CI 0.296 to 0.309) 
 
0.294 
(95%CI 0.273 to 0.314) 
0.632 
(95%CI 0.613 to 0.650) 
0.337 
(95%CI 0.316 to 0.359) 
 
<0.001 
 
<0.001 
 
0.008 
 
EQ5D VAS 
Pre op 
 
Post op 
 
Change 
 
71.7 
(95%CI 70.6 to 72.7) 
74.7 
(95%CI 73.6 to 75.8) 
3.1 
(95%CI 1.9 to 4.2) 
 
69.3 
(95%CI 68.9 to 69.7) 
72.3 
(95%CI 72.0 to 72.7) 
3.0 
(95%CI 2.6 to 3.4) 
 
62.7 
(95%CI 0.61.4 to 64.0) 
65.7 
(95%CI 64.4 to 67.1) 
3.0 
(95%CI 1.5 to 4.6) 
 
<0.001 
 
<0.001 
 
0.99 
 
Table 5.9: Analysis of the unadjusted pre-operative, post-operative and change in PROMs 
for the three Body Mass Index (BMI) groups. 
 
The change in OKS, EQ5D index and EQ5D VAS for each group adjusted for age, gender, ASA 
grade, number of co-morbidities and general health rating are given in table 5.10. After 
adjustment the mean change in OKS was greatest for the BMI 40-60kg/m2 group (mean 
difference vs. BMI 15-24.9kg/m2 group 0.5 (95%CI -0.5 to 1.5), p=0.78, mean difference 
versus BMI 25-39.9kg/m2 group 0.9 (95%CI 0.1 to 1.6), p=0.03). The mean difference 
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between the BMI 15-24.9kg/m2 and BMI 25-39.9kg/m2 groups was 0.4 (95%CI -0.3 to 1.1), 
p=0.57. For the adjusted EQ5D index the mean change was also greatest for the BMI 40-
60kg/m2 group although the differences with the other groups were not significant (mean 
difference versus BMI 15-24.9kg/m2 group 0.014 (95%CI -0.021 to 0.048), p=1.00, mean 
difference versus BMI 25-39.9kg/m2 group 0.019 (95%CI -0.008 to 0.045), p=0.29). The mean 
difference between the BMI 15-24.9kg/m2 and BMI 25-39.9kg/m2 groups was 0.010 (95%CI -
0.048 to 0.021), p=1.00. The adjusted EQ5D VAS  the  mean change was greatest for the BMI 
15-24.9kg/m2 group although when compared to the other groups the differences were not 
significant (mean difference versus BMI 40-60kg/m2 group 1.9 (95%CI -0.4 to 4.1), p=0.13, 
mean difference versus BMI 25-39.9kg/m2 group 0.5 (95%CI -1.0 to 2.1), p=1.00). The mean 
difference between the BMI 15-24.9kg/m2 and BMI 40-60kg/m2 groups was 1.3 (95%CI -0.4 
to 3.1), p=0.20. For all PROMs the differences observed for the changes in scores between 
groups were small and below the levels felt to indicate clinical significance (OKS 3 points, 
EQ5D index 0.1 points, EQ5D VAS 5 points). 
 
 
 
Adjusted    
PROMs 
BMI 15-24.9kg/m2 
n = 1292 
BMI 25-39.9kg/m2 
n = 11,363 
BMI 40-60kg/m2 
n = 1018 
p value 
(ANOVA) 
OKS             
change 
15.4 
(95%CI 14.9 to 16.0) 
15.1 
(95%CI 14.9 to 15.2) 
15.9 
(95%CI 15.3 to 16.5) 
 
0.02 
EQ5D Index 
change 
0.309 
(95%CI 0.291 to 0.327) 
0.304 
(95%CI 0.297 to 0.310) 
0.323 
(95%CI 0.301 to 0.344) 
 
0.24 
EQ5D VAS   
change 
3.6 
(95%CI 2.5 to 4.8) 
3.1 
(95%CI 2.7 to 3.5) 
1.7 
(95%CI 0.2 to 3.3) 
 
0.11 
Table 5.10: Analysis of the change in Patient Reported Outcome Measures (PROMs) for the 
three Body Mass Index (BMI) groups after adjustment using multiple linear regression. 
 
Patient reported complications are given in table 5.11. Rates of wound complications 
increased as BMI increased (BMI 15-24.9kg/m2 121 of 1292 (9%); BMI 25-39.9kg/m2 1351 of 
11,363 (12%); BMI 40-60kg/m2 168 of 1018 (17%), p<0.001). The rates of other 
complications (bleeding problems, readmission, need for further surgery) were, however, 
similar for the three groups. 
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Patient reported complication BMI  
15-24.9kg/m2 
n = 1292 
BMI  
25-39.9kg/m2 
n = 11,363 
BMI  
40-60kg/m2 
n = 1018 
p value 
 
Wound Problems (%) 121 (9%) 1351 (12%) 168 (17%) <0.001 
Bleeding Problems (%) 68 (5%) 721 (6%) 66 (6%) 0.30 
Readmission (%) 127 (10%) 1083 (10%) 101 (10%) 0.88 
Further Surgery (%) 49 (4%) 394 (4%) 25 (2%) 0.18 
Table 5.11: Patient reported complications for the three Body Mass Index (BMI) groups. 
 
Analysis 7: Discussion. 
This analysis demonstrates that although patients with high BMIs had lower post-operative 
knee and general health scores, the improvements they experienced were comparable in 
magnitude to those of patients with a lesser BMI. Obese patients thus gained as much 
benefit from knee replacement as patients with a “normal” BMI, even if they do not end up 
at a similar post-operative level. Other than wound problems, the rates of complications 
were not significantly different for morbidly obese patients (BMI 40-60kg/m2) when 
compared to those with a “normal” (15-24.9kg/m2) BMI. 
 
A recent review concluded that there was currently insufficient evidence to form a definitive 
view on functional and quality-of-life outcomes following TKA when comparing obese and 
non-obese patients (Dowsey 2008). This analysis found that BMI is related to both the pre 
and post-operative OKS and EQ5D index in a linear fashion, with morbidly obese patients 
having significantly lower scores than patients with a normal BMI. The improvements in 
both of these PROMs for morbidly obese patients were, however, equivalent to patients 
with a “normal” BMI and did not “tail off” above a certain BMI threshold. This suggests 
there is as much benefit, in terms of improving knee function, general health and quality of 
life to be gained by operating on these patients. Considering solely the post-operative 
scores discriminates against patients with higher BMIs by suggesting they cannot gain the 
success achieved by non-obese patients and ignoring the fact that their functional gains are 
equivalent. This brings into question the validity of the arbitrarily determined BMI 
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thresholds implemeted by some healthcare commisioning organisations as a barrier to 
surgery. 
 
The observed trend of lower pre-operative knee scores as BMI increases also suggests their 
may be a selection bias against obese patients relating to the point at which surgery is 
offered surgery. This may reflect current referal guidelines determined by healthcare 
comissioners (NHS North Lincolnshire 2011, NHS Warwickshire 2011) stating patients over 
predefined BMI thresholds should lose weight before undergoing joint replacement, or a 
reluctance on the part of the operating surgeon to undertake such cases. These “delays” to 
surgery allow progression of the natural disease process and a worsening of symptoms. This 
observation may also be related to the influence obesity itself has on the functional 
elements of the PROMs scores, such as difficulty with mobilty or ascending and descending 
stairs due to patient habitus and associated comorbidites, rather than functional limitations 
attibutable to the knee.  
 
Other than wound problems the rates of complications between the three BMI groups did 
not significanly differ. These findings contrast with a number of previous studies showing 
higher rates of complications in the obese population (Winiarshi 1998, Foran 2004, Namba 
2005, Amin 2006, Dowsey 2010). This may reflect differences in patient and surgeon 
reporting of complications. Obese patients may be more likely to report wound problems if 
they are informed pre-operatively that they are at greater risk of these problems. This could 
be a potential source of bias when using the patient’s reported wound problems to compare 
obese and non-obese patients. This study did not assess the impact of BMI upon implant 
survival which is inferior in morbidly obese patients with 5 year survival rates of only 74% 
(Amin 2006). While it is important to consider complication rates and implant survivourship 
when making decisions regarding surgery one must remember that it is the PROMs 
outcomes that are linked to improvements in quality of life. Thus the value of TKR is 
primarily related to these scores. If patients are fully informed of the elevated risks for 
equivalent improvements in PROMs then these factors should not, in themselves, be a 
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reason to withhold surgery. There are many factors that become increasingly prevelant as  
BMI increases (comorbidities, technical feasibilty, anaesthetic issues), each of which may 
preclude surgery. BMI, however, should not in itself be a barrier to surgery. The decision to 
proceed should lie with the treating orthopaedic surgeon after careful consideration of all 
aspects of the case and the likely impact of surgery at an individual level.  
 
Analysis 7: Summary 
Although increasing BMI is associated with poorer pre and post-operative PROMs, the 
improvement experienced by patients was similar irrespective of BMI. It is crucial that those 
in control of health resources do not penalise obese patients based on the limited functional 
outcome data available from previous studies and a selective view of post-operative scores 
alone, in which they are disadvantaged by lower pre-operative scores. Instead the overall 
improvements in function and general health should be the barometer of success.  
  
Analysis 7: Limitations and reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
Body Mass Index is poorly recorded within the NJR database. In the early years of the 
registry (2004/2005) less than 25% of all records contained information relating to BMI. This 
has steadily increased to reach a figure of 55% in 2012 (NJR-AR 2012), but it is still only a 
fraction of all NJR records.  This meant that BMI data was only available for 13,673 of the 
22,691 (60%) NJR-PROMs records analysed.  While the demographic details of those 
patients with and without BMI data were similar there were marked differences in the 
surgical data recorded for these two groups (see analysis 5). This suggests there may be bias 
in the way BMI is recorded. How this might have influenced this analysis is unclear.  
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We chose to remove records with missing BMI data (case deletion). Consideration was given 
to imputation of BMI data for the missing records to increase the number of records 
available for analysis.   But due to the large amount of missing data and our inexperience 
with these techniques we did not pursue this. For future registry analyses, and if this work 
was to be repeated, I would strongly consider using imputation to help increase the yield of 
the dataset, especially for variables such as BMI for which a large volume of data was 
missing. Using imputation may also help to limit any confounding effects that might be 
associated with the exclusion of data.   
 
The adjustment models for this analysis included only age, gender, American Society of 
Anesthesiologists (ASA) grade, number of co-morbidities and general health rating. In 
previous analyses (analysis 1 and 5) the pre-operative PROMs scores were found to be 
strong predictors of the improvements observed with surgery, however we chose not to 
include them in the adjustment of this BMI data. This was because we felt its inclusion 
would not reflect the situation seen in clinical practice in which obese patients present with 
poorer pre-operative function than their non-obese counterparts. By including the pre-
operative PROMs we would have been analysing the influence BMI had on the 
improvements in PROMs assuming that these patients start off from a similar starting point 
i.e. answering the question ‘how much would an obese patient improve if they started at 
the same level as a non-obese patient?’. We felt that the unadjusted analysis presented in 
table 5.9 better reflected the clinical problem faced by clinicians and was most helpful when 
counselling patients about the expected improvement following knee replacement. The 
reality is that, for whatever reason, obese patients have poorer scores pre-operatively. 
Because of this they have more scope for improvement and this is probably one of the 
reasons why they achieve equivalent levels of functional improvement to non-obese 
patients. Based on the information in table 5.9 clinicians can confidently tell obese patients 
that they will improve following surgery and that this improvement will be similar to that 
seen in patients who aren’t obese but that they are unlikely to achieve the same functional 
endpoint due to that fact that they start off from a worse position.  
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Chapter 6: Clinical outcomes after revision knee replacement 
6.1. Revision knee replacement  
Currently over 650,000 total knee replacements are performed annually in the United States 
(Carr 2012) and over 80,000 in England and Wales (NJR-AR 2012). This number is expected 
to increase further over the next 20 years, as the population of the world ages and medical 
interventions continue to increase average life expectancy (Kurtz 2007). The exponential 
increase in the use of this health technology brings with it the growing spectre of the failed 
knee replacement. Revision knee arthroplasty is a complex and demanding procedure 
requiring meticulous planning, a skilled surgical team and familiarity with an adequate 
inventory of a variety of surgical implants. Primary TKR is a successful operation that 
consistently relieves pain, improves knee function and produces levels of patient 
satisfaction in excess of 80% (Hawker 1998, Robertsson 2000, Baker 2007). Revision surgery 
is less predictable, with lower rates of survival, increased rates of complications, varied 
patient satisfaction, and an inconsistent ability to restore or improve quality of life (Saleh 
2002, Deehan 2006, Ghomwari 2009, Hossein 2010). 
 
Revision knee replacement encompasses a heterogeneous mix of pathology and indication 
and is, more often than not, handled by the occasional surgeon. This makes it difficult for 
the surgeon, the surgical team and the rehabilitation services involved to acquire the 
necessary knowledge and skills required to treat these complex cases. It also magnifies the 
logistical difficulties for potential researchers wanting to design meaningful research studies 
assessing and comparing the effectiveness of these procedures. Whilst most arthroplasty 
registers are designed to detect revision as their ultimate end-point the information in 
respect to revision available from these registers is extremely limited. Mode of failure data 
is inconsistently collected and the majority of registries offer no insight into functional 
performance, especially after revision surgery. In addition there are currently no prospective 
clinical trials being undertaken evaluating different approaches to revision knee surgery in 
England and Wales (NIHR 2012). 
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The orthopaedic community must therefore base surgical decisions about revision knee 
surgery on a restricted pool of observational, often retrospective, case series data. These 
papers often lack the power and design to ask questions pertinent to clinical practice. As 
such we currently have limited information about who needs an operation?, which 
operation should be done, by whom and how? What implant should we use, how should it 
be fixed and what level of constraint is required? How are functional outcomes influenced 
by the indication for revision, the type of surgery performed, and the number of previous 
revisions (law of diminishing returns)?. 
 
A number of previous studies have attempted to quantify the functional improvements seen 
with revision knee procedures by comparing them to the improvements seen after primary 
surgery. These comparisons have demonstrated lower rates of satisfaction following 
revision surgery (Revision 73% vs. Primary 86%) (Griedanus 2011). Post-operative general 
health measures (Short Form 12 (SF-12)) and knee scores (Hospital for Special Surgery (HSS), 
Oxford Knee Score (OKS) and Western Ontario and McMaster Universities Arthritis Index 
(WOMAC) are also lower after revision (Hanssen 1998, Hartley 2002, Saleh 2002, Griedanus 
2011). These effects are however, confounded by the substantially lower pre-operative 
scores observed with revision (Griedanus 2011). If instead we consider the improvements in 
these scores from their pre-operative baseline then differences between primary and 
revision surgery are less consistent (Hartley 2002, Griedanus 2011). Reported improvements 
for the WOMAC are greater for primary TKR (Hartley 2002, Griedanus 2011) but equivalent 
results are seen for the OKS (Griedanus 2011) and SF-12 (Hartley 2002, Griedanus 2011). 
This is important as the value of an intervention is related to its ability to improve function 
and quality of life rather than its final end point.  
 
One problem with these previous analyses is their inability to sub-stratify based upon the 
reason for revision. This is important as knee replacements are revised for a variety of 
reasons each of which might potentially influence outcome. The results of a revision for one 
reason may not be comparable with the results of a revision performed for an alternative 
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reason. Stratification by reason for revision may therefore help to identify groups that 
respond poorly to surgery and help identify the best surgical processes for treating specific 
patient groups.  
 
The simplest way of stratifying knee revisions is in to two groups, septic (infected) and 
aseptic (non-infected) revisions. For the septic cohort two stage revision is the established 
gold standard (Antti-Poika 1990, Lentino 2003, Leone 2010). Single stage revision remains 
the domain of the surgical enthusiast and is advocated on the basis several small case series 
(Göksan  1992, Scott 1993, Buechel 2004, Bauer 2006, Whiteside 2011). In selected cases 
single stage revision may be potentially advantageous, avoiding some of the problems of 
two stage revision such as stiffness and arthofibrosis resulting from a period with a spacer in 
situ, and sparing the patient a second procedure (Parkinson 2011). However, despite these 
perceived advantages there are currently no prospective comparative studies examining the 
influence of these differing approaches to surgery upon functional outcome. The aseptic 
cohort encompasses a myriad of reasons for revision, many of which can co-exist. It can 
often be difficult for the treating surgeon to ascribe a single reason for failure making it 
difficult to perform robust analyses on this group of patients. In those cases for which a 
specific mode of failure can be determined it would be useful to understand how patient 
characteristics and surgical factors influence the functional recovery following revision, and 
whether they are similar to those that influence recovery after primary knee replacement. 
In this way patient’s who derive the most / least benefit from surgery could be identified, 
allowing surgery to be targeted accordingly.  
 
The identification of patients who benefit the most following revision surgery is likely to 
become increasingly important. Revision surgery is expensive, and as the number of revision 
procedures increase so too will the economic necessity to identify the patients who will 
benefit the most from the existing surgical technology. It is therefore important to 
understand how patient and surgical factors influence the outcomes of revision surgery and 
to understand whether certain surgical indications and specific patient characteristics 
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preclude expensive revision surgery. Further research is needed to determine how the 
outcome of revision surgery can be maximsed, especially for the groups of patients who fail 
to improve following surgery. Could the surgical volume of the treating centre; type of 
infecting organism; level of implant constraint be important?.  
 
Increasing surgeon and centre operative volumes have been shown to improve outcome 
following both primary and revision knee surgery (Marlow 2010). This is consistent with the 
findings presented in analysis 4 (section 4.5) for unicondylar knee replacement. Increasing 
operative volume intuitively leads to greater familiarity and experience. This is particularly 
important for those surgeons and centres undertaking complex procedures, such as revision 
knee replacement, that are often performed infrequently (Lavernia 1995, Shervin 2007, 
Bozic 2010). The association between volume and outcome has recently led the paediatric 
cardiac surgery services within England and Wales to restructure their services. By 
centralising surgical expertise in fewer larger centres they aim to produce better patient 
outcomes, and ensure vital services are safe and sustainable for the future (NHS 2011). 
Benefits of this type of service model include delivery of a trained workforce of experts 
producing better training for surgeons in surgical centres at the forefront of modern 
working practices and technologies (NHS 2011). These specialist centres could ultimately 
form a network facilitating collaboration in research, clinical development and the sharing 
of knowledge (NHS 2011). This would help with future attempts to perform prospective 
research. Restructuring the revision service in a similar way into fewer higher volume 
centres could therefore be theoretically beneficial, particularly if an audit of current practice 
showed there were a large number of centres performing relatively few revision 
procedures.  
 
To try and address some of the issues discussed above we used the NJR and PROMs data 
available in an attempt to answer the following questions: 
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1. How do the pre-operative, post-operative and change in knee specific and general 
health scores differ between primary and revision TKR?  
2. How do the rates of patient satisfaction following primary and revision TKR differ?  
3. How does the reason for revision influence the patient reported outcome following 
revision TKR? 
4. Which patient / surgical factors influence improvements in PROMs following revision 
TKR? 
5. How does the approach to surgery (one versus two stage) influence the functional 
outcomes and rates of complications following revision of the infected knee 
replacement? 
6. How many centres in England and Wales are performing revision knee procedures 
and what volumes of these procedures are they undertaking? 
 
These questions are addressed in the subsequent 3 analyses.  
1. Analysis of the influence of reason for revision upon early PROMs following aseptic 
revision knee replacement 
2. Analysis of functional outcomes after one and two stage revision for the infected 
knee replacement.  
3. Analysis of centre operative volumes for revision knee replacements performed in 
England and Wales   
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6.2 Analysis 8: Analysis of the influence of reason for revision upon early PROMs following 
aseptic revision knee replacement 
 
Analysis 8: Aims 
To determine: 
1. How the pre-operative, post-operative and change in knee specific and general 
health scores differ between primary and revision TKR?  
2. How the rates of patient satisfaction following primary and revision TKR differ?  
3. How the reason for revision influences the patient reported outcome following 
revision TKR? 
4. Which patient / surgical factors influence improvements in PROMs following aseptic 
revision TKR? 
 
Analysis 8: Methods 
This analysis was performed on the NJR-PROMs dataset described in section 3.4.4. From this 
dataset data was extracted for all revision knee replacements (n=996) (figure 3.5).  As this 
analysis focused on aseptic revision surgery all cases for which the stated reason for revision 
included ‘infection’ (n=195) were excluded.  The nature of the PROMs data collection means 
that preoperative data for two-stage revisions corresponds to their function prior to the 
second stage procedure, not prior to their revision. For this reason we also excluded all 
aseptic revisions performed using a two-stage technique (n=4). The revision cohort 
therefore included only single-stage revisions performed for an indication other than 
infection (n=797). To assess the effectiveness of revision knee replacement the PROMs for 
these 797 revisions were compared to the PROMs for all 23,393 of the primary TKRs 
recorded on the NJR-PROMS database.  
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Patient demographics for the primary and revision TKR groups are given in table 6.1. When 
compared to primary TKR patients the revision patients were younger (67.8 versus 69.6 
years), had a higher proportion of patients graded as ASA Grade 3 or 4 (21% versus 15%) and 
had a greater proportion of patients whose surgery was performed within the National 
Health Service (98% versus 90%) by a consultant grade surgeon (92% versus 74%).   
 
 TKR 
n=23,393 
Revision TKR 
n=797 
p value 
Mean Age 69.6 
(S.D 9.0) 
67.8 
(S.D 10.0) 
<0.001 
Gender (%) 
- Female 
- Male 
 
13,223 (57%) 
10,170 (44%) 
 
420 (53%) 
377 (47%) 
 
=0.03 
ASA (%) 
- 1 
- 2 
- 3 
- 4 
 
2362 (10%) 
17,445 (75%) 
3512 (15%) 
74 (0%) 
 
65 (8%) 
562 (71%) 
170 (21%) 
0 (0%) 
 
<0.001 
Number of operations performed in the NHS (%) 20,932 (90%) 780 (98%) <0.001 
Number of operations performed by a consultant 
surgeon (%) 
17,371 (74%) 730 (92%) <0.001 
Number of patients with 3 or more comorbidities (%) 1979 (9%) 71 (9%) 0.66 
Mean Follow up 209 days 209 days   
 
Table 6.1: Demographics for the TKR and Revision TKR groups.  
 
PROMs examined for this analysis included the OKS, EQ5D index, and patient satisfaction. 
Patients recording either an “excellent”, “very good” or “good” response to the satisfaction 
questionnaire were classified as satisfied and those responding “fair” or “poor” as 
unsatisfied.  For the revision TKR group we were interested in the effects of the reason for 
revision upon patient outcomes. Information for this variable is available within the NJR 
database. To overcome the problem of multiple reasons for revision on the NJR data 
collection form we employed a hierarchical strategy for determining the primary reason for 
revision. This is described in section 3.5.2. Statistical analysis was performed as described in 
section 3.6. 
 186 
 
We were also interested in determining which patient and surgical factors influenced the 
improvements in PROMs observed after revision surgery. Preliminary analysis established 
that there was significant variation in the PROMs improvements dependent upon the 
reason for revision which might mask the influence of other factors. We therefore chose to 
focus on those revisions performed for aseptic loosening / lysis as this represented the 
largest sub-group (n=367) with the largest PROMs improvements. The demographic and 
surgical variables available for our regression models were similar to those used in analysis 5 
(table 3.8, section 3.4.4).  
 
The improvement in the OKS and EQ5D were used as the primary response outcomes and 
the standard modeling process described in section 3.6.3 was used for this analysis. Initial 
analysis to establish the relationship between the individual explanatory variables and 
magnitude of the OKS/EQ5D improvements was undertaken using one-way analysis of 
variance (ANOVA) and univariable regression. Multiple linear regression was then employed 
as described in analysis 5. Due to the smaller numbers available for this analysis a p value of 
p<0.05 was used to indicate statistical significance within each of the models.  For the final 
models the model estimates with 95% confidence limits are provided to allow comparison 
of the adjusted effect size between variables. Estimates effectively represent the predicted 
changes in the OKS and EQ5D for that variable once the effect of all other variables included 
in the model are considered. For continuous variables (age, OKS and EQ5D scores) these 
estimates relate to the expected changes in the response outcome (OKS/EQ5D) for a unit 
change in the explanatory variable. For categorical variables the estimates are given relative 
to the base reference category.  Model residuals, 2-way interactions and other checks of 
model adequacy were satisfactory.  
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Analysis 8: Results 
The mean pre-operative, post-operative and overall changes in scores were greater for the 
primary group when compared to the revision group for both the OKS and EQ5D. The mean 
improvement in the OKS was 15.1 after primary surgery compared to 10.4 after revision 
(p<0.001). The relative improvement in OKS for revision TKR was therefore 69% (95%CI 64% 
to 74%) of the improvement observed for primary TKR. The corresponding values for the 
mean post-operative OKS were 34.0 and 26.6 respectively (p<0.001). Overall only 7% of 
patients failed to demonstrate an improvement using the OKS following primary surgery 
compared to 17% following revision surgery (p<0.001) (table 6.2).  
 
The mean improvement in the EQ5D was 0.303 after primary surgery compared to 0.231 
after revision (p<0.001). The relative improvement in EQ5D for revision TKR was therefore 
76% (95% CI, 71% to 81%) of the improvement observed for primary TKR.  The 
corresponding values for the mean post-operative OKS were 0.710 and 0.541 respectively 
(p<0.001). Overall 21% of patients failed to demonstrate an improvement using the EQ5D 
following primary surgery compared to 34% following revision surgery (p<0.001) (table 6.2). 
Both groups demonstrated improvements in each of the 5 EQ5D domains postoperatively; 
however, the improvements were more noticeable in the primary TKA group, with a greater 
proportion of patients ending up in Level 1 following surgery (table 6.3). 
 
A greater proportion of patients described their surgery as “excellent” following primary 
TKR (5,124 of 22,960 respondents (22%)) when compared to revision TKR (102 of 786 
respondents (13%)). The proportion of patients with “poor” results was greater for the 
revision group (Revision, 82 of 786 respondents (10%) versus Primary, 856 of 22,960 
respondents (4%)) (figure 6.1). Overall 83% of primary TKA were satisfied compared to 66% 
for revisions. 
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 TKR Revision TKR p value 
OKS  
Mean Pre op 
 
Mean Change 
 
Mean Post op 
 
% No improvement 
 
18.9 
(95% CI 18.8 to 19.0) 
15.1 
(95% CI 15.0 to 15.3) 
34.0 
(95% CI 33.9 to 34.2) 
7% 
 
16.2 
(95% CI 15.6 to 16.8) 
10.4 
(95% CI 9.7 to 11.1) 
26.6 
(95% CI 25.8 to 27.4) 
17% 
 
<0.001 
 
<0.001 
 
<0.001 
 
<0.001 
EQ5D Index  
Mean Pre op 
 
Mean Change 
 
Mean Post op 
 
% No improvement 
 
0.407 
(95% CI 0.4.03 to 0.411) 
0.303 
(95% CI 0.298 to 0.307) 
0.710 
(95% CI 0.707 to 0.714) 
21% 
 
0.310 
(95%CI 0.286 to 0.334) 
0.231 
(95% CI 0.205 to 0.258) 
0.541 
(95% CI 0.518 to 0.565) 
34% 
 
<0.001 
 
<0.001 
 
<0.001 
 
<0.001 
Table 6.2: Comparison of the pre-, post-operative and change in score alongside the 
proportion of patients with no reported improvement for the OKS and EQ5D index for the 
TKR and Revision TKR groups. 
 
EQ5D dimension  TKR Revision TKR 
 
 
  
Pre op 
 
 
Post op 
 
 
Net 
change 
 
Pre op 
 
 
Post op 
 
 
Net 
Change 
Mobility Level 1 
Level 2 
Level 3 
6.0 
93.8 
0.2 
47.6 
52.2 
0.1 
+41.6 
-41.6 
-0.1 
3.9 
95.3 
0.8 
22.9 
76.9 
0.1 
+19.0 
-18.4 
-0.7 
Self-Care Level 1 
Level 2 
Level 3 
69.4 
30.0 
0.6 
78.7 
20.8 
0.6 
+9.3 
-9.2 
0.0 
57.5 
41.2 
1.3 
62.1 
37.1 
0.8 
+4.6 
-4.1 
-0.5 
Usual Activities Level 1 
Level 2 
Level 3 
8.7 
78.0 
13.3 
42.5 
52.7 
4.8 
+33.8 
-25.3 
-8.5 
5.8 
73.3 
20.9 
20.5 
66.8 
12.7 
+14.7 
-6.5 
-8.2 
Pain / Discomfort Level 1 
Level 2 
Level 3 
0.9 
59.7 
39.4 
32.6 
61.5 
5.9 
+31.7 
+1.8 
-33.5 
1.4 
48.2 
50.3 
15.4 
68.1 
16.5 
+14.0 
+19.9 
-33.8 
Anxiety / 
Depression 
Level 1 
Level 2 
Level 3 
63.0 
33.5 
3.5 
76.7 
21.1 
2.2 
+13.7 
-12.4 
-1.3 
52.5 
40.4 
7.1 
60.5 
33.4 
6.2 
+8.0 
-7.0 
-0.9 
Table 6.3: Euroqol domains and percentage change pre- to post-operatively for the TKR and 
Revision TKR groups. 
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Figure 6.1: Satisfaction rating for the TKR and Revision TKR groups. 
 
Reason for revision was seen to influence the OKS, EQ5D and satisfaction rate. The best 
post-operative scores were seen in patients revised for either aseptic loosening or lysis (OKS 
27.8, EQ5D 0.560). Even in this group, however, the improvements in the OKS/EQ5D, the 
post-operative OKS/EQ5D and the rate of satisfaction were still lower than the equivalent 
scores following primary TKR (p<0.001) (table 6.4). The worst OKS and EQ5D scores were 
seen in revisions performed for stiffness. In this group the improvement in OKS (5.6) and the 
post-operative OKS (21.1) were significantly worse than the corresponding values for 
revisions undertaken for aseptic loosening (OKS improvement = 11.3, post-operative OKS = 
27.8) (p<0.001). Satisfaction rates were also considerably lower between these two groups 
(Aseptic loosening / Lysis = 72% versus Stiffness = 47%, p<0.001).  
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 Malalignment Aseptic Loosening / 
Lysis 
Component Wear Dislocation / 
Instability 
Stiffness Unexplained 
Pain 
Other / No reason 
stated 
N 94 367 34 81 33 84 104 
Mean Age (Years) 68.6 69.3 67.8 66.0 63.9 65.5 65.9 
Gender (M:F) 44:50 190:177 13:21 29:52 19:14 43:41 39:65 
 
OKS 
Mean Pre-op  
 
Mean Change 
 
Mean Post op 
 
% No improvement 
 
 
 
15.4 
(95%CI 13.7 to 17.0) 
11.3  
(95%CI 9.4 to 13.1) 
26.7 
(95%CI 24.3 to 29.0) 
11% 
 
 
16.5 
(95% CI 15.7 to 17.3) 
11.3 
(95%CI 10.2 to 12.4) 
27.8 
(95%CI 26.6 to 28.9) 
16% 
 
 
14.6 
(95%CI 12.4 to 16.9) 
11.6 
(95%CI 8.1 to 15.2) 
26.3 
(95%CI 22.5 to 30.0) 
21% 
 
 
17.0 
(95%CI 14.9 to 19.0) 
7.2  
(95%CI 4.9 to 9.5) 
24.2 
(95%CI 22.0 to 26.5 ) 
24% 
 
 
15.5 
(95%CI 12.9 to 18.2) 
5.6 
(95%CI 2.0 to 9.1) 
21.1  
(95%CI 16.8 to 25.4) 
28% 
 
 
16.8 
(95%CI 15.0 to 18.5) 
9.6  
(95%CI 7.4 to 11.7) 
26.4 
(95%CI 23.5 to 29.3) 
15% 
 
 
15.6 
(95%CI 14.1 to 17.0) 
10.5 
(95%CI 8.5 to 12.6) 
26.1 
(95%CI 23.9 to 28.3) 
19% 
 
EQ5D index 
Mean Pre-op  
 
Mean Change 
 
Mean Post op 
 
% No improvement 
 
 
0.255 
(95%CI 0.187 to 0.323) 
0.293 
(95%CI 0.221 to 0.365) 
0.548 
(95%CI 0.479 to 0.617) 
33% 
 
 
0.328 
(95% CI 0.292 to 0.363) 
0.232 
(95%CI 0.192 to 0.271) 
0.560 
(95%CI 0.526 to 0.593) 
33% 
 
 
0.329 
(95%CI 0.216 to 0.442) 
0.203 
(95%CI 0.069 to 0.337) 
0.533 
(95%CI 0.439 to 0.627) 
33% 
 
 
0.329 
(95%CI 0.256 to 0.403) 
0.208 
(95%CI 0.129 to 0.287) 
0.537 
(95%CI 0.467 to 0.608) 
40% 
 
 
0.303 
(95%CI 0.173 to 0.432) 
0.176 
(95%CI 0.015 to 0.338) 
0.479 
(95%CI 0.334 to 0.624) 
44% 
 
 
0.310 
(95%CI 0.232 to 0.387) 
0.172 
(95%CI 0.091 to 0.252) 
0.481 
(95%CI 0.395 to 0.568) 
35% 
 
 
0.277 
(95%CI 0.213 to 0.341) 
0.263 
(95%CI 0.191 to 0.334) 
0.540 
(95%CI 0.478 to 0.601) 
34% 
 
 
Satisfied (%) 
 
 
64% 
 
72% 
 
73% 
 
60% 
 
47% 
 
58% 
 
59% 
 
Table 6.4: PROMs for the revision TKR group dependent upon reason for revision.
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The only variables observed to influence improvement in the OKS and EQ5D within the 
initial univariate analysis of the aseptic loosening / lysis group (n=367) were age (OKS only), 
the pre-operative OKS (both OKS and EQ5D), the pre-operative EQ5D (both OKS and EQ5D), 
pre-operative general health (OKS only), and anxiety level (EQ5D only) (table 6.5). In 
similarity to the findings of analyses 1 (section 4.2) and 5 (section 5.2) greater PROMs 
improvements were observed with increasing age, a deceasing pre-operative OKS / EQ5D 
score, better pre-operative general health and a lower level of pre-operative anxiety.  
 
Predictor variable Dependent variable 
 OKS improvement EQ5D improvement 
Patient factors 
Age (years) 0.008 0.81 
Pre-operative OKS <0.001 <0.001 
Pre-operative EQ5D index 0.01 <0.001 
Number of comorbidities 0.64 0.20 
Gender 0.43 0.58 
Pre-operative disability  0.45 0.23 
Pre-operative general health 0.05 0.57 
Depression 0.06 0.62 
Anxiety level 0.37 0.01 
ASA grade 0.13 0.18 
Surgical factors 
Lead surgeon grade 0.25 0.30 
Hospital type 0.78 0.84 
Table 6.5: Summary of the p values for univariable analysis with improvement in OKS and 
EQ5D index as the response variables. 
 
Once the influence of other variables was considered the only factors seen to influence 
outcome within the multiple linear regression models were age, pre-operative OKS and pre-
operative general health for the OKS (all p<0.05) and pre-operative EQ5D, pre-operative OKS 
and anxiety level for the EQ5D (all p<0.001) (table 6.6).  The variables present within the 
final models and the sizes and direction of their co-efficients were similar to those observed 
for the primary TKR analysis performed in analysis 5 (section 5.2). 
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 OKS improvement EQ5D improvement 
Predictor Variable Estimate 95% CI p value Estimate 95% CI p value 
Patient variables       
Age 0.14 0.03 to 0.24 =0.001 - - - 
Pre-operative OKS -0.42 -0.55 to -0.29 <0.001 0.007 0.001 to 0.013 <0.001 
Pre-operative EQ5D index - - - -0.922 -1.003 to -0.840 <0.001 
Pre-operative general health 
Excellent 
Very Good 
Good 
Fair 
Poor 
 
Reference 
1.42 
2.01 
-0.66 
-6.34 
 
 
-0.91 to 3.75 
0.07 to 3.95 
-2.84 to 1.51 
-10.26 to -2.42 
 
 
0.22 
0.04 
0.55 
0.002 
 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
Anxiety level 
No anxiety/depression 
Moderate anxiety/depression 
Severe anxiety/depression 
 
- 
- 
- 
 
- 
- 
- 
 
- 
- 
- 
 
Reference 
0.052 
-0.183 
 
 
-0.004 to 0.110 
-0.278 to -0.088 
 
 
0.07 
<0.001 
Table 6.6 Summary of the variables significant in the final multiple linear regression models. 
Estimators with 95% CI are presented to allow comparison of the effect size of each 
variable. For categorical variables the estimators are given as differences relative to the first 
category. For continuous variables the estimate describes the effect on the change in score 
if the predictor variable was increased by one point.  
 
Analysis 8: Discussion 
This analysis found that post-operative patient reported knee specific and general health 
scores and their associated improvements from baseline were greater following primary 
TKR when compared to aseptic revision TKR. Revision TKR has been shown to produce 
improvements in knee function using a variety of assessment modalities including the OKS, 
KSS and WOMAC (Hanssen 1998, Hartley 2002, Deehan 2006, Ghomwari 2009, Hossein 
2010, Greidanus 2011). The findings from this study are comparable with results from the 
New Zealand registry where reported 6 month post-operative OKS scores were 37.2 and 
29.4 following primary and revision TKR respectively (NJR-AR 2010). Post-operative knee 
scores assessed using the Hospital for Special Surgery Score (Good to Excellent results: 
Primary 92% versus Revision 81%) (Hanssen 1998), WOMAC (Primary 80.2 versus Revision 
69.1) (Greidanus 2011) and OKS (Converted to 0-100 range: Primary 78.3 versus Revision 
68.4) (Greidanus 2011) are consistently better for primary when compared to revision TKR. 
Similarly post-operative SF-12 scores have been shown to be better following primary TKR 
(Primary 83.5 versus Revision 71.6) (Hartley 2002, Greidanus 2011).  
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The evidence relating to differences between primary and revision with respect to the 
changes from baseline for these assessment tools is however lacking. Direct comparisons of 
primary and revision TKR demonstrated the improvements for the SF-12 (Hartley 2002, 
Greidanus 2011) and OKS (Greidanus 2011) were equivalent and the scores for the overall 
WOMAC, as well as its pain and function components were only marginally better following 
primary TKR (Hartley 2002, Greidanus 2011). This analysis is therefore the first to 
demonstrate that the improvements from baseline are smaller for patients undergoing 
revision procedures irrespective of assessment modality. 
 
Rates of satisfaction following primary TKR range from 81 to 86% (Robertsson 2000, Baker 
2007, Bourne 2010). Reports of satisfaction following revision vary between 73% and 88% 
(Hossein 2010, Greidanus 2011). The satisfaction rate for primary TKA (83%) observed in this 
analysis is therefore comparable.  However, the rate following aseptic revision surgery 
(66%) is lower than previous reports. This may be a reflection of the shorter duration of 
follow up and the differing methods of collection for this data.  Patients rated the outcome 
of their surgery as “Poor” in 4% of primaries and 10% of revisions. This indicates that while 
the overall rates of satisfaction differed, the proportion of patients reporting the poorest 
results was small for both groups.  
 
Revisions performed for aseptic loosening and lysis were associated with the greatest post-
operative OKS/EQ5D scores and the highest rates of satisfaction.  Revisions for 
malalignment and component wear produced comparable outcomes when compared to 
aseptic loosening / lysis. The improvements in scores for revisions undertaken for 
dislocation/instability, unexplained pain and stiffness were typically smaller with the worst 
OKS/EQ5D scores and satisfaction rates seen in the stiffness group. The reason why 
revisions for stiffness perform poorly may be related to poorer post-operative range of 
motion and function. Unfortunately due to the type of data collected we could not explore 
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this hypothesis in further detail. There are currently no direct comparative studies assessing 
the effects of reason for revision upon functional outcome and satisfaction, with studies 
combining results from aseptic revisions without sub stratifying those performed for aseptic 
loosening against other reasons.  In one of the few studies to examine revisions performed 
for aseptic loosening Bertin et al (Bertin 1985) found 91% of 53 revisions reported relief of 
pain and 80% could walk for over 30 minutes.  Reports of revisions performed for stiffness 
demonstrated low post-operative KSS scores and only modest improvements in scores at a 
mean of 43 months post-operation (KSS pain post-op = 46.9, improvement = 31.9, KSS 
function post-op = 58.4, improvement = 18.4) (Kim 2004). These findings indicate that 
surgeons should expect different improvements and final functional scores dependent upon 
the reason for revision and that even in the “best” aseptic loosening / lysis group the 
expected results are lower than those observed after primary TKR.  
 
For the aseptic loosening / lysis group the factors influencing improvements in PROMs were 
similar to those previously observed for primary TKR, namely the relevant pre-operative 
PROMs in conjunction with pre-operative general health and / or a measure of mental 
health (in this case the anxiety level). Interestingly a number of the factors associated with 
PROMs improvements in the primary setting were not associated with improvements in the 
cohort of aseptic loosening / lysis patients. This may be due to the fact that the aseptic 
loosening / lysis group was a lot smaller (367 versus 23,393 patients) meaning the analysis of 
this group was underpowered to detect ‘weak’ associations with marginal size effects.  
 
Analysis 8: Summary 
The observed improvements in knee function and general health following revision TKR are 
only 69% to 76% of those observed for primary TKR. In addition these outcomes are 
considerably worse in specific groups dependent upon the reason for revision.  On average 
all revisions improved from baseline irrespective of the reason for revision although 
revisions for stiffness and unexplained pain produced the smallest improvements. This 
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information is useful as it allows surgeons to counsel patients about the expected 
improvements and final functional outcomes following revision relative to the levels 
achieved after their primary TKR. In addition it provides surgeons with information about 
how these outcomes change in the context of the reason for revision. Within the group of 
patients undergoing revision for aseptic loosening / lysis the key factors influencing the 
PROMs improvement were the relevant pre-operative PROMs, pre-operative general health, 
age and anxiety level.   
 
Analysis 8: Limitations and reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
The NJR-PROMs data is not suited to the analysis of revision data. For primary TKR the 
majority of functional improvement has occurred by 6 months and is unlikely to improve 
further after this time point (Johnston 2009). PROMs data collection at 6-8 months (90% of 
PROMs records) is therefore appropriate. However, it takes longer to reach a functional 
plateau after revision TKR owing to the extent of the surgery and the time required for 
recovery. For revision TKR this plateau phase may not be reached until at least year after 
surgery (Malviya 2011) meaning further improvements occurring later during postoperative 
recovery could not be appreciated. While comparison of PROMs assessments at 6 months is 
valid it may not reflect the final endpoint for the revision cohort. Interpretation of ‘post-
operative’ and ‘improvement’ scores must therefore be interpreted with caution. This 
highlights one of the problems with using a national dataset with standardised data 
collection, namely that the number and timing of post-operative assessments cannot be 
altered. Using these databases to assess conditions for which they were not primarily 
designed (revision rather than primary surgery) is therefore problematic.  
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The PROMs project is still in its infancy and currently only collects data from a sample of all 
primary and revision TKRs performed. The number of revisions with PROMs records is 
approximately 10% and includes less than a thousand cases with useable PROMs data. This 
compares to primary TKR for which >23,000 useable records are available. The smaller 
number of records for revision procedures limited our ability to analyse this group, 
especially when the groups were sub stratified by the indication for revision. For this reason 
the analysis of revision data was, on the whole, restricted to descriptive rather than 
analytical and investigative analyses.    
 
The NJR dataset and data collection forms are designed to monitor primary implants 
prospectively over time and in those cases that come to revision record specific information 
relating to that procedure. A number of revisions are, however, revisions of primaries 
performed prior to the inception of the NJR or are re-revisions of prior revisions. For these 
groups of patients there is often limited information recorded about their previous surgery 
as the NJR was not designed to collect this information. One of the key determinants of 
outcome after revision surgery is the number of previous revisions (NZJR-AR 2012). This is 
almost impossible to ascertain from the NJR dataset unless the revision is being performed 
on a primary procedure that has also been registered with the registry. As such we could not 
include this important information with our analyses. Additionally, unlike many other 
registries, the NJR does record information about the complexity of the revision i.e. whether 
the revision was a major (change of all components) or minor (change of polyethylene only) 
revision. It may be possible to determine this information from the implant records but this 
would require a detailed examination of each individuals NJR records which is likely to be 
time consuming and potentially uninformative. 
 
As the PROMs project grows the number of records linked to revision cases will increase. It 
may therefore be possible to examine this cohort in more detail in the future. However, due 
to some fundamental problems, including limited follow up and failure to record key clinical 
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information, the analysis of this group will remain limited unless changes to the way in 
which data is collected can be made.  
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6.3 Analysis 9: Analysis of functional outcomes after one and two stage revision for the 
infected knee replacement  
  
Analysis 9: Aims 
1. To determine how the approach to surgery (one versus two stage) influences the 
functional outcomes and rates of complications following revision of the infected 
knee replacement? 
 
Analysis 9: Methods 
This analysis was performed on the NJR-PROMs dataset described in section 3.4.4. From this 
dataset data was extracted for all revision knee replacements (n=996) (figure 3.5).  As this 
analysis focused on septic revision surgery only those cases for which the stated reason for 
revision included ‘infection’ (n=195) were included. The 195 revisions included 33 single 
stage revisions, 73 first of two stage revisions and 89 second of two stage revisions. Data for 
both the first and second stage of the two stage procedures was available for only 5 patients 
within the two stage group. Due to the limited numbers with complete data it was therefore 
impossible to generate meaningful change scores spanning both the first and second of the 
two stage procedures for this group. Analysis therefore focused on comparing final 
outcomes for the single and two stage group by comparing the post-operative PROMs for 
the single stage and second of two stage groups. This comparison required the assumption 
that the two groups were similar prior to surgery i.e. they started off in the same place prior 
to the first stage of surgery. This was felt to be a valid assumption as the pre-operative 
demographic variables for the single stage and first of two stage groups were similar (table 
6.7). Analysis of the combined pre- and post-operative PROMS data for the single stage 
revision group was performed to demonstrate the effect size in the improvements seen 
after revision for infection for this group of patients.  
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PROMs examined for this analysis included the OKS, EQ5D index, patient satisfaction and 
rates of post-operative complications. Patients recording either an “excellent”, “very good” 
or “good” response to the satisfaction questionnaire were classified as satisfied and those 
responding “fair” or “poor” as unsatisfied.  Statistical analysis was performed as described in 
section 3.6. 
 
 Operation Type  
 Single Stage 2nd of 2 stage p value 
N 33 89  
Mean Age (Years) 69.4 
(S.D 10.7) 
70.3 
(S.D 8.9) 
0.67 
Gender  
 Female 
 Male 
 
15(46%) 
18(55%) 
 
35(39%) 
54(61%) 
 
0.54 
ASA grade 
 1 
 2 
 3/4 
 
1(3%) 
22(67%) 
10(30%) 
 
3(3%) 
56(63%) 
30(34%) 
 
0.93 
Hospital Type:  
NHS hospital  
Other hospital  
 
32 (97%) 
1 (3%) 
 
89 (100%) 
0 (0%) 
 
- 
Lead Surgeon: 
 Consultant 
 Other grade 
 
31 (94%) 
2 (6%) 
 
84(94%) 
5(6%) 
 
0.93 
Number of comorbidities 
 2 or less 
 3 or more 
 
28 (85%) 
5 (15%) 
 
78 (88%) 
11 (12%) 
 
0.69 
Table 6.7: Demographic details for the two infected revision groups.  
 
Analysis 9: Results 
The overall mean post-operative OKS for the single and second of two stage revisions was 
23.4 (95% CI 21.2 to 25.6) and for the EQ5D index was 0.484 (95% CI 0.414 to 0.554). There 
were no significant differences between either group for the post-operative OKS or EQ5D 
index (Table 6.8). The distribution of patients in each level of the 5 EQ5D domains was also 
comparable (Table 6.9).  The proportions of patients reporting Excellent/Very good/Good 
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levels of satisfaction were similar between the two groups (single = 20 of 33 respondents 
(61%) vs. two stage = 50 of 87 respondents (57%) (p=0.76)). Overall 8 patients (24%) from 
the single stage and 21 patients (24%) from the two stage groups felt the result of their 
operation was poor (p=0.99).  
 
 
 Procedure type Mean S.D 95% CI p 
value 
OKS Score Single stage revision 25.1 13.1 21.1 to 29.1 0.39 
2nd of 2 stage revision 22.8 12.4 20.2 to 25.4 
EQ5D Index Single stage revision 0.498 0.397 0.364 to 0.632 0.75 
2nd of 2 stage revision 0.473 0.355 0.397 to 0.548 
Table 6.8: Comparison of the post-operative OKS and EQ5D for the single stage and second 
of two stage groups.  
 
EQ5D index dimension  Single Stage 
 
Second of two 
Stage 
Mobility Level 1 
Level 2 
Level 3 
18% 
76% 
6% 
14% 
85% 
1% 
Self-Care Level 1 
Level 2 
Level 3 
58% 
36% 
6% 
48% 
48% 
5% 
Usual Activities Level 1 
Level 2 
Level 3 
18% 
61% 
21% 
14% 
59% 
27% 
Pain / Discomfort Level 1 
Level 2 
Level 3 
19% 
63% 
19% 
18% 
62% 
20% 
Anxiety / Depression Level 1 
Level 2 
Level 3 
58% 
33% 
9% 
57% 
34% 
8% 
Table 6.9: Breakdown of the post-operative EQ5D index by its 5 constituent domains for the 
two groups. Level 1 = no problems, Level 2 = moderate problems, Level 3 = severe problems. 
Numbers represent the percentage of patients at that particular level for each domain. 
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When comparing rate of complications there were no differences in the rates of self-reported 
complications between the two groups (table 6.10).  
 
 Operation group  
Complication Single Stage 
n = 33 
Two Stage 
n = 89 
p value 
Post-operative bleeding 5 (15%) 14 (16%) 0.94 
Wound problems 8 (24%) 30 (34%) 0.32 
Requirement for further surgery 7 (21%) 23 (26%) 0.60 
Requirement for readmission 8 (24%) 31 (35%) 0.27 
Table 6.10: Complications recorded for the two infected revision groups.  
 
For reasons previously outlined it was not possible to link the second stage to its 
corresponding first stage meaning that preoperative function of the two stage group could 
not be adequately assessed. To assess the size effect of the functional improvements 
associated with revision the paired pre and post-operative data for the subset of single 
stage revisions was compared.  The mean pre and post-operative OKS were 15.3 (95% CI 
13.0 to 17.6) and 25.1 (95% CI 21.1 to 29.1) respectively giving a mean improvement of 9.8 
(95% CI 5.2 to 14.4). For the EQ5D index the equivalent pre and post-operative means were 
0.254 (95% CI 0.129 to 0.379) and 0.498 (95% CI 0.364 to 0.632) with a mean improvement 
of 0.244 (95% CI 0.109 to 0.379). The pre and post-operative EQ5D domains scores are given 
in table 6.11. 
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EQ5D index dimension  Pre-operative Post-operative 
Mobility Level 1 
Level 2 
Level 3 
6% 
88% 
6% 
18% 
76% 
6% 
Self-Care Level 1 
Level 2 
Level 3 
58% 
39% 
3% 
58% 
36% 
6% 
Usual Activities Level 1 
Level 2 
Level 3 
3% 
52% 
46% 
18% 
61% 
21% 
Pain / Discomfort Level 1 
Level 2 
Level 3 
3% 
49% 
49% 
19% 
63% 
19% 
Anxiety / Depression Level 1 
Level 2 
Level 3 
58% 
39% 
3% 
58% 
33% 
9% 
Table 6.11: Breakdown of the pre and post-operative EQ5D index by its 5 constituent 
domains for the single stage revision group (n=33). Level 1 = no problems, Level 2 = 
moderate problems, Level 3 = severe problems. Numbers represent the percentage of 
patients at that particular level for each domain. 
 
Analysis 9: Discussion 
This analysis failed to demonstrate any differences in the final PROMs scores when two 
different approaches to treatment of the infected knee replacement were compared. Two 
stage revision is currently considered the gold standard procedure for treatment of the 
infected knee arthroplasty (Leone 2010). One stage revision may be successful in carefully 
selected patients in the hip (Moyad 2008), and has been described in the knee (Göksan  
1992, Scott 1993, Buechel 2004, Bauer 2006, Whiteside 2011). Existing literature on two 
stage revision is plentiful, consisting mainly of retrospective case series, and suggests 
positive results with the exception of a few reports where outcomes have been poor due to 
certain factors such as virulent organisms and revision after failed debridement (Mittal 
2007, Macmull 2010, Gardner 2011). The reports relating to single stage revision are more 
sparse and are generally of poorer quality. However, positive results, comparable to two-
stage revision have been achieved in enthusiastic centres (Jämsen 2009).   
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Gooding et al reported a mean satisfaction score of 71 out of 100 in 115 retrospectively 
reviewed two-stage revisions for infection using a PROSTALAC spacer (Gooding 2011). No 
further breakdown of satisfaction data was presented within this report. The overall 
satisfaction (patients rated as Excellent/Very Good/Good) within this analysis was only 58%, 
however, this may be related to the way in which satisfaction is recorded within the PROMs 
and the method we employed for turning a 5 point scale into a binary outcome.  
 
A number of studies have used validated knee scores, usually the Knee Society or Hospital 
for Special Surgery scores, to quantify outcome following revision for infection (Laffer 2006). 
Jamsen et al reviewed 31 studies reporting outcomes after knee revision for infection, and 
found that the majority of patients scored above 80 out of 100 for these assessment 
modalities, equating to scores in the ‘excellent’ category (Jämsen 2009). No difference was 
observed between single and two stage revision.  In one of the few comparative studies to 
date Bauer et al found no difference in the clinical and functional results between one and 
two stage procedures in a series of 30 single stage and 77 two stage revisions (Bauer 2006). 
For the cohort presented here the overall mean post-operative OKS was 23. This compares 
to a mean OKS of 24 reported by Gooding at an average of 9 years follow up (Gooding 
2011). This emphasises that revision for infection is associated with poor functional results, 
especially when compared the mean OKS of 35 reported after primary TKR (Analyses 1 and 
5). 
 
A number of small case series have examined functional outcomes and satisfaction after 
single stage revision for infection and suggest they are good (Göksan  1992, Scott 1993, 
Whiteside 2011). Of the 17 knees reviewed by Scott et al no one reported an increase in 
their level of pain following revision and 15 patients reported either no pain or a significant 
improvement in their level of pain (Scott 1993). Göksan reported severe pain on walking in 
just 2 of their 18 single stage revisions (Göksan  1992). Walking aids were used by 11 
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patients but 8 of these for reasons other than the revision knee. More recently Whiteside et 
al reported a mean Knee Society Score of 83 (out of 100) at two years follow up in their 
series of 18 single stage revisions (Whiteside 2011). 
  
Due to the prospective nature of the PROMs data collection it has been possible to quantify 
the improvements gained following revision in a cohort of single stage patients. 
Improvements from baseline were observed for both the OKS and EQ5D index. There were 
also improvements for the 5 EQ5D domains most notably involving Mobility, Ability to 
perform usual activities, Pain and Anxiety. These findings help quantify the value of revision 
in this setting and provide some information about the magnitude of improvement relative 
to that observed after aseptic revisions (analysis 8).  
 
The fact that we found no differences in the postoperative OKS, EQ5D and patient reported 
satisfaction for one and two stage revision for infection has a number of potential 
explanations. An obvious problem with this analysis was the lack of statistical power due to 
the small numbers in the single stage group and the possibility of type II statistical error. 
Alternatively it could be that patients revised for infection have a final outcome that is 
similar at the end of the surgical episode, irrespective of the procedure performed and it is 
the presence of infection rather than the mode of treatment that is the key determinant of 
outcome. Another possible explanation could be that single stages may be functionally 
superior in cases where the infection is successfully eradicated but be prone to higher rates 
of re-infection which are associated with poorer outcomes, the result being that their 
overall performance is equivalent to two stage revisions. As no information on 
microbiological outcomes or re-infection were available, it was not possible to sub analyse 
dependent upon infection severity or the eradication of infection. As such it was not 
possible to ascertain whether singles stages were reserved for less severe cases or whether 
there was a relationship between re-infection and patient outcomes, particularly whether 
successful eradication of infection produces a better final outcome. However despite an 
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inability to establish re-infection rates the results presented, which include any potential re-
infections, give a good overall view of patient outcomes following these two procedures. 
 
The clinical implications of this study are that surgeons should not recommend singe stage 
revision for infection to patients based on the perception that it is associated with better 
functional outcomes and higher levels of patient satisfaction, as results suggest both single 
and two-stage revision are equivalent. Furthermore patients should be counselled that the 
functional outcome after revision for infection is likely to be poor irrespective of the type of 
procedure performed.  
  
Analysis 9: Summary 
There was no difference between single stage and two stage revision as assessed by a 
variety of patient reported outcome measures. Surgeons should not recommend singe stage 
revision for infection to patients based on the perception that it is associated with better 
functional outcomes and higher levels of patient satisfaction until further evidence is 
available. Prior to revision patients should be counselled that the functional outcome after 
revision for infection is likely to be poor irrespective of the type of procedure performed.  
 
Analysis 9: Limitations and reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
In similarity to analysis 8 this analysis also suffered from methodological problems related to 
the ability of NJR-PROMs data to assess outcomes after revision. Functional recovery after 
revision for infection takes even longer than recovery following revision for aseptic causes 
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(Malviya 2012), raising questions about the validity of using PROMs data to assess this group 
of patients.  Even in the revision setting the majority of functional improvement has 
occurred by 6 months and scores are starting to plateau. Useful data can therefore be 
obtained at this point, but it is unclear whether comparisons at 6 months adequately reflect 
differences in PROMs once full recovery has occurred.  
 
Details relating to the type of infection (e.g. microbiological results) were unavailable 
meaning we could not stratify for the infecting organism. Similarly data on reasons for 
selection of one procedure or the other was not available due to the retrospective registry 
based design. The benefit lost in not having these data is, to some extent, offset by the 
larger numbers of cases made available through the use of a national dataset. This would 
not have been possible in a single centre study where microbiological and surgical episode 
data would have been available. In the future it may be possible to gain information about 
the type of infection by linking the NJR and PROMs datasets with information held by the 
Health Protection Agency (HPA). This may give some useful information about the influence 
of the infecting organism upon outcome and may be an avenue for further work in the 
future.  
 
As discussed within the methods section it was not possible to link the data on second stage 
procedures to the first stage, and thus pre-operative data was not available for this group. 
We were therefore only able to compare postoperative scores (with their inherent 
limitations (see above)).  We have to assume pre-operative parity as we had no way of 
knowing whether the second of two stage and single stage groups were matched prior to 
their revision episode. In addition no detail on the timing of second stage procedures in 
reference to their first stage procedure was available, a factor which may obviously play a 
part in outcome. One may postulate a potential selection bias, whereby single stage 
procedures may be done on less severe cases, positively biasing the results of this operation 
type. However, as the results did not show single stage revision to be superior, this potential 
effect has not significantly skewed the results.  
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Finally the numbers included in the study could be criticised as being too small. Post-hoc 
power analysis based on the distribution and size of the smaller single stage group showed 
this study to be sufficiently powered to detect a difference of 6.7 points on the OKS and 0.2 
points on the EQ5D with 80% power and p<0.05. While these size effects are quite large, 
calculation shows that approximately 165 patients would be required in each arm to detect 
a clinically relevant size effect of 3 points on the OKS and 0.1 points on the EQ5D. Smaller 
size effects would therefore not be detected within this analysis. However, in defence of this 
analysis it must be recognised that achieving the requisite number to adequately power an 
analysis of these two techniques is unrealistic. As such the best way to compare these 
groups in the future might be through a meta-analysis of smaller analyses as presented 
here.  
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6.4 Analysis 10: Analysis of centre operative volumes for revision knee replacements 
performed in England and Wales   
 
Analysis 10: Aims 
1. To determine centre operative volumes for revision knee replacement by auditing all 
centres performing revision knee procedures in England and Wales against two pre-
defined standards linked to hospital volume:  
a. Operative volume should be greater than 10 revisions per year. 
b. More than 2.5 revisions should be performed for every 100 primary 
arthroplasties implanted.  
 
Analysis 10: Methods 
To perform this analysis data was extracted from the NJR database for all revision knee 
replacement performed between 1st July 2008 and 30th June 2010. In total 359 centres 
undertook at least one revision during this period. For each centre information on the 
volume of primary and revision knee procedures undertaken during this 2 year period was 
available. Additional information on the hospital name, hospital type (NHS, Independent 
hospital, Independent Sector Treatment Centre (ISTC)) and associated NHS Trust was 
collected. This information was independently verified using the hospital internet home 
page and the Dr Foster Hospital Guide (www.drfosterhealth.co.uk/hospital-
guide/#hospsearch ).  
 
For each centre we audited two aspects of surgical volume, the annual revision volume and 
the proportion of revisions per 100 primary procedures. These were chosen as both 
influence the exposure to revision and development of revision experience. Based on the 
work of Lavernia et al (Lavernia 1995), Judge et al (Judge 2006) and Yasunaga et al 
(Yasunaga 2009)  on the effects of surgical volume in primary and revision arthroplasty we 
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defined hospitals as “low volume” if they performed <20 revisions over the 2-year period 
(10/year). Centres performing more than 20 revisions over the two years were defined as 
“high volume”. These centres were further sub stratified (20-49 per 2 years, 50-99 per 2 
years, >99 per 2 years) based on volume to help determine the geographical spread of the 
highest volumes centres. The number of revisions performed per 100 primary knee 
arthroplasties has not been previously described.  We therefore arbitrarily assigned centres 
performing less than 2.5 revisions per 100 primary arthroplasties as “low ratio revisers”. 
 
Using hospital postcodes each hospital was plotted on a map of England and Wales to 
demonstrate the distribution of centres undertaking revision surgery and their associated 
surgical volume.  Postcodes were linked to grid references via the National Statistics 
Postcode Directory (NSPD) August 2010, available from EDINA UK Borders 
(http://edina.ac.uk/). Mapping was undertaken in ArcGIS 9.3 (ESRI, Redlands, California, 
USA).  
 
Analysis 10: Results 
During the 2-year analysis period 396 different centres performed 153,133 primary knee 
arthroplasties. Of these 359 (91%) performed 9,659 knee revisions, equivalent to 6.2 
revisions for every 100 primary arthroplasties performed. Revision centres included 208 
(58%) NHS hospitals performing 8,148 revisions, 141 (39%) independent hospitals 
performing 1258 revisions and 10 (3%) Independent Sector Treatment Centres (ISTC) 
performing 253 revisions. 
 
The median number of revisions performed per hospital was 14 over 2 years (Range 1 to 
287). There was a difference in the number of revisions performed by hospital type with 
NHS hospitals performing a median of 28 per 2 years (Range 1 to 287) compared to 6 per 2 
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years (Range 1 to 84) for independent hospitals and 22 per 2 years (Range 1 to 73) for ISTCs 
(NHS vs. Independent, p<0.001).  
 
Figure 6.2 demonstrates the volume of knee revision procedures performed at each centre. 
In total 28 centres performed only 1 revision per 2 years (table 6.5). Two hundred and 
twelve (59%) centres were classified as “low volume” (<20 revisions per 2 years) accounting 
for 1573 (16%) revisions (table 6.5). In contrast the 12 highest volumes centres (>99 
revisions per 2 years) performed 2304 (24%) revisions. In total 78 of the 208 (38%) NHS 
hospitals were classified as “low volume” compared to 128 of 141 (91%) of the independent 
hospitals and 6 of 10 (60%) of the ISTCs. The geographical distribution of centres performing 
revisions is shown in figure 6.3.  
 
 
Figure 6.2: Bar chart of the number of revisions performed between 1st July 2008 and 30th 
June 2010 in the 359 institutions entering revision knee data on to the NJR, ordered by 
revision volume. Line key: Red = 20 revisions, Orange = 50 revisions, Green = 100 revisions 
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Number of revisions 
per 2 years 
Number of 
centres 
Centre type Percentage Cumulative  
Percentage 
1 28 Independent  - 21 
ISTC - 1 
NHS - 6 
7.8% 7.8% 
2-5 65 Independent - 43 
ISTC - 2 
NHS - 20 
18.1% 25.9% 
6-10 61 Independent - 40 
ISTC - 0 
NHS - 21 
17.0% 42.9% 
11-19 59 Independent - 24 
ISTC - 3 
NHS - 31 
16.4% 59.3% 
20-49 91 Independent - 12 
ISTC - 2 
NHS – 78 
25.3% 84.7% 
50-99 43 Independent - 1 
ISTC - 2 
NHS - 40 
12.0% 96.7% 
>99 12 Independent - 0 
ISTC - 0 
NHS - 12 
3.3% 100.0% 
Table 6.12: Number of revisions performed at each centre between 1st July 2008 and 30th 
June 2010 (Key: Independent = Independent Hospital, ISTC = Independent Sector Treatment 
Centre, NHS = NHS Hospital).  
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Figure 6.3: Distribution of the 359 centres performing knee revision surgery (Key given in 
the top left corner of the plot). Analysis based on 2 years of surgical practice. 
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The median number of revisions per 100 primary knee arthroplasties was 5 (Range 0 to 
300). Prior to further analysis the hospital with a value of 300 was excluded as this was 
found to be a significant outlier representing an independent hospital that performed 2 
primaries and 6 revisions during the period of analysis. There was a difference in revisions 
per 100 primaries dependent upon hospital type with NHS hospitals performing a greater 
number (Median 7, Range 0 to 76) than either independent hospitals (Median 3, Range 0 to 
16) or ISTCs (Median 2, Range 0 to 6) (NHS vs. Independent and/or ISTC, p<0.001).  
 
In total 80 centres were classified as “low ratio revisers” (22 NHS Hospitals, 52 Independent 
hospitals, 4 ISTCs). Fifty-seven centres performed >10 revisions per 100 primaries including 
all of the 12 highest volume hospitals possibly indicating the tertiary nature of their practice. 
 
In total 212 centres were classified as either “low volume” or “low ratio revisers” and thus 
fell below the audit standards. All 80 “low ratio revisers” were also “low volumes” centres. 
Ninety-one per cent of all independent hospitals (128 of 141) fell below the audit standards. 
Of the 147 centres meeting the audit standards 130 were NHS hospitals (63% of the 208 
NHS hospitals), 13 were independent hospitals (9% of the 141 independent hospitals) and 4 
were ISTCs (40% of the 10 ISTCs). A final geographic plot was constructed based on the 
following three groups 1) Volume <20 per 2 years and <2.5 revisions per 100 primaries; 2) 
Volume <20 per 2 years or <2.5 revisions per 100 primaries; 3) Volume ≥20 per 2 years and 
≥2.5 revisions per 100 primaries.  This demonstrated that the 147 centres in the group 3 
were evenly distributed within England and Wales (figure 6.4).  
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Figure 6.4: Distribution of the centres performing knee revisions dependent up their 
combined volume measures (see text for details) (Key given in the top left corner of the 
plot). Analysis based on 2 years of surgical practice. 
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Analysis 10: Discussion 
This analysis demonstrates that a significant proportion of centres in England and Wales are 
performing knee revisions in small volumes. The majority of centres (213 of 359 (59.3%)) fell 
below one or other of our audit standards for volume (<20 revisions per 2 years or <2.5 
revisions per 100 primaries) and 80 centres fell below both. This included nearly all 
independent hospitals.  The distribution of both of the annual revision volume and the 
number of revisions per 100 primaries are skewed to the right, indicating that there are a 
high number of low volume centres and centres doing considerably more primaries than 
revisions.   
 
An association between increased volume and a variety of outcomes including functional 
scores (Katz 2004, Katz 2007, Shervin 2007), mortality (Lavernia 1995, Judge 2006), length of 
stay (Lavernia 1995, Bozic 2010), complication rates (Judge 2006, Chowdry 2007), ITU 
requirement (Harmon 1999) and rates of home discharge (Brown 2001) has been previously 
reported across a range of surgical procedures.  Greater familiarity and experience with 
complex surgical procedures increases confidence and understanding at both the individual 
surgeon and hospital level. In their systemic review of 163 articles, Chowdhury et al found 
that 74.2% of the papers reviewed reported significantly improved outcomes in higher 
volume centres (Chowdry 2007). Increasing hospital volume has been shown to improve 
functional results at 2 years post Total Knee Replacement (Katz 2004, Katz 2007) and reduce 
mortality rates after primary and revision knee arthroplasty (Lavernia 1995, Judge 2006). 
 
This analysis poses two questions: what volume of surgery is enough? and how might 
services be rationalised?. A number authors have suggested values for minimum surgeon 
volumes (>15 to >100 TKR per year) (Hervey 2003, Katz 2004, Schulze 2006) and trust 
volumes (>50 TKR/THR per year) for primary arthroplasties (Judge 2006). As far as we are 
aware no such value for knee revision exists, largely due to methodological issues in the 
previous studies analysing this subset of patients (Marlow 2010). We have suggested that 
 216 
 
hospitals should undertake a minimum of 20 revisions every 2 years (10 per year) based on 
the results from previously published work (Lavernia 1995, Judge 2006, Yasunaga 2009). 
This threshold is at the lowest end of those used in articles assessing the impact of hospital 
volume and therefore should only exclude the very lowest volume users. It also seems 
intuitively reasonable when one considers that in many centres there may be multiple 
surgeons each performing only 1 or 2 revisions per year. We also felt that the proportion of 
revisions to primaries was an important variable to consider and suggest that centres should 
ideally be performing >2.5 revisions per 100 primaries. We found that no centre doing >20 
revisions per 2 years performed <2.5 revisions per 100 primaries which serves to vindicate 
this value as a cut off.  
 
The issue of how to rationalise service poses a particular problems, especially in areas of 
increased population density and also in areas with a high proportion of patients who want 
their operation done in an independent hospital environment. One way to reduce the 
number of low volume centres (213) would be for hospitals within the same trust to 
centralise service at a local level. This would reduce the number of “low volume” centres by 
38 and require only 215 revisions to be relocated. The majority of ISTCs (134 of 151 (89%)) 
fell below the suggested audit standards. These hospitals undertook only 1511 revisions, 
representing 16% of all revisions. By rationalising the use of independent hospitals and ISTCs 
the number of centres performing revisions would be halved. Many larger NHS facilities 
have access to private facilities that could accommodate the private workload whilst 
maintaining higher centre volumes.  
 
Unfortunately this analysis was unable to examine the number of surgeons performing 
revision knee replacements and their associated distribution of surgeon level volume data. 
Some might argue that much of the time it is experienced high volume surgeons operating 
in low volume centres. The assumption being that high volume surgeons consistently 
achieve excellent results despite hospital volume. However, evidence suggests that high 
volume surgeons operating in a low volume centres are unable to attain comparable result 
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to those achieved by operating in high volume centres (Harmon 1999). Conversely if low 
volume surgeons operate in high volume centres they achieve better results than if they 
operated in low volume centres, albeit never as good as the high volume surgeon.  This 
indicates that both surgeon and centre volume are interrelated (Harmon 1999). The ideal 
situation being a high volume surgeon operating in a high volume centre, with services 
rationalised to produce centres doing above a minimum threshold of procedures each year.  
 
Analysis 10: Summary 
This analysis found that a significant number of institutions are performing small volumes of 
knee revision procedures. To ensure safe and sustainable practice with better outcomes for 
patients, consideration should be given to whether this service would be better 
concentrated in fewer centres performing higher revision volumes.  
 
Analysis 10: Limitations and reflection 
In addition to the general methodological limitations of the NJR and PROMs datasets 
discussed later (section 8.2) this analysis contained a number of specific limitations.   
 
Due to the nature of the data this analysis was entirely descriptive. Due to the small 
numbers of cases done in each unit and the limited outcome measures available we were 
unable to directly examine whether there was link between volume and outcome for 
revision procedures. Revision PROMs records for this cohort totalled <800 as analysis was 
based on procedures performed between 1st July 2008 and 30th June 2010. This equates to 
just over 2 PROMs records for each of the 359 centres within this analysis. Re-revision is a 
rare outcome, takes time to occur and is difficult to link to the previous revision procedure. 
These factors made it impossible to adequately examine the impact of volume upon 
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functional recovery, patient satisfaction and re-revision and highlight the difficultly in 
performing any meaningful analysis on this very heterogeneous group of patients.  
 
Some of the issues surrounding the assessment and definition of surgical volume have 
previously been discussed (analysis 4, section 4.5). These are further highlighted in this 
analysis were, even by including 2 years’ worth of data, a number of centres were only 
performing 1 procedure. We also had no information on surgeon volume which in our prior 
analysis of UKR volume (analysis 4) was shown to be a more important predictor of outcome 
than centre volume. It may be that the procedures done in the lowest volume centres were 
done by ‘high volume’ surgeons and therefore had the potential to achieve the best results. 
Due to inadequacies in the data it was not possible to examine this in any detail and this 
question remains unanswered.  
 
While it is logical to assume these complex procedures do better in the hands of specialist 
‘high volume’ centres and surgeons, the literature supporting this contention is limited and 
we have been unable to add significantly to it. This analysis demonstrates that there is 
variation in the volume of procedures performed at centres across England and Wales but 
what this means, how it relates to patient outcomes and how it should impact upon service 
delivery is a matter for debate.  
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Chapter 7: Overview of the main findings from the analyses performed 
The key findings from each of the analyses performed are stated below: 
Analysis 1: Analysis of functional improvements and rates of complications for UKR and TKR 
(pages 82 to 92) 
 There were no demonstrable differences in the improvements in either knee-specific 
PROMs, general health PROMs or rates of complications between UKR and TKR. 
 
Analysis 2: Analysis of the reasons for revision and rates of failure for unexplained pain for 
UKR and TKR (pages 93 to 101) 
 The overall rates of revision and rates of revision for unexplained pain are significantly 
higher for UKR when compared to TKR. 
 
Analysis 3: Analysis of the reasons for revision and rates of failure for medial and lateral 
UKR (pages 102 to 117) 
 The rates of survival and reasons for revision for medial and lateral UKR are similar. 
  
Analysis 4: Analysis of the effect of centre and surgeon operative volume on UKR rates of 
failure (pages 118 to 134) 
 UKR failure rates are lowest when surgery is performed by specialist, high volume 
centres and surgeons.  
 
Analysis 5: Analysis of the influence of surgical factors on PROMs (pages 141 to 153) 
 Of the surgical factors analysed only implant brand and hospital type were seen to 
influence the magnitude of the PROMs improvements. However the effects of these 
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factors were small when compared to patient factors, and in particular the pre-operative 
PROMs and general health status.   
 
Analysis 6: Analysis of the relationship between pre- and post-operative factors and patient 
satisfaction with TKR (pages 154 to 167) 
 The most important determinants of satisfaction are the patient’s perception of the 
success of their operation and post-operative function. Pre-operative variables have a 
minimal influence upon post-operative satisfaction. 
 
Analysis 7: Analysis of the relationship between Body Mass Index and PROMs (pages 168 to 
178) 
 Although increasing BMI is associated with poorer pre and post-operative PROMs, the 
improvement experienced by patients is similar irrespective of BMI. 
 
Analysis 8: Analysis of the reason for revision upon early PROMs following revision knee 
replacement (pages 184 to 197) 
 Revision knee replacements only experience a fraction of the functional improvements 
experienced after primary total knee replacement. The magnitude of the PROMs 
improvements and level of patient satisfaction are dependent upon the reason for 
revision with revision for unexplained pain and stiffness having the worst functional 
outcomes.  
 
Analysis 9: Analysis of functional outcomes after one and two stage revision for the infected 
knee replacement (pages 198 to 207).  
 The functional outcome after revision for infection is poor. There is no difference in 
functional outcome between one and two stage revisions surgery in this setting.  
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Analysis 10: Analysis of centre operative volumes for revision knee replacements performed 
in England and Wales (pages 208 to 218) 
 A significant number of institutions are performing small volumes of knee revision 
procedures 
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Chapter 8: Discussion 
The analyses performed in chapters 4, 5 and 6 demonstrate the versatility of the combined 
NJR and PROMs data to answer a range of pertinent clinical questions. These large national 
datasets contain a wealth of data. Research using the information held within them, while 
observational in nature, has many strengths. There are, however, a number of general 
limitations to the analyses performed, a number of which have already been discussed. 
These include specific deficiencies in the data held within these datasets, which is a problem 
that is not isolated to registry data. In addition there are issues relating to the methods of 
data collection, as well as the previously discussed problems inherent when performing 
research using observational data (see section 1.4). The specific strengths and weakness of 
the NJR and PROMs datasets are discussed in the following sections. Particular emphasis is 
given to their deficiencies and merits relative to more traditional pragmatic clinical trial 
designs.   
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8.1 Strengths of the NJR/NJR-PROMs dataset 
 Size of the datasets available for analysis 
The analyses presented involved cohorts that are an order of magnitude greater than 
anything that could be achieved in a prospective randomised clinical trial. The size of both 
the NJR dataset (>400,000) cases and the NJR-PROMs dataset (>25,000 cases) made it 
possible to use a variety of different statistical approaches and perform analyses of rare 
events with high statistical power.  Using national cohorts of this size moves interpretation 
away from sampling and towards population or census reporting, a magnitude of sampling 
where statistical tests of goodness of fit are not as relevant as the truth is in effect known 
(Burnham 2002).   
 
The size of the NJR dataset allowed us to investigate the influence of a number of different 
factors upon implant revision. Analysis 4, for example, demonstrated an important 
association between surgeon and centre operative volume. It is unlikely the relationship 
observed in this analysis could have been appreciated without using a dataset of this size. 
Furthermore it is impossible to imagine how the impact of operative volume upon outcome 
could have been investigated using a prospective clinical trial design, or indeed in any other 
way. A dataset of this size is needed as both the explanatory variable in question (operative 
volume), and the event in question (revision) necessitate large numbers to allow the 
relationship to be appreciated.   
 
The size of the NJR dataset also allowed us to gain an insight into infrequently performed 
procedures, such as lateral UKRs and revisions. In analysis 3 the revision rates, the factors 
influencing the revision rates and the reasons for revision for laterally implanted UKR were 
investigated and compared to those seen with medially implanted UKR. UKR make up 
approximately 9% of all knee replacements performed annually in England and Wales (NJR-
AR 2012) and this analysis found that only 6% of these are implanted in the lateral 
compartment. Lateral UKR therefore represent only 0.5% of the 80,000 knee replacements 
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performed each year. As this procedure is performed relatively infrequently any RCT 
involving medial and lateral UKR would require the co-operation of a number of different 
centres and surgeons to achieve the number of lateral UKR needed for a meaningful 
comparison to be made. This would make it logistically complex, expensive and time-
consuming. A prospective trial would, in theory, have the ability to incorporate the 
collection of other pertinent outcomes (e.g. functional outcomes) in its design. However, as 
the PROMs project matures and the number of records for lateral UKR increases, these data 
will become available.  Functional data for these groups could be extracted directly from an 
NJR-PROMs dataset using the methods used in analysis 3 to determine implant laterality, 
and used in analysis 1 to compare functional outcomes for two different implant types. 
Unfortunately the small number of PROMs records presently available for the lateral UKR 
group (n=21) meant comparison of these groups was not possible within the analyses 
presented here. The additional clinical information that a RCT would provide, given the 
major drawbacks of this type of research design to address this clinical question, make it 
difficult to imagine a role for the RCT in this setting.     
 
Revision is a rare outcome as most implants fail at a rate of less than 1% per year. For a 
prospective clinical trial to detect a meaningful difference in an event of this type requires 
the recruitment of large number of patients. While difficult, this isn’t an insurmountable 
hurdle to overcome. When, however, interest lies in subgroups that are undergoing revision 
for differing reasons the event of interest becomes even rarer and the numbers needed 
increase substantially. These problems are circumvented by the size of the NJR dataset. 
Analysis 2 demonstrated the differing modes of failure observed with TKR and UKR and 
allowed comparative survival analyses to be performed dependent upon the reasons for 
revision. Similarly analysis 3 examined the differing reason for revision between medial and 
lateral UKR. It is only with an observational dataset as large as the NJRs that such analysis 
could be performed.  
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The size of the NJR-PROMs dataset, while smaller than the NJR dataset, also conferred a 
number of benefits. The PROMs project is still in its infancy, having commenced in April 
2008, and has up until now been designed to be a sample analysis of both primary and 
revision knee replacement procedures. Due to the number of primary and revision knee 
replacement procedures undertaken annually in England and Wales there are, however, still 
a substantial number of PROMs suitable for analysis demonstrating the power of PROMs 
collection linked to a national registry. The number of patients available for analysis has 
allowed us to not only answer specific research questions but also to go further and study 
specific subgroups and identify important predictors of response to a number of different 
interventions. This is demonstrated in analyses 1, 5 and 6 where statistical modeling 
techniques were used to determine how a variety of covariates influence functional 
improvements and patient satisfaction after knee replacement. The size of the dataset 
allowed us to quantify the size effects of these covariates and better understand their 
relative influence upon the outcomes of interest. Having quantified these effects we were 
then able to adjust the analyses to account for any potential confounding factors. It allowed 
information on a large number of decisions, interventions and outcomes to be assessed 
simultaneously.  The pragmatic design of the RCT does not readily allow such associations to 
be identified (Sox 2009).  
 
In similarity to the NJR dataset, the NJR-PROMs dataset is also sufficiently large enough to 
allow the outcome of infrequently performed procedures to be analysed. This is 
demonstrated in analyses 8 and 9 in which the functional outcomes of revision procedures 
performed for a variety of different reasons were compared. Over the next 5 years both the 
NJR and PROMs projects will further mature. The NJR led ‘extended PROMs’ project will 
provide additional functional data for knee replacements through the collection of PROMs 
at additional post-operative time points. This will provide a substantial volume of 
information that could be used to assess a larger number of clinical outcomes, giving us the 
ability to examine in even greater detail the effects of different approaches to surgery.    
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 National sampling  
National observational data provides information about the performance of different 
approaches to surgery in the ‘real-world’. Data recorded within the NJR reports 
contemporary national practice and reflects what is happening in the generality of the 
National Health Service. The NJR, by its very nature, tries to capture data on all patients. It 
does not have any exclusion criteria and as such it includes patients and surgeons often 
omitted from clinical trials.  
 
In contrast clinical trials often have strict inclusion and exclusion criteria which can create a 
false environment that is not representative of everyday practice. There is therefore 
uncertainty as to whether the benefits achived by average patients in these trials can be 
extrapolated to the average patient undergoing routine clinical care (Rawlins 2008). Under 
or over-representation of certain groups within the trial framework may artificially under or 
over estimate the size effect of the outcome under investigation. This is demonstrated in 
analysis 1,5 and 6 which demonstrated the significant impact a variety of patient related 
factors have upon outcome. Randomisation helps to eliminate bias between comparative 
groups within RCTs. It ensures the patient cohorts under inverstigation are similar, but it 
does not ensure these cohorts, or indeed the surgeons performing the interventions, are 
representative of the national popluation. Results from surgical enthusiasts are not always 
representative of the results attainable by the average surgeon (Labek 2010), but it is the 
results of the average surgeon that are of the greatest interest. The generalisability or 
external validity of clinical trials is largely dependent upon their inclusion and exclsuion 
criteria. How representative and applicable to national practice their conclusions are is a 
matter of judgement (Altman 2001).   
 
A further advantage of national sampling is the ability to ‘map’ trends in current practice. 
Analysis 10 demonstrates how this can be achieved by geographically mapping the volume 
of revision TKR prcedures perfromed in England and Wales.  Analyses of this type provide 
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important imformation about the provision and organisations of service which are of direct 
interest to helthcare commisioning bodies. This information can then be linked with other 
epidemiological population data such a social demographics, deprivation scores and 
population densities to examine how these procedures are utilised within different social 
and geographical settings. 
 
 Standardisation of PROMs follow up  
The PROMs data used for these analyses has the advantage of using standardised 
prospective collection methods with the inclusion of both pre- and postoperative data. 
Simple cross-sectional collection of PROMs from existing registries is problematic as patients 
will be at different periods in there follow-up dependent up the date when their procedure 
was performed. While the timing of the post-operative PROMs sampling is contentious (Kay 
2011) the way in which the project has been designed ensures that the majority of post-
operative questionnaires are collected at equivalent time-points. By employing inclusion 
criteria linked to the time to follow up and limiting the minimum and maximum periods of 
follow up the confounding effects of this variable can be negated. As is demonstrated in a 
number of our analyses even when the minimum follow-up is limited to 6 months the 
number of PROMs records available is still large enough to permit these analyses to be 
performed.  
 
 Standardisation of PROMs metrics 
The PROMs employ the OKS and the Euroqol-5D for the assessment of knee specific 
function and generic health/health utility respectively. Each of these measures was chosen 
based on a review of their reliability, validity and responsiveness (Browne 2007). These 
measures, alongside questions relating to complications, operative success and patient 
satisfaction, form the standard PROMs assessment for all knee replacements procedures. 
Previous studies investigating knee replacement have used a variety of different outcome 
tools (Dunbar 2004). This makes direct comparison and amalgamation of results for the 
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purpose of meta-analysis difficult. Standardised PROMs data collection allows the results of 
different approaches to surgery, different unit performance and different implant 
performance to be directly compared. In addition the inclusion of the generic health 
measures within other PROMs questionnaires (hip replacement, hernia repair, varicose vein 
surgery) also allows the value of procedures for different surgical problems to be directly 
compared.  
 
Furthermore, whereas other outcome studies have used surgeon derived outcome 
measures, the PROMs projects focusses exclusively on patient reported outcomes. By using 
patient reported outcomes, PROMs concentrate on outcomes of importance to patients and 
eliminates the bias in reporting that can often accompanying surgeon derived outcomes. 
This is in line with current NHS reform (Darzi 2008) and mirrors the approach to data 
collection advocated by a number of national funding bodies (ARUK 2012).  
 
 Time and cost 
Prospective clinical trials are time consuming. They take time to develop and design and in 
many cases require funding prior to commencement. It can therefore take years for a 
project to get started. Currently nationally funded RCTs examining knee replacement (KAT 
and TOPKAT trials) are scheduled to take 15 and 10 years for recruitment and publication 
respectively. The TOPKAT trial has been undertaken to better define the role of the UKR, a 
debate which rages today. However, we will have to wait until 2020 for the results of this 
work to become available. These two RCTs are being undertaken at a combined cost of >£4 
million.  
 
In contrast, the time and costs needed to undertake analyses using registry data are smaller. 
The analyses presented here (and a number of other analyses) were all produced within a 
24 month period. This includes the 6 months it took to set up the projects, put an 
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appropriate analytical team in place, and apply for and access the data. The costs of these 
analyses are difficult to quantify. NJR data entry is now mandatory with each institution 
responsible for the costs associated with collection and input of their own data. The 
collection of PROMs data is a national initiative funded through the Department of Health. 
These costs, along with the costs related to the management and administration of these 
datasets, are hidden from the researcher using registry data. The only direct costs to the 
research team for these analyses were the £1081 payable to the NHS information centre as 
a one off fee for extraction of the PROMs data and the salary of one of the research team 
members.   
 
 Standardised statistical methods 
The recent publication of guidance on the statistical reporting of registry outcomes is a step 
forward in the attempt to standardise reporting from registries (Ranstam 2011). 
Standardised methodology ensures results from different registries and healthcare systems 
are as comparable as is possible given the inherent demographic differences in the 
population that they serve. The guidelines provide a framework for on-going and 
subsequent registry projects which we have attempted to adhere to wherever possible.  
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8.2 Limitations of the NJR/NJR-PROMs dataset 
 Logistics of data handling  
Access to the PROMs and NJR datasets requires approvals from both the NHS information 
centre and the NJR research committee. Unfortunately there is significant disparity between 
the request processes and requirements for these two organisations which presents an 
obstacle to data access. Each process has their own requirements for data access and 
storage which include verifying the site and security arrangements for the required data, 
provision of a named Caldicott guardian, completion of information governance and data 
handling/re-use agreements. Although there is significant overlap in the processes for each 
application the two are quite separate meaning repetition and duplication of a number of 
the necessary steps. From initial application to receipt of the data can take between 6 and 
12 months. This problem is compounded if projects require the use of data from other 
national datasets (e.g. Hopsital Episode Statistics, Office of National Statistics, Health 
Protection Agency etc.). This must be factored into the proposed timeframe of and potential 
projects. While attempts have been made to streamline the NJR side of the application 
process through the appointment of a research co-ordinator and a 3 week deadline for 
project review by the NJR research sub-committee the process for PROMs application 
remains unchanged.  
 
Because the two applications are completely separate the requested data comes as two 
separate databases (an NJR and a PROMS dataset) that have to be linked, verified, cleaned 
and recoded prior to analysis. While linkage is performed by Northgate, the NJR data 
handler, the other elements have to be performed by the research team. This can be a time 
consuming and complex process for the unwary researcher. Thankfully the NJR and PROMs 
datasets contain a number of unique identifiers which make linkage relatively 
straightforward. If additional datasets are to be used then the complexity of linkage 
increases as key identifiers may not be present in all datasets and algorithms based on a 
number of different patient identifiers may need to be employed. The use of patient 
identifiers also adds the requirement for ethical approval, increasing the time required to 
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produce a workable dataset still further. An appropriate amount of time must be set aside 
for this process. While one of the strengths of observational registry data is that projects 
can be completed in a shorter time frame it must be realised that there is still a significant 
time requirement to ensure project completion, most of which relates to data application 
and preparation.  
 
 Issues with the NJR dataset 
Data quality: 
The NJR uses three key indicators to determine its performance: compliance; consent; and 
linkability (see section 1.3.1). Ideally the rates for compliance, consent and linkability should 
be greater than 95% to allow confidence in the data that are produced. Generally, missing 
data of less than 5% of the total is unlikely to distort the overall results (NJR-AR 2012). 
Currently only the percentage of linkable procedure (95.5% in 2011/12) exceeds this 
benchmark, although the rates for compliance (90.3% in 2011/12) and consent (90.4% in 
2011/12) are improving year on year (NJR-AR 2012). 
 
Compliance is expected to improve still further with the introduction of recent legislation to 
make submission of NJR data mandatory. Amendments made in April 2011 to the Standard 
NHS Contract for Acute Services require all providers to participate in audits relevant to the 
service they provide within the National Clinical Audit and Patient Outcomes Programme 
(NCAPOP), of which the NJR is part. The submission of complete data to the NJR is, 
therefore, now mandatory for all NHS Trusts and foundation Trusts within England. The 
Welsh Government has also agreed that the NJR is mandatory for all NHS Wales hospitals.  
 
While these key indicators continue to improve there is, as yet, no information about the 
accuracy of the data recorded in the registry. If a procedure is performed on a specific 
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patient on a given day by a particular surgeon it is currently unclear whether that 
information is accurately reflected within the records held within the registry. Other 
registries have audited their data recording and found concordance rates to be above 95% 
(Swedish registry AR 2009). However, as yet no audit of NJR data has been completed and 
therefore lingering concerns remain. This is an important issue to resolve if registries are to 
be used as tools to shape surgical decision making and as reservoirs for research.   
 
Duration of follow-up: 
The NJR started recording data in 2003 and the censor date for the NJR data used in these 
analyses was 31st December 2010. Accordingly the maximum follow-up for these analyses 
was 8 years. Because of the numbers of implants at risk at eight years was small, we were 
only able to assess mid-term survival and in most cases chose to focus on results at 5 years 
where the number of patients at risk was large and reliable estimates of survival could be 
made. It is possible that with longer follow-up the implants under scrutiny might exhibit 
differing patterns of failure and as such the analyses performed may produce alternative 
results. While we can therefore be confident of the observations made at 5 years we cannot 
make any inferences about longer term behaviour and implications for clinical practice. 
Currently a number of other registries are able to report 10 (AJR-AR, NZJR-AR) and 15 year 
survival rates (Swedish arthroplasty register), however, they do either not contain the 
volume of cases to allow for the analysis of smaller sub groups of interest or do not record 
patient reported / functional outcomes. This problem will be corrected as our own registry 
matures over the next 5 to 10 years. It will also coincide with a likely increase in the 
coverage of PROMs collection and introduction of initiatives such as extended PROMs which 
will provide additional functional comparison to be made, further increasing the power of 
the NJR.  
 
 
 
 233 
 
Identification of revisions: 
No method for the identification of revisions is fool proof. Identifying revisions through a 
registry may miss some revisions, usually because the revision is not recorded by the 
surgeon or operating unit or the procedure is miss-coded as a re-operation. As a 
consequence the true revision rate is underestimated.  
 
These analyses used NJR–NJR linkage to establish the rate of revisions rather than NJR–HES 
linkage, on which previous NJR survival analyses have been based. This is consistent with the 
methods now used by the NJR for its annual reporting and outlier analyses. The Hospital 
Episodes Statistics (HES) is a national statistical database containing information on all 
admissions to NHS hospitals in England. It was previously used as an alternative source for 
the identification of revision procedures.  Comparison of the merits of NJR–NJR and NJR–
HES linkage suggest that whereas NJR–NJR linkage underestimates revisions to some 
undetermined extent, NJR–HES data are likely to overestimate revisions because of the 
inclusion of some reoperations which are erroneously recorded as revisions (NJR-AR 2012). 
It is likely, then, that the real revision rate lies somewhere between the two. This problem is 
only really an issue when comparing revision rates from different registries using different 
linkages and means of identifying revisions, or when basing clinical decisions on isolated 
values. It is, however, unlikely to substantially bias comparisons between groups, such as 
the medial and lateral UKRs analysed in analysis 3, as revisions for all groups are likely to be 
underestimated and hence biased to the same extent. Comparisons of the rates of failure 
between groups within the same registry should therefore be valid as long as a consistent 
method of identifying revisions is employed.  
 
Adjustment of revision data: 
To ensure data capture is as complete as possible most registries collect a refined set of 
information on a number of key variables (Robertsson 2007). These typically include 
demographic details (age, gender and a rating of co-morbidity (typically the ASA grade)), 
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information relating to the indication for surgery, and a number of pertinent intra-operative 
and post-operative variables. Patient characteristics are often used as the basis for clinical 
decision making and may also influence clinical outcomes (Sox 2009). This can lead to 
uncertainty about whether differences in clinical outcomes are related to differences in 
patient characteristics or the interventions being compared.  
 
To overcome this problem most observational analyses attempt to account for differences 
in patient characteristics by employing statistical methods that make adjustments for 
differences in these factors. As the number of variables collected by registries is limited, so 
the number of variables that can be used for adjustment is also limited. Variables that could 
potentially influence the revision rate may therefore not be appreciated. This will always 
remain a concern with comparisons made using observational data (Sox 2009). This problem 
can only be overcome by randomly assigning patients to the different intervention under 
investigation. This simple action eliminates much of the uncertainty that envelops the 
interpretation of observational research (Sox 2009) and highlights the value of the RCT in 
defining a causal relationship between intervention and outcome.   
 
 Issues with the NJR-PROMs dataset 
Missing data: 
As with many questionnaire based projects the PROMs project suffers with problems of 
missing or non-returned questionnaires. In addition, once the NJR and PROMs datasets 
were linked it became evident that there were a number of cases for which the date of 
operation stated on the NJR database was significantly different to those recorded by 
patients on their post-operative questionnaire. Our analysis of the linked NJR-PROMs 
dataset for knees suggests that the number of records lost for these two reasons may be 
upwards of 30%. Increasing the completion rates and accuracy of the date of operation 
recording should be a priority as the PROMs projects moves forward. 
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Specific PROMS issues: 
There are a number of issues specific to the use of PROMs which transcend both 
observational research and randomised controlled trials. It is worth briefly discussing these 
so it can be appreciated that these measures have their own inherent flaws.   
 
Firstly, interpretation of PROMs must be undertaken in the face of changing patient’s 
expectations with the outcomes of hip and knee replacement. Care must therefore be taken 
when analysing variables such as patient dissatisfaction as this may be a manifestation of 
unrealistic expectation rather than poor outcome. It is questionable whether the 
information collected within the PROMs adequately captures the important issue of patient 
expectation (Danielson 2010). Secondly, while collapsing the EQ5D index into a single score 
is useful it also means losing information about the domains in which any differences in 
health-related quality of life occur. Thirdly, PROMs are based on the assumption that any 
change in health is directly linked to the operation under scrutiny without consideration of 
other extraneous factors that may concurrently affect the health and well-being of the 
patient. Fourthly, absence of improvement does not necessarily indicate an unsuccessful 
outcome when treating a degenerative condition. In some cases the goal of surgery may be 
to slow the rate of disease progression and degradation in quality of life, or to avoid a future 
health problem. These will not be adequately captured using PROMs. Finally, PROMs is 
entirely subjective which means it is not a “hard” definable endpoint. The implication of this 
is that it may neither be adequate nor appropriate as a basis for making important decisions 
about health care provision. As it is subjective it also excludes certain patient groups 
(dementia, severe cognitive impairment) from analysis. 
 
The use of PROMS on a population scale is also not without problems. National sampling 
presents logistic issues, interpretation requires care and the use of PROMs that have been 
designed to sample specific populations of patients as a basis for clinical decision making is 
questionable (Carr 2012). Some authors have questioned whether the routine collection of 
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PROMs data in clinical cohorts should be used to assess the impact of health care 
interventions on patient outcomes and to guide resource allocation. These same authors 
believe that to answer such questions requires data (and more than just PROMs) from well 
controlled comparative studies rather than data from clinical cohorts (Dawson 2010). While 
the recording of national PROMs data represents a step forward the comments of these 
authors suggest that we may be extending the remit of these measures for purposes that 
they were not intended for. There is a risk that with such a valuable resource at our disposal 
we become over-reliant on it for all the answers.  
 
Confounding: 
In similarity to the problems seen when making comparisons using NJR data, comparisons 
made using PROMs data are also prone to the influence of confounding. As the PROMs 
project records a greater breadth of information relating to patient characteristics more 
detailed adjustment can be made. Using statistical modeling it was possible to account for 
many of the potential confounding factors. However, if data is not recorded it cannot be 
used within these models. Presently, variables such as mental health rating and educational 
status which are known to influence patient reported outcomes are not recorded and 
therefore cannot be used. Our regression models only accounted for approximately a 
quarter of the observed variation in the OKS improvement and a half of the observed 
variation in the EQ5D improvement (analyses 1 and 5). Inclusion of additional variables as 
described above may have improved these percentages and produced better explanatory 
models.     
 
Validity of some outcomes in PROMs: 
The key PROMs outcomes (OKS and EQ5D) are valid, responsive and consistent assessment 
tools (Browne 2007). However a number of the other assessment modalities are not. The 
ordinal scales used to assess satisfaction and success have not been validated but mirror 
similar adjectival scales used for assessing patient reported satisfaction in national cohorts 
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(Robertsson 2001, Baker 2007, Bourne 2010). The benefit of these scales is that they give a 
simple representation of the patient’s perceptions of the results of surgery. It is also unclear 
how useful patient reported complications rates are, particularly if there has not been any 
attempt to verify this information against hospital records.   
 
PROMS follow-up: 
Analyses based on data from established national databases such as the NJR and PROMs are 
constrained by their design. This includes the type, quantity and timing of data collected. 
When setting up a prospective clinical trial these aspects of data collection are tailored to 
the research question. The question comes first and the data comes second. In 
observational registry research the opposite is true, the data comes first and the question 
comes second.  
 
This being the case, our PROMs analyses had to be based on solitary 6 month follow-up data 
as this is what the PROMs project currently collects. Inferring benefit based on two PROMs 
observations (one pre-operative and one post-operative) makes the timing of the second 
observation crucial. Whereas the majority of functional improvement after knee 
replacement occurs within six months, further small improvements can be expected up to a 
year post-operatively (Kay 2011). These analyses therefore do not consider the differences 
that may appear with continued follow-up. 
 
The NJR is currently performing a programme of extended PROMS sampling in a ‘one off’ 
cohort of approximately 10,000 patients. This will involve regular PROMs assessment out to 
5 years post-operatively. However, due to the financial and logistical contraints of national 
sampling there are currently no plans to make this part of the rountine PROMs collection. 
The analyses presented have attempted to limit the effect of the short follow-up by 
ensuring a minimum follow-up of 6 months. By this time point the majority of improvement 
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in functional scores has already occurred and scores are starting to plateau (Judge 2011). In 
addition these analyses were not intended to report the final improvements gained 
following surgery, but to compare outcomes between different cohorts at an equivalent 
timepoint. The presence of a difference in the improvement in scores at 6 months is 
therefore valid, especially as the scores are likely to improve only minimally thereafter.  
 
Representativeness of PROMs: 
To produce a useable NJR-PROMs dataset a number of pertinent exclusions were employed. 
The included data was then compared to both the excluded data and data for the total 
population of patient undergoing knee replacement using the NJR annual report (NJR-AR 
2012). This suggested that, other than a small difference in the ASA grades, the patient 
characteristics of these groups were well matched. The final TKR and UKR cohorts were also 
similar to those patients undergoing these two procedures according to the NJR annual 
report (NJR-AR 2012). The final NJR-PROMs cohort therefore seemed to be a representative 
sample of the wider population undergoing knee replacement procedures. 
 
While their demographics were similar the number of UKR procedures was smaller than 
expected. UKR makes up 9% of all knee replacements entered on to the NJR but within the 
NJR-PROMS dataset is represented by 2% of primary knee procedures (analysis 1). The 
reason for this is not entirely clear. It may be related to the fact that the initial collection of 
PROMs data was restricted to NHS funded procedures. As a greater number of UKR than 
TKR procedures are privately funded and undertaken in independent rather than NHS 
hospitals these patients may not have been invited to participate in PROMs collection. 
While this may explain some of the discrepancy it is unlikely to explain it all. Questions 
about whether this sample is a true representation of all patients undergoing UKR must 
therefore remain.  
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8.3 Conclusion 
National knee arthroplasty registers contain a wealth of information. They were originally 
designed as tools for auditing the performance of different approaches to knee surgery at a 
national level, but are increasingly being used as a conduit for clinical research. The NJR is 
now the largest registry in the world and as it matures with the collection of 10 years data it 
will become an increasingly powerful aid to clinical decision making. The recent addition of 
PROMs data, which can be linked to the NJR through a straightforward linking mechanism, 
represents a significant step forward in terms of the assessment of patient outcomes. It is a 
move away from revision rate as the predominant method by which registries assess 
outcome following surgery. This was a major criticism of registry analysis in the past (Wylde 
2011).  
 
The ability to link PROMs data to the NJR will, for the first time, allow researchers to look at 
how different patient groups view the results of the various different surgeries they are 
offered. The limitations of data such as this must not, however, be underestimated. Making 
decisions based on PROMs data is problematic and it is important that patients are not 
denied access to successful treatments because a small minority is seen to benefit less that 
the majority.  While there are many advantages to registry based research, it is clear that 
this type of research can never replace prospective clinical trial designs. As the current chair 
of the NJR editorial board and president of the British Orthopaedic Association states: 
 
‘It is important to point out that registry data, whilst very important, needs to be 
supplemented by other prospective studies and randomised controlled trials to provide a 
broader picture.“ (M.Porter 2012) 
 
Randomised controlled trials, despite their own inherent limitations, are still the best way of 
proving a causal relationship.  Well-designed trials limit confounding and bias and remove 
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the uncertainty of surgical decision making using randomisation. While it is possible to limit 
these problems in observational datasets through statistical modelling, they will always 
remain to some degree.  
 
Recent initiatives, such as the comparative effectiveness research movement, increasingly 
appreciate that it is only by using data from both observational databases and clinical trials 
that robust recommendations relevant to current clinical practice can be made.  The key 
question researchers have to answer now is how these two approaches can be integrated, 
how we can maximise the value of our registry data and in what situations should a clinical 
trial be used in preference to registry analysis and vice versa?. 
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8.4: Reflection of work undertaken as part of this thesis 
 
The completion of this medical doctorate has helped me develop both professionally and 
personally. Time spent in full time research has allowed me to build on the skills and 
knowledge gained during my previous Masters in Evidence Based Practice (Orthopaedics). 
Taught modules at Newcastle University covering critical appraisal, literature searches, 
database creation and management and paper writing have proved invaluable. They have 
supplemented the practical experience gained by working directly with, and subsequently 
writing and publishing work from, the NJR and PROMs datasets. Prior to starting this thesis I 
was already enrolled in a postgraduate diploma in statistics course. Specific modules on 
medial statistics and generalised linear modelling allowed me to be confident in the 
statistical analysis I was performing and gave me the confidence to undertake the majority 
of the analyses presented in this thesis independently. Based on my experience, I would 
suggest that some form of formal statistical training is essential for future researchers 
wanting to work with datasets of this size.  
 
The initial research requests submitted to the NJR pre-dated the decision to undertake this 
thesis and my time as the NJR research fellow. At that time I was unaware of the magnitude 
of the datasets, the level of analysis required and I hadn’t constructed my research team. I 
consequently made the mistake of only naming a small number of research collaborators 
within these requests and on the subsequent data re-use and data storage agreements. This 
meant that when I received the ‘raw’ data I was the only person able to access, view and 
analyse it. This left me somewhat isolated. It made it difficult to seek help when I had 
problems manipulating or interrogating the data as I was unable to show someone exactly 
what the problem was. Fortunately the NJR had employed two research fellows at this time 
and this meant I could share problems with the other fellow, Simon Jameson. As he was 
working with the same datasets we were often able to help one another to resolve 
problems and offer advice and guidance when problems were encountered. Without his 
support I would not have been able to complete a number of the analyses presented in this 
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thesis. If I were to start again I would construct my research team prior to making any data 
requests, ensuring they had the necessary skill mix to help with a range of database and 
statistical issues. In addition I would definitely ensure they were named on the NJR and 
PROMS data-reuse agreements so that they could properly support the research process.  
 
One of the great things about registry data is that once you have it in your possession you 
are ready to start working with it. Experiments do not need be conducted, results to not 
need to be awaited and patients do not need to be recruited and followed up. This makes it 
very easy to develop and test out ideas for research projects. For example, the BMI analysis 
presented in analysis 7, arose from a simple e-mail from one of my clinical supervisors 
asking ‘is there a link between BMI and functional outcome?’. Two hours later I was able to 
reply that ‘yes, there did seem to be’ and from this simple exchange analysis 7 was 
developed. I was able to work in this way due to my position as the NJR fellow. All research 
output was subject to review by the NJR research committee to ensure the data had been 
used appropriately; the analysis was of sufficient quality and most importantly that it did 
not overlap, replicate or conflict with the work of other researchers using the registries 
data. In situations where there was overlap analyses would have had to have been 
reworked or abandoned. Thankfully this was not the case for any of the work presented in 
this thesis. The ability to work in this way and get immediate answers was a major 
advantage of the NJR fellow post. It is undoubtedly the reason why I have been able to 
produce such a large volume of work in such a short space of time. Researchers hoping to 
replicate this level of activity must bear in mind that they will probably not be afforded the 
same degree of latitude when working with the registries data.  
 
This work has given me the opportunity to travel and present at a range of national and 
international meetings. The feedback from colleagues about the work has been 
overwhelmingly positive and demonstrates the interest there is for registry based 
observational research and the value clinicians attribute to this type of work.  However, the 
more I reflect on this work the more I realise its limitations. This has tempered the initial 
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enthusiasm I had when working, presenting and publishing using this data.  I have only come 
to realise the problems and limitations of these datasets by spending over 2 years working 
with them. These limitations are not appreciated by the majority of clinicians. Having 
spoken to clinicians and answered questions about these analyses it is clear that many of 
them are using them as the basis for clinical decision making without fully appreciating their 
flaws. For this reason researchers using large observational datasets such as the NJR and 
PROMs need to be openly critical of their work and report responsibly so that results can be 
placed in the context of the data. I now wonder whether some of the bold statements made 
in early papers and presentations can truly be justified and consequently take a much more 
critical view of the results I present. While there is undoubted value in this work it does not 
give us all the answers. Where possible it needs to be supplemented by well designed 
clinical trials.  
 
A number of possible areas for future work have already been discussed within the 
limitations and reflections sections of each of the individual analyses. This piece of work has 
shown that registries can produce meaningful research output. But how this compliments 
research from clinical trials remains unclear. Future work needs to compare and contrast 
the strengths and limitations of registry research to those encountered when using 
prospective randomised clinical trial designs. In this way we might be able to better 
understand how and when these differing approaches should be used, which will allow us to 
develop effective and cost-efficient research strategies for the investigation of arthroplasty 
outcomes.  
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Chapter 9: Appendices 
 
9.1: Appendix i: NJR Research application form 
 
APPLICATION FORM      NJR Ref: 
Application to Use Data from the National Joint Registry (NJR) for the Purposes of Research 
Study Title:  
 
(1) Chief Investigators  
 
(2) Statistician responsible (Names):  
 
(3) Has ethical approval been sought for this application? 
IF YES, approved or not (please provide details and progress): 
IF NO, reasons why not 
 
(4) Information Governance:  Please provide information on your policies including data storage, 
security, transfer and destruction, along with the monitoring processes: 
 
Has approval from the National Information Governance Board (NIGB) been obtained?  Please give 
details : (See above) 
 
(5) If you have requested access to patient identifiable data please give your rationale: 
 
(6) Does this study involve linking to patient identifiable data from other sources? If yes, please give 
details: 
 
(7) Does this study involve requesting any additional information from health professionals or 
patients? If yes, please give details: 
 
(8)  Please provide details of the financial sponsor for this work: 
 
(9)  Please provide details of any conflict of interest: 
 
(10) List a minimum of 5 Key Words: 
 245 
 
 
(11)Have you applied previously? If yes, please give details: 
 
(12)Please provide details of funding with regards to meeting the cost of this application: 
 
(13) Research Protocol (Maximum 2 sides of A4 in total): 
 Lay Summary of the study (maximum 100 words): 
 Background, timeframe and rational of the research: 
 Objectives and expected outcome of the research: 
 Study type (hypothesis testing, generating or both): 
 Study design (Including justifications): 
 Study population (persons, place, time period, exclusion and inclusion criteria for data 
required): 
 Data required: 
 Data fields required: 
 Selection of comparison group(s) or controls – if applicable: 
 Sample Size /power calculation: 
 Exposures, outcomes and covariates (please describe the strategies and data sources for 
determining the main exposures, key health outcomes and all other variables relevant to the 
study objectives): 
 Data/statistical analysis (outline the methodology to be used for data management and the 
statistical approaches to be used in data analysis): 
 Project timeline: 
 Patient/user group involvement: 
 Limitations of study design, data sources and analytical methods: 
 
(14) Plans for disseminating and communicating study results: 
 
(15) Contribution to overall knowledge base /healthcare of patients: 
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NJR Research Request Specification 
 
A. Joint      B. Procedure Type 
Hip      Primary     
Knee      Revision    
Ankle      Linked Primary – Revision  
Shoulder    
Elbow    
 
    
C. Patient Demographics   D. Provider 
Gender      Strategic Health Authority  
Age at procedure    Provider Type    
Body Mass Index    Trust/Company ID   
ASA Grade     Unit ID     
Consultant ID    
Lead Surgeon ID   
Lead Surgeon Grade   
First Assistant Grade   
Trust Name*    
Hospital Name*   
    
E. Procedure Details 
 Procedure Type      
 Patient Procedure     
 Side       
 Indications for Primary Procedure   
 Reasons for Revision     
 Approach      
Bone graft      
Thromboprophylaxis     
Untoward Intra-operative Events   
 
F. Implant Data 
 Manufacturer*    
 Catalogue Number*   
 Detail*     
 Batch Number*    
 Brand*     
 Implant Type    
 
   
* Restricted Data  
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TERMS & CONDITIONS 
 
1. The recipient agrees to be held responsible for the use of the data supplied by the NJR. 
Under no circumstances will the data be used for any other purpose than that specifically 
described in this application. There will be no release of the data in any kind to a third party 
without the specific written consent of the NJR.  
 
2. The recipient accepts responsibility for data protection on data that is received from the NJR 
and will ensure the information is kept confidential and used for the purpose of this research 
application only.  
 
3. All data received from the NJR is treated as background Intellectual property and remains 
solely owned by the NJR. 
 
4. The recipient will provide a written summary of the work performed on data supplied by the 
NJR at regular 6 monthly intervals following receipt of the data.  Each update should be 
received by the NJR no longer than 30 days after the period end.  On completion of the 
project, a final written report will be sent to the NJR within 3 months of the end date. The 
NJR reserves the right to request an update at any stage throughout the duration of the 
project where it is felt there is grounds and reason to do so.  
 
5. The recipient will provide a copy of any paper/abstract for review and comment by the NJR 
at least one month before submitting for publication.  Any reasonable amendments 
requested by the NJR with regards to its data will be incorporated.  The recipient agrees to 
cite the contribution made by the NJR in all publications arising from research on the data 
and will provide copies of such publications. The NJR reserves the right of veto. 
 
6. In the event that data supplied by the NJR generates ideas, rights, processes or products of 
potential commercial value, the recipient agrees to enter into a separate agreement with 
the NJR, to be negotiated in good faith in consideration of the contribution made by each 
party with regards to Intellectual Property ownership and exploitation rights.  
 
7. The recipient warrants that all ethical approval/clearance required by law to receive, house 
and carry out research on the data provided is in place, adhering to the Data Protection Act 
1998, in accordance with the support requirement under section 251 of the NHS Act 2006 
and section 136 of the Health & Social Care (Community Health & Standards) Act 2003. 
 
8. The NJR reserves the right to terminate at any stage if there is seen to be a material breach 
of this agreement. The NJR will seek both compensatory and punitive damages against any 
unauthorised release of the data.  
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9. The NJR uses data collected, collated and provided by third parties. As a result of this NJR 
takes no responsibility for the accuracy, currency, reliability and correctness of any data 
used or referred to in this report, nor for the accuracy, currency, reliability and correctness 
of links or references to other information sources and disclaims all warranties in relation to 
such data, links and references to the maximum extent permitted by legislation.  
 
The NJR shall have no liability (including but not limited to liability by reason of negligence) 
for any loss, damage, cost or expense incurred or arising by reason of any person using or 
relying on the data within this report and whether caused by reason of any error, omission 
or misrepresentation in the report or otherwise. This report is not to be taken as advice. 
Third parties using or relying on the data in this report do so at their own risk and will be 
responsible for making their own assessment and should verify all relevant representations, 
statements and information with their own professional advisers. 
 
The data provided by the NJR is sourced externally. All provisions of clinical data sets are 
made in good faith by the NJR based on the data collected at source. The NJR retain no 
responsibility for the quality of the data provided at source. 
 
10. This agreement is subject to English law. 
 
SIGNATORIES for the Recipient 
 
a. Statistician responsible: 
I have read the Terms & Conditions and agree to abide by them. To the best of my 
knowledge, all the information given on this form and my application form is accurate. 
 
Sign      Date 
Name (printed) 
 
b. Chief Investigator: 
I have read the Terms & Conditions and agree to abide by them. To the best of my 
knowledge, all the information given on this form and my application form is accurate. 
 
Sign      Date 
Name (printed) 
 
c. Institutional Signatory: 
I have read the Terms & Conditions and agree to abide by them. To the best of my 
knowledge, all the information given on this form and my application form is accurate. 
 
Sign      Date 
Name (printed) 
Position 
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9.2: Appendix ii: NJR K1 and K2 FORMS 
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9.3: Appendix iii: PROMs Questionnaires 
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9.4: Appendix iv: Ethics correspondence 
 
Ethics correspondence between Paul Baker (NJR Fellow), Bill Hackett (Committee 
coordinator, Northern and Yorkshire research ethics committee) and Paddy Stevenson 
(Chairman, Sunderland research ethics committee). 
 
From: Paul Baker  
Sent: 08 September 2010 11:52 
To: Bill Hackett  
Subject: Chairman’s advice 
Dear Bill,  
 
I am a SpR working on a number of projects allied to the National Joint Registry for England and 
Wales with Prof Deehan. We are confident that the proposed projects fall under the category of 
service evaluations and as such do not require formal ethical/NRES input. Prof Deehan, however, has 
suggested I contact Paddy Stevenson as a local ethics chair just to run the proposal by him to ensure 
that this is the case and we don't run into any trouble further down the line. Would it be acceptable 
to seek the Chairman’s advice on the two projects I intend to undertake? If so how is the best way to 
contact him and what is the process for this kind of request?  
Many Thanks  
Paul Baker  
SpR Orthopaedics  
Northern Deanery 
 
From: Bill Hackett  
Sent: 08 September 2010 11:58 
To: Paul Baker  
Cc: Paddy Stevenson 
Subject: RE: Chairman’s advice  
Hello Paul,  
Yes that’s all fine.  Just email Paddy at Newcastle and I’m sure he’ll respond ASAP. 
Paddy.stevenson@newcastle.ac.uk. 
Best wishes,     
Bill  
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From: Paddy Stevenson  
To: Bill Hackett; Paul Baker  
Sent: 08 September 2010 12:16 
Subject: RE: Chairman’s advice 
Hi Paul, I would be happy to review them. 
Paddy 
 
From: Paul Baker  
To: Paddy Stevenson  
Sent: 14 September 2010 12:13 
Subject: RE: Chairman’s advice 
Dear Dr Stevenson, 
  
Many thanks for having a look at the attached proposals (Analysis of revision knee 
arthroplasty in England and Wales & PROMs following primary total knee replacement and 
unicondylar knee replacement). I think they are fairly self explanatory as they were 
completed on the NJR research request proforma which highlights most of the areas you 
will be interested in.  
  
If you need any further information please let me know. If after reading the proposals you 
want to discuss them, then I can be contacted on my mobile: XXXXXXXXXXXX. 
  
Thanks again. 
  
Paul Baker 
 
From: Paddy Stevenson  
To: Paul Baker 
Date: Tue, 14 Sep 2010 14:28:02  
Subject: FW: Chairman’s advice 
Dear Paul 
I’m happy that the first proposal ‘Analysis of revision knee arthroplasty in England and 
Wales’ does not require ethical approval / consent. With the second project ‘PROMs 
following primary total knee replacement and unicondylar knee replacement’ could you 
confirm no consent is being sought and all data will be collected and anonymised. 
Thanks. 
Paddy 
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From: Paul Baker  
To: Paddy Stevenson  
Sent: 15 September 2010 20:19 
Subject: RE: Chairman’s advice 
Dear Paddy, 
  
The second PROMs study will be conducted using anonymised data from the NJR which they 
are collecting routinely now. They obviously have their own information governance 
approvals etc. I have spoken to the NJR data handlers who inform me all the data can be 
coded/anonymised at source before it is transferred to me for analysis. I won't be seeking 
consent as I have no indication who the patients are or where or when they underwent 
surgery.  
  
Hope this clarifies matters. 
  
Paul 
 
From: Paddy Stevenson  
To: Paul Baker  
Date: Fri, 17 Sep 2010 13:28:25  
Subject: RE: Chairman’s advice 
Makes sense. 
I agree that they don’t require formal ethical review. 
Paddy 
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